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1
General introduction
1.1 Introduction
Nosocomial infections form a major public health problem in the Western world and accurate
knowledge of the causal impact of these infections on mortality is important, not only to be
able to assess the severeness of these infections but also to understand the importance of early
treatment and to be able to estimate the high costs which they put to the community as a result
of an extended length of stay and extra cost by hospitalization. Despite decades of research in
the medical literature, assessment of the attributable mortality due to nosocomial infections in
the intensive care unit (ICU) remains controversial, with several studies describing effect es-
timates ranging from being neutral to extremely risk increasing (Carlet, 2001; Melsen et al.,
2009; Muscedere, 2009). This large variability has been primarily explained by differences in
the patient population under study (case-mix), the definition and diagnosis of several nosoco-
mial infections as well as the use of various definitions of attributable mortality contributes to
that variation (Timsit et al., 2011). In this thesis we focus on methodological shortcomings at the
level of the data analysis. A major step forward in the analysis of ICU-data with the application
to nosocomial infections has been made by Wolkewitz et al. (2008, 2009), Nguile-Makao et al.
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(2010) and Beyersmann et al. (2008) in which they introduced nosocomial infections as a time
dependent covariate to reduce time dependent bias (Van Walraven et al., 2004). But, as investi-
gators have to rely on observational data alone, careful adjustment for confounding by severity
of illness is required to disentangle the complex relationship between infection and mortality.
This is because infection is essentially a complication of underlying critical illness so that pa-
tients who acquire infection tend to be more severely ill than patients who do not.
In order to accommodate the challenges related to the estimation of the attributable mortality
of nosocomial infections in the ICU, a new method from the field of causal inference was devel-
oped in chapter 2 and applied in the ICU-literature to find an answer to the question if patients
die from or with infection in chapter 3. In this process, close collaboration with physicians
who were convinced of the need for more sophisticated statistical methods, was very important.
Instead of further improving the previous methodology we additionally explored two other top-
ics within the field of causal inference. This change of focus was motivated by the fact that
the weighted estimator for the causal effect of infection, involves a model selection process in
which it is unclear how to decide which covariates to select. This model selection process can be
important, considering that weighted estimators can be highly inefficient due to highly variable
weights. Therefore, in chapter 4 we moved our focus to model selection and model misspecifi-
cation in causal inference where we describe a model selection procedure in terms of the quality
of the effect estimate of interest. In chapter 5 we developed insights on to whether inverse
probability weighting can be avoided altogether, using the simpler problem of simultaneous es-
timating the natural direct and indirect effects as a case study.
This thesis is a combination of stand alone papers with additional extensions and further insights
obtained during my four years of research. Chapter 2 was published in Lifetime data analysis
(Bekaert et al., 2010b). The developed methodology is applied in chapter 3 and published in The
American Journal of Respiratory and Critical Care Medicine (Bekaert et al., 2011), the world’s
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leading intensive care unit journal. Chapter 4 appeared in Statistical Methods in Medical Re-
search (Vansteelandt et al., 2010a) where my contribution was mainly on the model selection
part of the paper. Finally the work on the estimation of natural direct and indirect effects re-
sulted in two additional papers which are currently under revision. The general idea which was
independently developed by Theis Lange is submitted as a proof of concept paper. In a follow
up paper we propose additional estimators for the natural direct and indirect effect which can be
simply implemented in standard software.
In the remainder of this chapter we give a general introduction to some of the primary topics
related tho my thesis. The aim is to give a concise explanation and to provide enough informa-
tion to enable the reader to understand the other chapters.
1.2 Causal inference
In this section I give a brief summary of some basic ideas from causal inference. A more
detailed description of these ideas can be found in some very interesting papers which I strongly
recommend to those who whish to learn more about the topic. A nice paper on the definition
of causal effects is written by Herna´n (2004). The problem of time varying confounding and
the use of marginal structural models MSMs is wel described in Robins et al. (2000) with an
application in Herna´n et al. (2000). For an introduction to causal DAGs see Greenland et al.
(1999a)
1.2.1 Defining causal effects
Let us think about a patient who has been admitted to the ICU, acquires an infection and dies
within the ICU. For simplicity we will ignore the timing of the events but discuss this topic in
more detail in chapter 2. Imagine that we can somehow know, that the patient would still be
alive had he not acquired infection. In that case, infection caused the patient’s death and infec-
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tion had a causal effect on the patients’survival. This example illustrates how we reason about
causal effects: in terms of a comparison of two outcomes for the same patient where an action is
taken and withheld, every thing else being the same. When the two outcomes differ, we say that
the action has a causal effect on the outcome. Throughout this thesis I will refer to the action as
the exposure or treatment.
Consider now a dichotomous exposure variable A (1: infected, 0: not infected) and a dichoto-
mous outcome variable Y (1: death, 0: survival). Now, we use Y (a) to denote the outcome
variable that would have been observed under the infection state a. For our example patient,
infection A has a causal effect on the outcome Y because Y (1) 6= Y (0). In the causal inference
literature, the variables Y (1) and Y (0) are referred to as potential or counterfactual outcomes
because they represent situations that can be potentially observed, but may not actually have
occured (counter to the fact).
To link these counterfactual outcomes to the observed data we will assume that for the infected
(A = 1) patient in the example the counterfactual outcome Y (1) = 1 is equal to his observed
outcome Y = 1. This brings us to the first key assumption in causal inference, which we will
make throughout: the consistency assumptions (VanderWeele, 2009) which formally states that
if Ai = a, then Yi(a) = Yi(A) = Yi or a subject with observed treatment A equal to a, has
observed outcome Y equal to his counterfactual outcome Y (a). In other words, it assumes there
exists an intervention whereby infection is acquired (prevented) for all patients and that this in-
tervention is non-invasive, in the sense that for patients who would naturally acquire (prevent)
infection, the same event time and status would be observed under that intervention as was nat-
urally observed.
Because, for every patient admitted to the ICU we thus only observe one outcome, individ-
ual causal effects cannot be identified and we therefore focus on the average causal effect in
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a population of individuals. Take e.g. a random subset of 100 patients admitted to the ICU of
the Ghent University Hospital in 2011 as our population of interest. Imagine that we know both
counterfactual outcomes for all of the patients. So for each patient we have Y (1) which is the
outcome that would have been observed if he were infected and Y (0) if he remained infection
free. Infection has an average causal effect on mortality if E[Y (1)] 6= E[Y (0)] in our popu-
lation of ICU patients. In the real world, we only observe one counterfactual outcome because
a patient is either infected or not. For every patient the observed outcome is equal to Y and
the observed infection status is A. We say that infection A is associated with mortality Y if
E[Y |A = 1] 6= E[Y |A = 0] or if there is a difference in mortality in the infected A = 1 and the
infection free A = 0 patients which form two disjoint subsets of the population. In contrast to
the causal effect of infection which is defined as a difference in mortality in the entire population
under two different hypothetical infection states a (1 = infected or 0 = not infected).
Let us put aside the practical and ethical concerns and think about a study (experiment) in which
we randomly (by flipping a coin) divide a group of patients in the ICU into two groups (group
1 and 2). Imagine that its possible to infect all patients of group 1 and prevent infection for
all patients in group 2. Afterwards we look at the mortality differences between both groups.
Because group membership is randomized it is irrelevant for the value of E[Y |A = a] which
particular group was infected. We say that the patients in both groups are exchangeable because
the mortality in group 1 would have been the same as the mortality in group 2 had the patients
in group 2 been infected instead of those in group 1. More formally this means that Y (a)
∐
A
for both a = 1 and a = 0, which denotes that Y (a) is independent from A. In that case the
association E[Y |A = 1] − E[Y |A = 0] equals the causal effect E[Y (1)] − E[Y (0)]. So in
perfectly randomized experiments, association is equal to causation.
In practice it is not possible to conduct such experiment and we need to rely on observational
data. The question now is how such observational data can be used for causal inference. We
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know that acquiring infection in the ICU will not be a random process but depends on the pa-
tient’s underlying severity of illness L. In order to infer the causal effect of infection on mor-
tality we need to assume that Y (a)
∐
A|L which is usually referred to as the no unmeasured
confounders assumption as it effectively states that variables reflecting the patient’s underlying
severity of illness L are the only confounders of the association between infection and mortality.
If this assumption holds then the conditional association between infection A and mortality Y ,
given L, will reflect the causal effect of infection within levels of L. Because of the consistency
assumption E[Y |A = 1, L] − E[Y |A = 0, L] equals E[Y (1)|A = 1, L] − E[Y (0)|A = 0, L].
Further by the no unmeasured confounders assumption this equals E[Y (1)|L] − E[Y (0)|L] or
E[Y (1)− Y (0)|L] which reflects the causal effect of infection within levels of L. This implies
that inferring causal effects from the observational data will require some covariate adjustment
by L. In standard regression analysis this is done by including the covariates L in the model.
More sophisticated methods use weights to adjust for confounding.
1.2.2 Direct and indirect causal effects
An important problem within both epidemiology and many social sciences is to decompose the
effect of given treatment or exposure into different causal pathways and quantify the importance
of each of these pathways. In view of this, it is very important to distinguish between common
causes of the exposure and the outcome (confounders), and so called mediators, which are vari-
ables that are possibly affected by the exposure and lie on the causal path (in the direction of the
arrows) from the exposure to the outcome. In this section we introduce the concept of direct and
indirect causal effect using a counterfactual approach
Let for each subject Y (a,m) be the outcome that we would, possibly contrary to the fact, have
observed for that subject had the exposureA been set to the value a and, the mediatorM was set
to m. Similarly, the counterfactual variable M(a) denotes the value of the mediator if, possibly
contrary to the fact, the exposure A was set to a. Let C be a set of baseline confounders for the
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exposure-outcome, exposure-mediator and the mediator-outcome relationship. In general, there
are two types of direct and indirect effects. The controlled direct effect can be seen as a result
from a non-invasive intervention changing the exposureA (from a to a∗) and fixing the mediator
M atm and is formally defined asE[Y (a,m)−Y (a∗,m)] which is the comparison of the coun-
terfactual responses Y (a,m) corresponding to different levels a, but the same level m, for all
individuals. Note that the magnitude of the controlled direct effect may differ across each possi-
ble value of M . Under the assumption of no unmeasured confouders for the exposure-outcome
and exposure-mediator relationship and consistency assumption this effect
E[Y (a,m)− Y (a∗,m)] = E[Y (a,m)|A = a,M = m]− E[Y (a∗,m)|A = a∗,M = m]
= E[Y |A = a,M = m]− E[Y |A = a∗,M = m]
can be estimated from observed data.
The second type of effect is called the natural direct effect. It encodes the effect ofA on Y when
the mediator M takes on the value it would naturally have under a value a for A. Following
the tradition in the causal inference literature (Hafeman and Schwartz, 2009), we will describe
natural direct and indirect effects in terms of so-called nested counterfactuals, Y (a,M(a∗)), de-
noting the outcome that would have been observed ifAwere set to a andM to the value it would
have taken if A were set to a∗. In particular, we will compare Y (a,M(a∗)) with Y (a∗,M(a∗))
to obtain a measure of the natural direct effect of changing the exposure from a to a∗. Such
comparison can for instance be made in terms of an average difference within levels of covari-
ates, E[Y (a,M(a∗)) − Y (a∗,M(a∗))|C], or marginally, E[Y (a,M(a∗)) − Y (a∗,M(a∗))];
as a risk ratio, P [Y (a,M(a∗)) = 1]/P [Y (a∗,M(a∗)) = 1], etc. Likewise we will compare
Y (a∗,M(a)) with Y (a∗,M(a∗)) to obtain a measure of the natural indirect effect.
The expression for the controlled direct effect assumes (1) that Y (a,m)
∐
A|C or that there are
no-unmeasured confounders for the A− Y relationship and (2) that Y (a,m)∐M |A,C or that
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one knows all confounders of the association between M and Y . The set C must thus contain
all of the confounders of both the A − Y relationship and the M − Y relationship. In addition
to the previous assumptions, the expressions for natural direct and indirect effects require that
M(a)
∐
A|C or that one has measured all confounders of the association between A and M .
Additionally there should not exist variables L that are effects of exposure and that confound the
M − Y relationship so that Y (a,m)∐M(a∗)|C. In chapter 5 we show how, under previous
assumption, natural direct and indirect effects can be estimated from observational data.
1.2.3 Causal DAG’s
In the previous section we used counterfactual theory to formalize causal effects together with
the identifying conditions necessary to estimate those effects. In this section we will introduce
a graphical representation of the data generating mechanism behind the observational data. As
in the previous section, let A, Y and L represent infection, mortality and disease severity, re-
spectively. Then the data generating mechanism can be represented by a causal directed acyclic
graph (DAG) as in Figure 1.1 which consists of 4 nodes representing the random variables
(A, Y, L and U ) and five edges (arrows). The diagram is directed because the edges imply a
direction in which A may cause Y but not the other way around. Further, it is called acyclic be-
cause there are no cycles because a variable cannot cause itself (even through another variable).
In general a causal DAG is a DAG in which the arrows can be interpreted as direct causal effects,
and all common causes of any pair of variable are included in the graph.
In the DAG represented in Figure 1.1, the arrow between L and A expresses that the proba-
bility of acquiring an infection may depend on the patient’s underlying disease severity which is
possibly affected by unmeasured variables U . The direction of the effect (harmful or protective)
can not be distinguished from the DAG.
Thinking about the data generating mechanism is an important first step in the analysis of ob-
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A Y
L U
A Y
M U
Figure 1.1: Causal DAG to illustrate the phenomena of confounding
servational data. A DAG is therefore used together with d-seperation: a graphical rule to verify
statistical independencies. In our example, mortality status Y would be statistically independent
of infection A if f [Y |A = 1] = f [Y |A = 1] = f [Y ]. If we look at different paths (arrow-based
route between two variables, disregarding the direction of the arrows) in the DAG a path can be
either open or blocked. In the DAG represented in Figure 1.1 the path A → Y ← L is blocked
because two arrowheads on the path collide in Y . Y is therefore referred as a collider. On the
other hand, the paths L → A → Y , A ← L → Y and A ← L ← U → Y are open paths
because no two arrowheads on the path collide. An open path can be blocked after conditioning
on a non-collider. Conditioning on a collider will have the effect of opening the blocked path.
Note that the path A ← L ← U → Y cannot be closed by conditioning on U because U is an
unmeasured confounder.
DAG’s are very useful tools in this step because they can reveal possible sources of bias. One
well known sort of bias is confounding in which the association measure differs from the causal
effects measure. A detailed explanation about confounding will be given in chapter 4. In gen-
eral, confounding exists when the exposure and the outcome share a common cause. In our
example the underlying disease severity L is a confounder for the relationship between infection
A and mortality Y . More formally this means that Y (a)
∐
A will not hold. When we don’t
adjust the analysis for L, the association measure will be a mix of the causal effect along the
path A ← Y and the spurious association induced by the open path A ← L → Y because
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here, L is a non-collider. In order to obtain an unbiased estimate of the causal effect of infection
on mortality we will need to condition or adjust the analysis for the patient’s severity of illness
because Y (a)
∐
A|L. Conditioning on L will block the path A ← L → Y and we will obtain
a direct infection effect along the path A→ Y by comparing infected and non-infected patients
with the same underlying severity of illness L.
In the DAG in Figure 1.2, M is called a mediator because it lies on the causal path from A
to Y .
A Y
L U
A Y
M U
Figure 1.2: Causal DAG to illustrate the phenomena of mediation
An unadjusted analysis of the data generated under the DAG in Figure 1.2 estimates the total
causal effect which is a combination of the direct causal effect along the path A → Y and the
indirect causal effect along the path A→M → Y . Using d-separation it is clear that condition-
ing on M will not result in the estimation of the direct causal effect because M is a collider on
the path A→M ← U → Y and induces a spurious association.
Until now we didn’t think about exposures which can vary over time. In the next section we
will introduce the problem of time varying confounding and show why standard statistical meth-
ods will fail in the estimation of the causal effect of such exposures.
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1.2.4 Time varying confounding
A patient admitted to the ICU can acquire infection on each day during his stay and the time
of infection is evidently not known upon admission. For each patient, we therefore observe At
which indicates 1 for infection at or prior to time t and 0 otherwise. Here t denotes days since
ICU admission. Let At = (A0, A1, . . . , At) be the infection history through day t. L0 is a col-
lection of baseline confounders and Lt time-dependent severity of illness indicators. Similarly,
Lt = (L0, L1, . . . , Lt) denotes the severity of illness history through day t. On each day t we
assume that all confounders for the relation between infection and mortality are measured by
Lt and At−1. Actually, as in any observational study, it is not possible to check (test) from the
observed data on Lt, At and Y whether there is confounding by unmeasured risk factors Ut. We
only can hope that confounding by Ut is very weak.
At Y
Lt
At-1
Ut
Figure 1.3: Causal DAG to illustrate the principle of time varying confounding
The key problem of time dependent confounding is illustrated in the simplified DAG given
in Figure 1.3. Because a patient’s health status Lt is affected by prior infection At−1, several
of these covariates are intermediate on the causal path from early infection to mortality, and
therefore should not be adjusted for. This is not only because standard regression would remove
indirect infection effects mediated through severity of illness, but also because it would induce
a so-called collider-stratification bias (Greenland, 2003). On the other hand Lt is a confounder
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for the relation between late infection At and mortality and therefore should be adjusted for. A
solution to this problem is given by the use of marginal structural models MSMs (Herna´n et al.,
2000).
1.2.5 Marginal structural models (MSMs)
Marginal structural models (MSMs) are models for the marginal distribution of a certain couter-
factual outcome and were developed by Robins et al. (2000). They enable proper adjustment
for time-dependent confounding. Let Y (a) be the mortality status Y that would have been ob-
served at the end of follow-up had all subjects followed the hypothetical infection path a. Such
potential infection path a = (a1, a2, ..., aE) equals a vector of elements at, for t going from day
1 (i.e. admission) in the ICU to a fixed end-of-follow-up time E, representing a hypothetical
regime in which all ICU patients would be uninfected in the ICU during all days t with at = 0
and infected in the ICU on all remaining days t′ with at′ = 1.
As in Robins et al. (2000), the logistic MSM for Y (a) might take the form
logitP [Y (a) = 1] = β0 + β1cum(a) (1.1)
with cum(a) ≡∑t−1t=1 at denoting the number of days a patient would have been infected prior to
time t under infection path a. The parameter eβ1 expresses the effect of an extra day of infection
on the odds of death, had all patients had the same infection history a. If the exposure-outcome
relationship is not confounded the parameters of model (1.1) can be unbiasedly estimated by a
logistic regression model of the observed data
logitP [Y = 1|A = a] = β′0 + β′1cum(a) (1.2)
If the exposure-outcome relationship is indeed confounded by Lt and At−1 , then β′1 6= β1
and the standard logistic regression estimate of the causal effect will be biased. If all confounders
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for the exposure-outcome relationship are measured by Lt and At−1, then the causal parameter
β1 can be estimated using inverse probability weighting (IPW) to correct for confounding. Using
the observational data, we estimate the exposure effect from an outcome regression model but
weigh each observation by the inverse of the probability of the observed exposure level given
the time dependent confounders.
A detailed theoretical description of this approach can be found in chapter 2, a more heuris-
tic explanation of how marginal structural models are fitted is given in chapter 3 of this chapter.
1.3 Competing risk analysis
In this section we will provide an introduction to competing risk analysis. A very good reference
on this topic is Chapter 8 in Kalbfleisch and Prentice (2002); a simpler introduction is the book
by Pintilie (2006). There is also a nice tutorial by Putter et al. (2007). The main goal of this
section is to explain the two approaches to competing risk analysis (cause specific hazard vs.
sub-distribution hazard) and give some arguments why we prefer one approach over the other
when the interest is in estimating the attributable mortality of nosocomial infections. A more
technical explanation how a causal analysis of competing events is done is given in chapter 2.
1.3.1 Competing events in the ICU
Not for every patient admitted to the ICU we observe the time of death at the end of follow up
because the survival times are censored by ICU-discharge. The Cox model assumes that cen-
soring is non-informative or that at each time, among patients who are alive and still in the ICU
at that time, the probability of discharge is independent of the actual survival time. A major
problem with the use of survival methods to analyze ICU mortality lies in the fact that patients
who get discharged from the ICU on a given day since admission are not comparable with those
who stay in the ICU on that day. They are discharged from the ICU because they need no more
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intensive care due to improved health conditions and therefore have a lower mortality risk than
the average. In that case, censoring carries information about, or depends on the survival time.
In the analysis of ICU-data we will therefore consider ICU death as the event of interest and
discharge from the ICU as the competing event because it prevents the event of interest from
occurring (once a patient is discharged form the ICU cannot die in the ICU), rather than just
preventing us from seeing it happen (censoring).
1.3.2 Quantifying the attributable mortality
A variety of measures (risk differences, odds ratios, relative risks, hazard ratios,...) to quantify
the attributable mortality of infections are used in the ICU-literature (Melsen et al., 2009). Some
of those measures e.g. hazard ratios, are difficult to assign a causal interpretation because they
have a sort of built in selection bias: the risk sets (the number of subjects at risk of experiencing
the event of interest) may not stay comparable over time (Herna´n, 2010). This is even so in the
context of randomized experiments where the 2 treatment arms, while comparable at the onset of
the study, may not stay comparable over time when mortality is differential between both arms.
For each patient, we observe the time T from ICU admission to death or ICU discharge, whichever
comes first and the event type , which indicates 1 for the event of interest (ICU death) and
2 for the competing event (ICU discharge). In chapter 2, we infer the impact of acquir-
ing infection in the ICU on the Cumulative Incidence Function (CIF) of ICU-death ( = 1),
which is the probability of dying within the ICU before a given time, as a function of time or
F1(t) = P (T ≤ t,  = 1). The CIF was then used to estimate the attributable mortality of
infection as the population attributable fraction (PAF) of ICU-mortality related to infection.
Generally, the PAF is defined (Rothman and Greenland, 1998) (page 295) as the fraction of all
cases (exposed and unexposed) that would not have occurred if exposure had not occurred. On
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each day, we calculated the PAF as the difference between the observed ICU-mortality (F1(t))
and the ICU-mortality that would have been observed (counterfactual) for the same population
if infection were prevented for all (F01(t)), divided by the observed ICU-mortality (see chapter
2 for more details).
F1(t)− F01(t)
F1(t)
, (1.3)
Under monotonicity, it can be interpreted as the percentage of the observed ICU-deaths that
could be avoided by preventing infection, or, as the percentage of the observed ICU-deaths who
died because of infection (Tian and Pearl, 2000), which provides a direct answer to tho the
question how many patients died with or from infection. The monotonicity assumption is in
epidemiology, often expressed as no prevention, in which no individual in the population can be
helped by exposure to the risk factor.
We are not the first ones to use the concept of the population attributable fraction to estimate
the attributable mortality of nosocomial infections. Schumacher et al. (2007) used the following
definition:
PAF (t) =
F1(t)− F1(t|At = 0)
F1(t)
where F1(t) equals the observed mortality before time t and F1(t|At = 0) the mortality before
time t within the subgroup of patients who were not infected before time t. These measures
were calculated using a multi state model approach (cause specific hazard analysis). Unlike our
proposed measure (1.3) this definition involves comparing different subsets of the patients who
are still in the risk set at each time, and thus cannot be assigned a causal interpretation.
1.3.3 Cause specific vs. subdistribution hazard
We can consider competing risk data as arising from a multistate model (Andersen et al., 2002;
Beyersmann et al., 2006; Schumacher et al., 2007) shown in Figure 1.4.
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Figure 1. Competing risks model with transition hazards 0i , i = 1, 2.
failure time T , T = inf{t>0 | Xt =0}, and the cause of failure is simply the state XT the process
enters at time T , XT ∈ {1, 2}. Consequently, = 1(T6C) · XT , where 1(·) is the indicator
function.
It is important to note that the stochastic behaviour of the competing risks process is completely
determined through the transition intensities 0i , i = 1, 2 [4, Chapter II.6],
0i (t) := lim
t↘0
P(T ∈ [t, t + t), XT = i | T>t)
t
, i = 1, 2 (1)
Note that the 0i (t)’s are the usual ‘cause specific hazards’. This is in contrast to the author’s
definition (Section 3 of [1]).
One should recognize that 0i (t), i = 1, 2, completely determines the all cause survival function
P(T >t)= exp(− ∫ t0 01(u)+02(u) du) and the cumulative incidence functions P(T6t, XT = i)=∫ t
0 P(T>u−) 0i (u) du, i = 1, 2, where the latter depends on both 01 and 02 through P(T>u−).
When analysing 01(t), say, observed competing events (i.e. transitions into state 2) and censoring
with = 0 may be treated alike when constructing the risk sets. Therefore, one may technically
treat competing events 2 as censorings for software coding. As a consequence, the author’s ‘cause
specific hazards’ analysis in Sections 4 and 5, where a status indicator equals 1 for observed
transitions into state 1 and is 0 otherwise, is a valid analysis for 01(t), acknowledging the
presence of the competing risk state 2.
For a comprehensive understanding of the patterns of failure in the observed data, the analysis
of 01(t) would need to be supplemented by analysis of 02(t). The latter analysis would this time
technically treat competing events 1 as censorings for software coding. It is worthwhile to note
that in order to make inference on the cumulative incidence functions, we would not only need to
estimate the regression parameters for proportional hazards models for 01(t) and 02(t), but also
the baseline hazards [4, VII.2.3].
Contrary to the common terminology described above, the author defines the ‘cause specific
hazard’ as the marginal hazard of a latent failure time. The author considers the failure time T
to be the minimum of two latent failure times Tev and Tcr, such that T = Tev, if the event 1 of
interest occurs (i.e. XT = 1), and T = Tcr, if the other competing event 2 occurs (i.e. XT = 2).
The author calls the hazard hev of the marginal distribution Tev ‘cause specific hazard’; it dif-
fers in general from the transition hazards (1), which are usually called ‘cause specific hazards’
[6, Chapter 7.2.5].
The latent failure time model has been subject to heated discussions (see, e.g. [12, Chapter 3.3]
for a laid-back discussion), because neither the joint distribution of Tev and Tcr nor their marginal
distributions and hazard functions are identifiable non-parametrically from the observable data
Copyright q 2007 John Wiley & Sons, Ltd. Statist. Med. 2007; 26:3676–3680
Figure 1.4: Competing risk model as a multistate model
The state which an individual is in at a given point in time is denoted by Xt ∈ {0, 1, 2}. A
patient is admitted to the ICU and stays in state 0. When a patient dies he/she moves to state
1 (event of interest), after discharge a patient moves to state 2 (competing event). Individuals
are moving out of the initial state 0 at their failure time T (time to death or ICU discharge) and
their cause of failure is then equal to the state XT where they moved to. The whole process
is determined through the transition intensities α0k with k = 1 or 2 which are the usual cause
specific hazards. For an event of type k we can define the cause-specific hazard function as the
hazard of failing from cause k in the presence of the competing events
αk(t) = lim
dt→0
1
dt
P (t ≤ T ≤ t+ dt,  = k|T ≥ t)
For this type of hazard it is possible to define a proportional hazards which is of the form
αk(t;X(t)) = αk0(t) exp(bkX(t))
where αk0(t) is a non specified baseline hazard function and bk is the unknown regression pa-
rameter. For the estimation of the cause specific hazard function of ICU-death, the standard
Cox proportional hazards model can b employed. The time to ICU-death is then treated as the
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observed survival time and the time to ICU-discharge is treated as additional censoring times.
ICU-discharge and censoring is treated in an identical manner because both just imply a reduc-
tion of the number of subjects at risk.
As mentioned in the previous section, our primary interest lies in the estimation of the at-
tributable mortality of infection as a function of the CIF. There is no one-to-one relationship
between the cause specific hazards and the CIF. In order to use the cause specific hazards ap-
proach to make inference on the CIF it is necessary to estimate the regression parameters for
the proportional hazards models for α01(t), α02(t) together with the baseline hazards. A more
direct approach is to model the subdistribution hazard which is defined as
λk(t) = lim
dt→0
1
dt
P (t ≤ T ≤ t+ dt,  = k|T ≥ t or (T < t and  6= k))
Fine and Gray (1999) proposed proportional hazards models of the form
λk(t;X(t)) = λk0(t) exp(βkX(t))
to model the subdistribution hazard λk(t;X(t)), where λk0(t) is a non specified baseline hazard
function and βk is the regression parameter. By definition, the subdistribution hazard is directly
related to the CIF of failure from cause k, by λk(t) = −dlog{1 − Fk(t)}/dt. This one-to-one
relationship was our main motivation to develop a method to adjust for time varying confound-
ing in the subdistribution hazard analysis of competing risks because, due to the difficult causal
interpretation of hazard ratios, we defined the attributable mortality of infection on the basis of
the CIF.
In general, the main difference between the two approaches lies in the definition of the risk
set. Like in the Cox model for the cause specific hazard, the regression model for the subdistri-
bution hazard includes individuals who have not failed from any cause by time t (risk set at time
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t defined by j : t ≤ T ), but additionally those who have previously failed from the competing
cause before t. The subdistribution hazard represents the probability of observing the event of
interest in the next time interval while knowing that either the event of interest did not happen
until then or that the competing risks event was observed. Subjects for whom the competing
event is observed stay in the risk set at all times.
2
Adjusting for time-varying confounding in the
subdistribution analysis of competing risks
This chapter is adapted from Bekaert et al. (2010b) and published in a special issue of Lifetime
data analysis on survival analysis, longitudinal analysis and causal inference. The original coau-
thors were my promotor, Stijn Vansteelandt and Karl Mertens who provided the data for analysis.
Summary
The assessment of the attributable mortality due to nosocomial infections in the intensive care
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unit (ICU) remains controversial, with several studies describing effect estimates ranging from
being neutral to extremely risk increasing. Interpretation of study results is further hindered by
inappropriate adjustment (a) for censoring of the survival time by discharge from the ICU, and
(b) for time-dependent confounders on the causal path from infection to mortality. Previously
(Vansteelandt et al., 2009), this was accommodated through inverse probability of treatment
and censoring weighting. Because censoring due to discharge from the ICU is so intimately
connected with a patient’s health condition, the ensuing inverse weighting analyses suffer from
influential weights and rely heavily on the assumption that one has measured all common risk
factors of ICU discharge and mortality. In this paper, we consider ICU discharge as a competing
risk in the sense that we aim to infer the risk of ‘ICU mortality’ over time that would be observed
if nosocomial infections could be prevented for the entire study population. For this purpose we
develop marginal structural subdistribution hazard models with accompanying estimation meth-
ods. In contrast to subdistribution hazard models with time-varying covariates, the proposed
approach (a) can accommodate high-dimensional confounders, (b) avoids regression adjustment
for post-infection measurements and thereby so-called collider-stratification bias, and (c) results
in a well-defined model for the cumulative incidence function. The methods are used to quan-
tify the causal effect of nosocomial pneumonia on ICU mortality using data from the National
Surveillance Study of Nosocomial Infections in ICU’s (Belgium).
2.1 Introduction
Nosocomial (i.e., hospital-acquired) infections are highly prevalent in intensive care unit (ICU)
patients because of their poor health conditions and, additionally, because of the prevalent use of
invasive treatments (e.g., mechanical ventilation) that make it more difficult for the human body
to conquer hostile bacteria. They form a major public health problem in the Western world. For
instance, in Belgium (which has a population size of about 10.5 million people), it is roughly
estimated that nosocomial infections contribute to the mortality of 2600 patients per year, to
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700 000 extra hospital days and to a total annual cost of 400 million EUR (Vrijens et al., 2009).
There is a longstanding interest in precise knowledge of the effect of these infections on mortal-
ity (Safdar et al., 2005; Davis, 2006; Heyland et al., 1999). This stems from the desire to better
understand their severity as well as the importance of a timely treatment. This is additionally
motivated by the need to justify the high costs that these infections impose on the society as a
result of prolonged hospital stay and extra hospitalisation costs.
The question whether nosocomial infections are severely harmful, remains a subtle one for sev-
eral reasons. First, infection must be viewed in combination with antibiotic treatment, which has
beneficial effects if applied appropriately (Kollef, 2003) but may have harmful effects otherwise
(e.g., due to antibiotic resistance). Second, patients who acquire these infections and subse-
quently die, may have been so severely ill that they would have died even without the infection.
In view of this, it will be crucial to have the ability to adjust for the evolution in disease severity
over time.
Despite the wide literature on the effect on mortality of acquiring a nosocomial infection in the
ICU, assessment of this effect remains controversial, with several studies describing effect esti-
mates ranging from being neutral to extremely risk increasing (Heyland et al., 1999; Fagon et al.,
1993; Papazian et al., 1996; Timsit et al., 1996a; Girou et al., 1998; Bercault and Boulain, 2001).
Interpretation of study results is further hindered by time dependent bias (i.e., bias due to ignor-
ing the time-dependent nature of the data (Beyersmann et al., 2008; Van Walraven et al., 2004))
and inappropriate adjustment for time-dependent confounding and for informative censoring due
to discharge from the ICU (Vansteelandt et al., 2009). Informative censoring (Kalbfleisch and
Prentice, 2002) results from the decision to discharge a patient from the ICU being closely re-
lated to his/her health status. Patients who get discharged from the ICU on a given day since
admission are therefore not comparable with those who stay in the ICU on that day. If a rich
collection of common risk factors of mortality and ICU discharge were measured, one could in
2-4 CHAPTER 2
principle accommodate this using inverse probability of censoring weighted estimators (Vanstee-
landt et al., 2009; Robins and Rotnitzky, 1992; Keiding et al., 1999). However, the resulting
analyses rely heavily on the assumption that all such risk factors have been measured and suffer
from influential weights because censoring tends to be strongly associated with mortality in this
setting (Vansteelandt et al., 2009). In this paper, we will therefore shift the focus and estimate
the impact of acquiring infection in the ICU on the Cumulative Incidence Function (CIF) of ICU
death (Prentice et al., 1978; Fine and Gray, 1999; Pepe and Mori, 1993). This is the probability
of dying within the ICU before a given time, as a function of time. Focussing on this estimand
not only rules out the censoring problem (since ICU death by a given time is observable for all
patients so that censoring becomes purely administrative due to end of follow-up); ICU mortality
is also of primary interest to ICU physicians, is frequently used in this domain (see e.g. Resche-
Rigon et al. (2006a); Valls et al. (2007); Wolkewitz et al. (2009)) and would be representative
of overall mortality if the hazard of death were relatively small after ICU discharge. A similar
focus is taken by e.g. Wolkewitz et al. (2009, 2008) and Beyersmann et al. (2006) who consider
discharge from the ICU and ICU mortality as competing risks to assess the impact of infection
on ICU mortality and length of stay in the ICU.
Given our focus on the CIF of ICU death, a natural approach would be to consider the infection
status as a time-dependent covariate in a model for the subdistribution hazard (i.e. the hazard
function corresponding to the CIF) (Wolkewitz et al., 2008; Beyersmann and Schumacher, 2008;
Barnett and Graves, 2008). This approach acknowledges that patients need to survive and stay
within the ICU long enough before acquiring infections (Beyersmann et al., 2008; Van Walraven
et al., 2004). However, because patients who do and do not acquire infection at a given time are
not comparable in terms of severity of illness, observed mortality differences between these
groups cannot be fully attributed to an infection effect. Including measures of disease severity
as additional time-varying covariates in the model for the subdistribution hazard does not accom-
modate this. First, it inevitably raises difficulties as to how to define these covariates, which were
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only measured during the ICU stay, after discharge (i.e., when the competing event has occurred)
(Beyersmann and Schumacher, 2008; Latouche et al., 2005). Second, because a patient’s health
status is affected by prior infection, several of these covariates are intermediate on the causal path
from early infection to mortality, and therefore should not be adjusted for via standard regres-
sion methods (Herna´n et al., 2000). This is not only because standard regression would remove
indirect infection effects mediated through severity of illness, but also because it would induce a
so-called collider-stratification bias (Greenland, 2003). Third, subdistribution hazards adjusted
for time-dependent covariates do not result in a model for the CIF anymore (Beyersmann and
Schumacher, 2008), just like standard survival Cox models with time-dependent covariates yield
no model for the survival function (Andersen et al., 1993). This complicates the interpretation
of the infection effect by the fact that a hazard ratio, unlike a comparison of the CIFs, does not
lend itself to a simple causal interpretation. This is so because, even if infected and uninfected
patients were exchangeable (Herna´n and Robins, 2006) upon ICU admission, the risk sets of
surviving infected and uninfected patients may not stay exchangeable over time (Herna´n et al.,
2004).
In view of these limitations, we will develop marginal structural models (Robins et al., 2000) for
the counterfactual subdistribution hazard with accompanying estimation methods. Using these
models, we will be able to infer the risk of ICU death over time that would be observed if noso-
comial infections could be prevented for the entire study population. The proposed framework
for causal effect estimation (a) can accommodate high-dimensional confounders, (b) avoids re-
gression adjustment for post-infection measurements, and (c) results in a model for the CIF. The
methodology is developed for complete data, but may extended to right-censored data using ad-
ditional inverse probability of censoring weights (Robins and Rotnitzky, 1992; Fine and Gray,
1999).
This chapter is organized as follows. In Section 2.2 we start by introducing the main concepts
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and develop inference under a model which imposes no parametric restrictions on the counter-
factual cumulative incidence function. This is then extended in Section 2.4 to semi-parametric
discrete-time marginal structural models for the subdistribution hazard. The methods are used
in Sections 2.3.3 and 2.4.2 to quantify the effect of nosocomial pneumonia on ICU mortality
using data from the National Surveillance Study of Nosocomial Infections in ICU’s (Belgium).
We end in Section 2.5 with a discussion on the assumptions and the relative advantages and
limitations of the proposed methodology.
2.2 Notation, definitions and assumptions
2.2.1 Observed data
For each patient, we observe the time T from ICU admission to death or ICU discharge, whichever
comes first and the event type , which indicates 1 for the event of interest (ICU death) and 2 for
the competing event (ICU discharge). In addition, for each patient, we observe a discrete-time
counting process {At, 0 ≤ t ≤ T} until death or ICU discharge, whichever comes first, where t
denotes days since ICU admission. Here, At indicates 1 for ICU acquired infection at or prior to
time t and 0 otherwise. Finally, for each patient, we observe a collection of baseline confounders
L0 and time-dependent confounders Lt on each day t, which will be listed in Section 2.3.3. Our
interest focuses on the Cumulative Incidence Function (CIF) of ICU death: P (T ≤ t,  = 1).
2.2.2 Counterfactual subdistribution hazard and cumulative incidence function
Unlike a competing risk analysis with time-dependent infection status (Wolkewitz et al., 2008;
Beyersmann and Schumacher, 2008), we will evaluate the CIF for the entire population under
different hypothetical or potential infection paths to guarantee that we compare the same patient
population each time. This requires that we define for each patient a counterfactual event time
Ta (Rubin, 1978; Robins, 1986), which represents the time until ICU death or ICU discharge,
whichever comes first, which an ICU patient would - possibly contrary to fact - have had under
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the given hypothetical infection path a. Such potential infection path a = (a1, a2, ..., aE) equals
a vector of elements at, for t going from day 1 (i.e. admission) in the ICU to a fixed end-
of-follow-up time E, representing a hypothetical regime in which all ICU patients would be
uninfected in the ICU during all days t with at = 0 and infected in the ICU on all remaining
days t′ with at′ = 1. Correspondingly, we define {a(t), t ≥ 0} to be a discrete-time stochastic
process expressing the counterfactual event status under infection path a on each day t. This
indicates 1 (or 2) on day t if the patient would have died in (been discharged from) the ICU under
that potential infection path, and 0 if no event would have occurred by that day. In addition, we
define a ≡ a(Ta). For an event of type k (k = 1, 2), we thus conceptualize the corresponding
counterfactual subdistribution event time
θak ≡ inf{t ∈ [0,∞[: a(t) = k}.
For k = 1 (k = 2), this is equal to Ta = inf{t ∈ [0,∞[: a(t) 6= 0} for patients who
die within (get discharged from) the ICU under the given infection path a and ∞ for patients
who get discharged from (die within) the ICU under that infection path. We further define the
counterfactual CIF corresponding to event type k as
Fak(t) ≡ P (Ta ≤ t, a = k) = P (θak ≤ t) ,
for all t ≥ 0. This is the probability that, under infection path a, an event of type k occurs at or
before time t.
Our focus in this article will be on inferring the CIF under monotone infection paths in which
at ≥ as for t > s. This will enable us to infer the effect of acquiring infection on a given
day, disregarding the possible impact of the duration of infection. For instance, we can define
the causal effect of acquiring infection on day t since admission in the ICU on the cumula-
tive incidence of ICU death as a comparison of 2 counterfactual CIFs under different monotone
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infection paths (a1, ..., at−1, at, ..., aE) = (0, ..., 0, 1, ..., 1) and (a1, ..., aE) = (0, ..., 0), indi-
cating regimes where all patients acquire infection on day t since admission versus never in
the ICU, respectively. By considering monotone infection paths only, we will be able to ignore
information on the duration of infection, which is often imprecisely measured, and will thus
average over patients with different duration of infection. Alternatively, the causal effect of in-
fection can be reported in terms of the population attributable fraction of ICU mortality related
to infection, which we define at each time t as
Fˆ1(t)− Fˆ01(t)
Fˆ1(t)
, (2.1)
where Fˆ1(t) is the estimated observed CIF of ICU mortality at time t and Fˆ01(t) is the estimated
counterfactual CIF of ICU mortality at time t under the no infection path. This expresses what
percentage of the observed ICU deaths by time t could be avoided by preventing infection. A
related comparison of observed and counterfactual infection-free responses was considered in
(Schulgen and Schumacher, 1996) to estimate the prolongation of stay attributable to nosocomial
infections. We believe that (2.1) links more closely to the originally concept of attributable risk
than other proposed measures (Schumacher et al., 2007), in particular because at each time it
compares the same population twice. In the appendix we give the derivation of the variance and
95% confindence interval of (2.1) .
2.2.3 Assumptions
To be able to identify the counterfactual CIF under all infection paths, the following 2 assump-
tions must be made (see Section 2.5 for a further discussion of the assumptions). First, we will
make the so-called consistency assumption which links the counterfactual data to the observed
data by assuming that Ta and a equal the observed event time T and status  for patients whose
observed infection data are compatible with (i.e. would have been observed under) the given
infection path a at that time (see also Section 2.3.1). To appreciate this assumption, note that
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our definition of ‘infection path’ assumes the existence of an intervention whereby infection is
prevented for all patients during a given period of time and acquired at a given later time t (pro-
vided they are still in the ICU). The consistency assumption then states that this intervention is
non-invasive in the sense that it has no effect other than causing infection at and not before time
t (VanderWeele and Vansteelandt, 2009). In particular, it assumes that for patients who would
naturally acquire (prevent) infection on day t, the same event time and status would be observed
under that intervention as was naturally observed. In this sense, the population attributable frac-
tion (2.1) reflects a ‘pure’ infection effect that would be realized if patients would somehow
‘naturally’ avoid infections. Second, we will make the no unmeasured confounders assumption
that, for each time t, among uninfected patients who have been in the ICU with the same co-
variate history Lt−1 ≡ (L0, ..., Lt−1) up to time t− 1, those who acquire infection at time t are
exchangeable with those who do not in the sense that a(t)
∐
At|At−1, a(t− 1) = 0, Lt−1 for
all t and all infections paths a; here, for any vector (Wt), W t refers to the history (W1, ...,Wt)
and W t refers to the future (Wt, ...,WE). Here we assume that, as was the case in our data
analysis (see Section 2.3.3), the infection status was measured on day t for all patients who did
not die or get discharged before day t.
2.3 Estimation under a nonparametric model for the counterfac-
tual cumulative incidence function
2.3.1 Compatible infection paths
To infer the counterfactual CIF under a given infection path a, we must select those patients
whose observed data are compatible with it: i.e. those for whom we would have observed
the same event time and status had such infection path been implemented. As an illustration,
we will show how this can be done for the infection path a(0) = (0, 0, 0, ..., 0) under which
patients stay infection-free and for the infection path a(5) = (0, 0, 0, 0, 1, ..., 1) under which
patients aquire infection 5 days after admission. Consider the following 4 hypothetical patients
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in Figure 2.1. Patient 1 stays in the ICU without infection for at least 10 days, patients 2 and 3
acquire infection in the ICU on day 5 and 4 respectively, and finally patient 3 gets discharged
from the ICU without infection on day 3. The days on which a patient is compatible with the
hypothetical infection paths a(0) and a(5) are indicated with a larger font size in Figures 2.1 A
and B, respectively, as we now explain.
No infection Figure 2.1 (A) illustrates that patients who have not acquired infection and are
still in the ICU by time t are compatible with a(0) at time t. For instance, at t = 3, all patients
in Figure 2.1 (A) are compatible with a(0); at t = 4, patients 1 and 2, unlike patient 3, are
compatible with a(0). In addition, patients who get discharged or die without infection before
time t (e.g. patient 4) are compatible with a(0) at time t because their same observed data would
have been obtained under a regime in which infection is prevented for all patients.
Acquiring infection on day 5 Figure 2.1 (B) illustrates that on all days t < 5, this infection
path coincides with the no infection path and thus the same patients are compatible with both
a(5) and a(0) on those days. For instance, patient 1 in Figure 2.1 (B) is compatible with a(5)
on all days t < 5; patient 3 is compatible with a(5) until the day before acquiring infection and
obviously, patients who acquire infection on day 5 (i.e. patient 2) are compatible with a(5) on
all days t. In addition, patients who get discharged or die without infection before day 5 (i.e.
patient 4), are compatible with a(5) on day t because they would also have been discharged/have
died prior to day 5 under a regime in which infection is acquired on day 5 (and not before) by
all patients who are still in the ICU on that day.
Note from the previous examples that a patient’s observed data can be compatible with (and
thus carry information about) multiple infection paths. For instance, a patient who is discharged
without infection 20 days after admission is compatible with all infection paths in which infec-
tion is acquired after day 20. When the end-of-follow-up time E is 30 days, this patient thus has
10 compatible infection paths (see Figure 2.2). In general, a patient who gets discharged without
infection at a given time t is compatible with all infection paths a(t+ s) for s > 0.
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ƚ ϭ Ϯ ϯ ϰ ϱ ϲ ϳ ϴ ϵ ϭϬ ͙
Ăƚ;ϬͿ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ ͙
WĂƚŝĞŶƚϭ ƚ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ Ϭ ͙
WĂƚŝĞŶƚϮ ƚ Ϭ Ϭ Ϭ Ϭ 1 1 1 1 1 1 ͙
WĂƚŝĞŶƚϯ ƚ Ϭ Ϭ Ϭ 1 1 1 1 1 1 1 ͙
WĂƚŝĞŶƚϰ ƚ Ϭ Ϭ Ϭ
ƚ ϭ Ϯ ϯ ϰ ϱ ϲ ϳ ϴ ϵ ϭϬ ͙
Ăƚ;ϱͿ Ϭ Ϭ Ϭ Ϭ ϭ ϭ ϭ ϭ ϭ ϭ ͙
WĂƚŝĞŶƚϭ ƚ Ϭ Ϭ Ϭ Ϭ 0 0 0 0 0 0 ͙

WĂƚŝĞŶƚϮ ƚ Ϭ Ϭ Ϭ Ϭ ϭ ϭ ϭ ϭ ϭ ϭ ͙
WĂƚŝĞŶƚϯ ƚ Ϭ Ϭ Ϭ 1 1 1 1 1 1 1 ͙
WĂƚŝĞŶƚϰ ƚ Ϭ Ϭ Ϭ

Figure 2.1: Selection of patients compatible with infection paths a(0) (A) and a(5) (B).
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Figure 2.2: Compatible infection paths for a patient who gets discharged without infection 20
days after admission (endpoint is 30 day ICU mortality).
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2.3.2 Estimation under a given infection path
In this section, we discuss the estimation of the counterfactual CIF for a given infection path
a. Define dakt to be the number of events of type k that occur at time t for the nat patients
who are compatible with infection path a at that time. If there were no confounding, then the
counterfactual cumulative incidence at time t for event type k under infection path a could be
estimated as the percentage of observed events of type k at or before time t amongst patients
who are compatible with a at that time:
∑t
s=1 daks
nat
=
∑n
i=1 I (i(t) = k)
∏t
s=1 {I(Ais = as)I (i(s) = 0) + I (i(s) 6= 0)}∑n
i=1
∏t
s=1 {I(Ais = as)I (i(s) = 0) + I (i(s) 6= 0)}
. (2.2)
In general, this is a biased estimator of the counterfactual CIF at time t because it uses only data
from people whose observed infection status was compatible with the chosen infection path at
that time, and these may not form a random subset of the target population. We will therefore
refer to it as the naı¨ve estimator of the counterfactual CIF. To adjust for this bias, we will use
inverse probability of treatment weighting (IPTW) and estimate the counterfactual cumulative
incidence at time t for event type k under infection path a as:
Fˆak(t) =
∑n
i=1 I (i(t) = k)Wiat∑n
i=1Wiat
, (2.3)
where
Wiat ≡
t∏
s=1
I(Ais = as)I (i(s) = 0) + I (i(s) 6= 0)
P (Ais = as|i(s), Ai,s−1, Li,s−1)
. (2.4)
Here, P (Ais = as|i(s), Ai,s−1, Li,s−1) denotes the probability of having infection status as
at time s conditional on the observed covariates ((s), As−1, Ls−1). Because patients who are
discharged or have died before time s stay compatible with infection path a when they were
compatible with this path at the time of discharge/death, no further selection is made within that
subgroup and thus we define P (Ais = as|i(s), Ai,s−1, Li,s−1) to equal 1 when (s) 6= 0. When
(s) = 0, this probability can be estimated using a pooled logistic regression model.
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In the Appendix, we show that (2.3) is a consistent estimator of the counterfactual cumula-
tive incidence at time t under infection path a when, in addition to the assumptions of Section
2.2.2, P (At = at|(t) = 0, At−1, Lt−1) is correctly specified at each time t. In the Appendix,
we further show that for given t, a conservative, asymptotic (1 − α)100% confidence interval
for Fak(t) can be obtained as
expit
logit{Fˆak(t)}± zα/2
√
1
n
V̂ar(Uitak)
Fˆak(t){1− Fˆak(t)}
 , (2.5)
where zα/2 is the (1 − α/2)100% percentile of the standard normal distribution, Uitak is the
weighted residual
Uitak ≡Wiat
{
I (i(t) = k)− Fˆak(t)
}
(2.6)
and V̂ar(Uitak) refers to the sample variance of Uitak.
2.3.3 Data analysis
We use the proposed techniques for the analysis of the National ICU Surveillance Study in Bel-
gium (Vansteelandt et al., 2009; Suetens et al., 1999, 2003). A step by step explanation together
with detailed R-code is provided in the appendix. All ICU’s in Belgian hospitals were invited
to participate in this surveillance study on a voluntary basis. For all patients admitted to the
ICU, data were recorded on personal characteristics, reasons for ICU admission, baseline health
status, and daily indicators of received invasive treatments and acquired infections in the ICU.
Nosocomial pneumonia (NP) was defined as pneumonia acquired by patients after the second
day of ICU stay, to exclude infections that were in incubation upon enrollment in the ICU. The
third day of stay in ICU will therefore be the starting point for our analysis, thus excluding pa-
tients who stayed less than 3 days. We restrict the analysis to surveillance data collected for the
years 2002 and 2003 in three of the largest hospitals, which have accurate daily measurements
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of received invasive treatments and acquired infections. A total of 4288 ICU patients were anal-
ysed. Of the 360 (8.4%) patients who acquired NP in the ICU and stayed more than 2 days,
75 (20.8%) died in the ICU, as compared to 360 (9.2%) deaths among the 3928 patients who
remained NP-free in the ICU; of these 360 (infected) patients, 245 or 68.2% (328 or 91.3%)
acquired infection during the first week (first two weeks) after admission. Among patients who
stayed more than 2 days in the ICU, the median length of stay in the ICU was 4 days (IQR 3,
95th percentile 14) for those without an infection history and 18 days (IQR 19, 95th percentile
30) for the remaining patients.
To estimate the CIF of ICU death under the no infection path a(0), we select those patients
for whom we would have observed the same event time and status had such infection path been
implemented (see Figure 2.1 (A) for an illustration). The number of patients na(0)t whose ob-
served data are compatible with a(0) at each time t, along with the number da(0) of those who
died at or before time t are given in the second and third column of Table 2.1. Similar numbers
are reported in columns 4 and 5 for the infection path a(5). Note that na(0)t diminishes each
time with the number of patients who acquire infection at that time. Patients who get discharged
without infection by a given time t stay compatible with this path until the end-of-study time E,
which was chosen to equal 30 days in our analyses. Note also that, by construction, identical
results are obtained for the infection paths a(0) and a(5) up to day 5. From day 5 onwards, the
number of patients whose data are compatible with a(5) stays constant until the end-of-study
time as it equals the number of patients who acquire infection on day 5 together with those who
died or were discharged without infection prior to day 5.
The naı¨ve estimator (2.2) corresponding to a(0) is obtained as the ratio of da(0) over na(0).
The resulting estimates are displayed in Figure 2.3 (A) and suggest roughly a 1% absolute re-
duction in ICU mortality at 30 days if infection were avoided for all patients. These estimates
are biased because they ignore confounding. We therefore calculate the IPTW-estimator (2.3).
This requires estimating the probability of acquiring infection at each time t. We have built a
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Naı¨ve IPTW
t na(0) da(0) na(5) da(5) na(0) da(0) na(5) da(5)
3 4228 86 4228 86 4290 87 4290 88
4 4167 144 4167 144 4283 148 4283 148
5 4118 176 2482 144 4290 182 4135 148
6 4075 208 2482 144 4289 221 4135 148
7 4043 226 2482 144 4278 243 4135 148
8 4024 242 2482 145 4277 264 4135 328
9 4008 257 2482 146 4280 283 4135 356
10 3996 272 2482 146 4285 303 4135 356
11 3983 286 2482 147 4279 322 4135 417
12 3976 296 2482 148 4282 336 4135 424
13 3967 307 2482 149 4280 351 4135 439
14 3960 311 2482 150 4276 358 4135 461
15 3952 319 2482 150 4273 372 4135 461
...
...
...
...
...
...
...
...
...
30 3928 360 2482 152 4284 443 4135 543
Table 2.1: Number of patients who died at or before time t and the number of patients com-
patible with a(0) and a(5), before and after weighting; na and da refer to the denominator and
numerator, respectively, of the naı¨ve estimator (2.2) and the IPTW-estimator (2.3).
pooled logistic regression model for this purpose, following the strategy explained in (Vanstee-
landt et al., 2009). The probability of acquiring infection was associated with the presence of
infection (other than NP) upon ICU admission and the following invasive treatments, received
the day before infection (i.e., at time t−1): mechanical ventilation, parenteral feeding and feed-
ing through naso- or oro- intestinal tube, tracheotomy, oral intubation, the presence/absence of
tracheotomy intubation, surgery and a central vascular catheter; and antibiotic treatment received
two days before infection (i.e., at time t− 2). We did not adjust for antibiotic treatment the day
before infection to exclude the possibility that this was already an effect of a latent infection.
Aditionally there was an association with gender and study center, evidence for effect modifica-
tion of the SAPS II score by type of admission, multiple trauma and surgery, and evidence for
effect modification of the effect of antibiotic treatment and parenteral feeding by study center.
Finally, we used regression splines for the time effect. Using the predicted values from the final
model, we calculated the probability of each patient being compatible with the chosen infection
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path up to time t, given baseline variables and time-dependent variables Lt−1. The calculation
of the resulting weights Wiat is illustrated in Table 2.2 for three effectively observed patients
who were discharged from the ICU at 5, 9 and 3 days after admission, respectively. In particu-
lar, the weight Wiat is obtained by taking the reciprocal of the product of the probabilities pi2is
over all time points s = 3, ..., t (the remaining columns of Table 2.2 will be explained in Section
2.4.2). Note the sharp increase in the weights when patients become infected. It follows that
an analysis of most infection paths, such as a(5), may be much influenced by extreme weights
so that less reliable inferences are typically obtained under these infection paths. For instance,
the weights of patients who are compatible with a(5) had a median and mean of 1.01 and 1.59,
an interquartile range and standard deviation of 0.03 and 9.47 and 1% and 99% percentiles of
1 and 9.93 (min. 1, max. 387.4). In contrast, inference for the infection-free path a(0) tends
not to suffer much from influential weights because most observed patient-days correspond to
no infection. For instance, the weights of patients who are compatible with a(0) had a median
and mean of 1.02 and 1.08, an interquartile range and standard deviation of 0.05 and 0.22 and
1% and 99% percentiles of 1 and 1.93 (min. 1, max. 9.64). This is useful because the most rel-
evant intervention is one where infection would be prevented for all patients and thus our most
substantive interest lies in a(0).
Using the calculated weights, we can now predict the number of patients who would have
died within the ICU by a given time had infection been prevented for all. This is given by the
numerator of (2.3) and is displayed in the 7th column of Table 2.1. The corresponding overall
number of patients (i.e. the denominator of (2.3)) is shown in column 6. It approximates the
overall sample size (i.e., 4288) because the idea behind inverse weighting is to infer how the
data would have looked like had all patients received the same intervention (e.g. been unin-
fected). The last 2 columns of Table 2.1 show similar results for the infection path a(5). The
IPTW-estimators (2.3) corresponding to a(0) and a(5) are again obtained as da(0)/na(0) and
da(5)/na(5), respectively, and displayed in Figure 2.3(B) along with the observed CIF. Not sur-
prisingly, the CIF corresponding to the infection-free path is now higher than before because it
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i t Ait pi1it pi2it pi3it Wiat htatk(Li0) htatk(Li0)Wiat
1 3 0 0.98 0.99 0 1.01 0.98 0.99
1 4 1 0.02 0.01 0.36 100 0.03 3
1 5 1 1 1 0.29 100 0.03 3
2 3 0 0.98 0.99 0 1.01 0.98 0.99
2 4 0 0.98 0.99 0.36 1.02 0.97 0.99
2 5 1 0.02 0.02 0.29 50 0.05 2.5
2 6 1 1 1 0.23 50 0.05 2.5
2 7 1 1 1 0.18 50 0.05 2.5
2 8 1 1 1 0.15 50 0.05 2.5
2 9 1 1 1 0.12 50 0.05 2.5
3 3 0 0.98 0.99 0 1.01 0.98 1
Table 2.2: Estimated weights for 3 patients who are discharged on days 5, 9 and 3, respectively,
corresponding to different infection histories; pi1it = P (Ait = ait|i(t) = 0, Ai,t−1 = 0, Li0),
pi2it = P (Ait = ait|i(t), Ai,t−1 = 0, Li,t−1), pi3it = P (i(t) > 0|i(t− 1) = 0, Ai,t−1, Li0).
acknowledges that patients who avoid infection during their ICU stay are relatively more healthy.
The IPTW-estimate of the CIF under infection path a(5) (Figure 2.3(B)) is now more realistic
than the naı¨ve one, although very imprecise (see Figure 2.4(B)). The fact that the IPTW-estimate
of the CIF under a(0) suggests slightly higher ICU death rates than in the observed population,
might be counterintuitive, although there is little that can be said about this comparison given
the imprecision of these estimates. The more efficient inferences developed in the next section
will shed further light on this.
2.4 Estimation under a semiparametric discrete-time marginal struc-
tural subdistribution hazard model
2.4.1 Model and estimation
The previous IPTW estimator is useful to infer the CIF of death that would be realized if all pa-
tients were uniformly exposed to the same infection path, but does not allow for direct compari-
son of CIFs corresponding to different chosen infection paths. It thus yields no effect estimates.
Furthermore, in finite samples, the IPTW estimator is not guaranteed to yield a non-decreasing
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Figure 2.3: Naı¨ve estimate (A) and IPTW-estimate (B) of the counterfactual CIF for ICU death
under infection paths a(0) and a(5), together with the observed CIF.
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Figure 2.4: IPTW-estimate (with 95% pointwise confidence intervals) and naı¨ve estimate of the
counterfactual CIF for ICU death under infection paths a(0) (A) and a(5) (B).
TIME-VARYING CONFOUNDING IN THE PRESENCE OF COMPETING RISKS 2-19
counterfactual CIF with time and can be very inefficient (see e.g. Figure 2.4(B)).
In view of this, we will develop models and accompanying inference for the counterfactual
subdistribution hazard corresponding to event type k, which we define conditional on baseline
covariates L0 as:
λak(t|L0) = P (Ta = t, a = k|Ta ≥ t ∪ (Ta < t ∩ a 6= k), L0}.
For k = 1, this represents the risk for a patient to die within the ICU on day t under infection
path a, given that he/she did not die in the ICU before that day. Note that the risk set at each
time t is composed of those who did not experience the event of interest (i.e., who did not die)
by time t, thus including those who experienced a competing event (i.e., who got discharged) by
time t. We can now define a discrete-time marginal structural subdistribution hazard model for
event type k to be a model for the counterfactual discrete-time hazard, possibly conditional on
baseline covariates L0.
For example, with δt ≡
∑t−1
s=1 as denoting the number of days a patient would have been in-
fected prior to time t under infection path a, one might postulate that
logit {λak(t|L0)} = ω(t) + β1at + β2δt + β3L0, (2.7)
where ω(t) represents an unknown function of time which will later be modelled using regres-
sion splines and where β1, β2 and β3 are unknown finite-dimensional parameters. When k = 1
and, as usual, the counterfactual hazard of death is relatively small at any given time, then
exp (β1at + β2δt) approximates the causal subdistribution rate ratio of ICU death at time t due
to infection path a (as compared to the no infection path).
If, for each patient in the sample, we had the ability to measure a for each potential infection
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path a, then we could fit model (2.7) by solving the following estimating equation
0 =
n∑
i=1
E∑
t=1
∑
at
Uitatk (htatk;β) , (2.8)
where β = (β1 β2 β3)′ and
Uitatk (htatk;β) ≡ I(ia(t− 1) 6= k)htatk(Li0)Γ
× [I(a(t) = k)− expit {ω(t) + β1at + β2δt + β3Li0}] .
Here, htatk(Li0) is an arbitrary scalar function of (t, at, Li0), e.g. the constant 1, and Γ is the
vector of predictors in the discrete-time marginal structural subdistribution hazard model, e.g.
(1 t at δt Li0)′ if ω(t) is chosen to be a linear function of time (i.e., ω(t) = β0+β4t with β0 and
β4 unknown). The above estimating equation is not feasible because {a(t), t = 1, ..., E} is not
measured for each patient under each potential infection path. Thinking along the lines explained
in Section 2.3, we will therefore select for each considered infection path, those patients whose
observed data are compatible with that path and use inverse probability weighting to account for
the selective nature of those subgroups. This is realized by solving the following equations,
0 =
n∑
i=1
E∑
t=1
∑
at
Uitatk (htatk;β)Wiat (2.9)
which only involve observed data.
The choice of htatk(Li0) can be very important in the analysis as it links directly to the efficiency
of the estimator βˆ for β obtained by solving this equation. In the Appendix, we show that for
a single infection path a, a locally efficient estimator within the above class is obtained by
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choosing
htatk(L0) =
[
t∑
d=1
P ((d) 6= 0|(d− 1), (d− 1) 6= 1, Ad−1 = ad−1, L0)
×
∏d−1
s=1 P ((s) = 0|(s− 1) = 0, As−1 = as−1, L0)∏d−1
s=1 P (As = as|(s) = 0, As−1 = as−1, L0)
]−1
where, for each t, we define
P ((d) 6= 0|(d− 1), (d− 1) 6= 1, Ad−1 = ad−1, L0) = 1
if d = t+ 1.
Here, the efficiency is local in the sense that it is only attained when infection and discharge/death
are independent of the considered time-varying confounders, conditional on the considered base-
line confounders. The index function htatk(Li0) can be interpreted as the reciprocal of a predic-
tion of the considered subject’s inverse weight Wiat in equation (2.9) on the basis of time, the
considered infection path and baseline confounders. As such, using this index function has the
effect of stabilizing the weights in the sense of making patients who get assigned small prob-
abilities P (At = at|(t) = 0, At−1, Lt−1), less influential in the analysis. In line with others
(Herna´n et al., 2000), we will refer to Wiat as an unstable weight and to htatk(Li0)Wiat as a
stable weight.
In principle, the third summation in (2.8) runs over all possible infection paths that are con-
sidered to be relevant to the investigator. In practice, depending on the chosen discrete-time
marginal structural subdistribution hazard model, the estimating functions Utatk (htatk;β) for
a given subject at a given time t may be identical with probability 1 between a number of in-
fection paths. For instance, suppose that β2 were set to zero in model (2.7). Then all infection
paths with at = 1 (or at = 0) yield the same estimating function value Utatk (htatk;β) at time
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t, regardless of the infection history at−1 or future at+1 ≡ (at+1, . . . , aE). In view of this, we
recommend to sum at each time t only over those infection paths in the estimating equation (2.9)
that yield unique estimating function values (with probability 1) at that time. This is inspired by
the fact that the efficient score for the parameters indexing a conditional mean model counts per-
fectly correlated observations only once (Chamberlain, 1987). The resulting analysis continues
to yield a consistent (and likely more efficient) estimator because it follows from the Appendix
that each term in the summation (2.9) has mean zero when evaluated at the truth.
A conservative estimate for the asymptotic variance of the estimator βˆ which solves equation
(2.9) can be obtained via the sandwich estimator
1
n
E−1
(
∂Ui (β)
∂β
)
V ar {Ui (β)}E−1
(
∂Ui (β)
∂β
)′
,
where we define
Ui (β) =
E∑
t=1
∑
at
Uitatk (htatk;β)Wiat
and where population expectations and variances can be replaced with sample analogs and β
with βˆ. The counterfactual CIF corresponding to infection path a among patients with baseline
covariate L0 = l0 can be estimated under the discrete-time marginal structural subdistribution
hazard model (2.7) as
Fˆak(t) = 1−
∏
s≤t
{1− λak(s|l0)} .
This counterfactual CIF is always well-defined because the marginal structural subdistribution
hazard model (2.7) only involves baseline covariates and no time-varying covariates. Using the
Delta method, a corresponding conservative, asymptotic 100(1 − α)% confidence interval for
given t is obtained as
1− exp
[
log{1− Fˆak(t)} ± zα/2σak(t)
]
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where
σ2ak(t) =
∑
s≤t
λ′ak(s|l0)
1− λak(s|l0)
V ar(βˆ)
∑
s≤t
λ′ak(s|l0)
1− λak(s|l0)
′
and where λ′ak(s|l0) is the first order derivative of λak(s|l0) w.r.t. β.
2.4.2 Data analysis
The stable weights htatk(Li0)Wiat were obtained by estimating htatk(Li0) based on two pooled
logistic regression models for discharge/death and infection in function of time. In our analysis,
the model for discharge/death contained the infection history and regression splines for the time
effect, but (for computational simplicity) no baseline covariates. Table 2.2 illustrates the calcu-
lation of the stable weights for three effectively observed patients. Note indeed that the resulting
weights in the last column of Table 2.2 are more stable than the unstable weights Wiat that were
previously considered. It can be shown that the unstable weights stay constant after discharge
and that the stable weights for a given infection path a remain constant at those times t where
at = 1. In general, the stable weights continue to change with time after discharge because they
involve the probability of getting discharged or infected at each time.
Naı¨ve
Estimate SE OR
β1 −3.27a 0.21 0.038
β2 0.12a 0.022 1.13
Table 2.3: The naı¨ve parameter estimates for model (2.7) including (the most important) baseline
covariates;a significant at the 5% significance level.
Parameter estimates of the infection effect were obtained by solving the weighted estimating
equations (2.9). This required extending the dataset by including all compatible infection paths,
as illustrated in Figure 2.2. We estimate the time-dependent intercept ω(t) in model (2.7) using
natural cubic splines with five knots. The analysis was adjusted for baseline covariates (ICU
center, SAPSII score on admission, infection upon admission, oral intubation on admission and
2-24 CHAPTER 2
IPTW (Wiat) IPTW (htatk(Li0)Wiat)
Estimate SE OR Estimate SE OR
β1 -0.33 0.35 0.72 -0.49 0.28 0.61
β2 0.095a 0.035 1.10 0.095a 0.024 1.10
β2 0.087a 0.032 1.09 0.059a 0.021 1.06
Table 2.4: IPTW-estimates for model (2.7) including (the most important) baseline covariates
using unstable and stable weights; a significant at the 5% significance level.
type of admission), which were also used in the infection models in the calculation of the stable
weights. To check the stability of the weights for a given patient at a given time t we calculated
that patient’s overall weight at that time as the sum of the weights over all compatible infection
paths. The resulting stable weights had a median and mean of 2.37 and 2.74, an interquartile
range and standard deviation of 2.57 and 1.97 and 1% and 99% percentiles of 0.41 and 7.35
(min. 0.16, max. 53.4). In contrast, the unstable weights had a median and mean of 13.08 and
15.71, an interquartile range and standard deviation of 15.91 and 25.19 and 1% and 99% per-
centiles of 1 and 90.36 (min. 1, max. 529.81).
The results for model (2.7) are given in the first two rows of Table 2.3 and 2.4. Note the large dif-
ference between the estimates obtained with and without inverse weighting. This underscores the
importance of confounding adjustment. The IPTW-estimates for β1 suggest a drop in the hazard
of death during the first 4-5 days after acquiring infection (which could possibly be explained
by extra care after infection or delayed decision of treatment interruption), but the evidence for
this is weak. We hence fitted a reduced model by setting β1 = 0 and found a 6.1% (95%CI 1.8
- 10.0) increase in the hazard of ICU death per additional day since acquiring infection (see the
third row of Table 2.3). This reflects the increased risk of death which is partly attributable to
a direct effect of infection on death, and partly to the increase in length of stay after infection,
which implies a greater chance of ‘observing’ death. Figure 2.5 shows the estimated counter-
factual CIFs obtained using the naı¨ve and IPTW-estimates from the final models (but now no
longer conditioning on baseline covariates). They give similar results as obtained in Section 2.3
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using the nonparametric estimators, but a drastic increase in efficiency for the infection paths.
In particular, the stable IPTW-estimator suggests a roughly 3% increase in ICU mortality due
to infection on day 5 as compared to no infection. Figure 2.6 allows for evaluating how much
the CIF of ICU death would change if all infections could be avoided. It suggests a population
attributable fraction of 30-day ICU mortality related to infection of 6.4%, indicating that 6.4%
of the observed ICU deaths at 30 days could have been avoided by preventing infection.
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Figure 2.5: Counterfactual CIF of ICU death for infection paths a(0) and a(5), as based on the
naı¨ve estimator (A), the unstable IPTW-estimator (B) and the stable IPTW-estimator (C).
2.5 Discussion
We have developed a general framework for estimating the causal effect of a time-varying ex-
posure on a survival outcome in the presence of competing risks. The validity of the approach
relies on the following four assumptions. First, it assumes correctly specified models for the
probability of infection at each time in function of the history of measured time-varying con-
founders. Second, it assumes that there are no patients who, on the basis of their time-varying
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Figure 2.6: Counterfactual CIF of ICU death for infection paths a(0), as based on the naı¨ve
estimator, the unstable IPTW-estimator (A) and the stable IPTW-estimator (B) together with the
observed CIF of death.
confounder history, are precluded from avoiding or acquiring infection. While we believe the
second assumption was realistic in our data analysis, in general, there may be patients who have
a small daily risk of infection on the basis of their time-varying confounder history. This can
lead to patients having large weights in the analysis who may thus become influential.
Both previous assumptions are (at least to some degree) testable on the basis of the observed
data. The next two assumptions are inherently untestable, so that their plausibility must be
judged against subject-matter knowledge. First, the proposed approach assumes that at each
time, all time-varying confounders for the association between infection and ICU mortality have
been measured. While this assumption might be approximately justified for our analysis, it is
likely not entirely met because we could only adjust for the applied invasive treatments, which
should be regarded as a surrogates for the actual disease severity. In next chapter, we applied
the proposed methods to the Outcomerea (French multicenter ICU database) database which
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carry very extensive information about the patients’ severity of illness. Second, the approach
additionally assumes that confounders measured at time t− 1, i.e. Lt−1, are a cause, rather than
a consequence of infection at time t. This assumption may not be satisfied when infection is in
incubation several days prior to its detection.
An important advantage of our approach is that it separates the adjustment for time-varying
confounders from the final model for the counterfactual CIF. This implies that this approach can
technically handle high-dimensional confounders without imposing a high computational bur-
den and even when confounders are themselves influenced by the infection. In addition, because
the model involves no time-varying covariates, the corresponding CIF is well defined and can
be displayed for the overall patient population, even with adjustment for high-dimensional con-
founders, without the need to restrict the CIF to patient subgroups. A further advantage is that,
because infection paths are well defined upon ICU admission, our approach does not require im-
puting or stopping the covariate process (including infection status) for patients who experience
the competing event (Beyersmann and Schumacher, 2008; Latouche et al., 2005). A final advan-
tage is that it yields fairly easily interpretable results. For instance, the results can be expressed
in terms of population attributable fractions comparing the observed population with how that
same population would have looked like if infection were prevented for all patients. However,
caution must be exercised because the results state the impact of hospital-acquired infections
on ICU mortality rather than overall mortality. This implies that the magnitude of the infection
effect is partly influenced by e.g. the decision to keep infected patients longer in the ICU (which
implies a greater chance of observing ICU death) or to send terminally ill patients home. Care
must also be exercised in noting that late infections are forced to have a small effect under our
model because most patients will have left the ICU by that time and thus not be affected. This
explains the discrepancy with the results of (Vansteelandt et al., 2009), who estimate the effect
of acquiring infections while still being present in the ICU.
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We did not discuss how to deal with censored event times as this was not an issue in our data
analysis. In the presence of the usual right-censoring, our method can be extended using ad-
ditional inverse probability of censoring weights along the lines of Fine and Gray (Robins and
Rotnitzky, 1992; Fine and Gray, 1999). Finally, we have chosen a development which adopts the
principles underlying marginal structural models (Robins et al., 2000). Alternatively, we could
have considered a development based on structural nested failure time models, as in (Schulgen
and Schumacher, 1996; Keiding et al., 1999). We have chosen not to do so because the survival
time of critically ill patients can be greatly influenced by the decision of doctors and family to
keep patients artificially alive, so that 30-day ICU mortality tends to be a more relevant endpoint
to physicians. In addition, it is so far unclear how to account for censoring due to ICU discharge
in this approach, without running into the aforementioned difficulties caused by inverse proba-
bility of censoring weighting.
In conclusion, we hope that the proposed methods will shed new light on addressing issues of
time-dependent confounding in survival analyses with competing risks and, more specifically,
will help improve our understanding of the role of nosocomial infections in ICU mortality.
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Appendix
Derivation of expression (2.5)
We drop the subject index i for notational simplicity. To derive expression (2.5), note that Fˆak(t)
is such that
∑n
i=1 Uitatk = 0, with Uitatk defined in (2.6). It then follows using standard argu-
ments for M-estimators that, under weak regularity conditions and for given t, the asymptotic
variance of Gˆak(t) ≡ logit
{
Fˆak(t)
}
equals
Var(Gˆak(t)) =
1
n
E−2
(
∂Utatk
∂Gak(t)
)
Var(Utatk),
where
E
(
∂Utatk
∂Gak(t)
)
= Fak(t){1− Fak(t)}.
The result (2.5) is now immediate. It yields a conservative (1 − α)100% confidence interval
by the fact that it does not acknowledge estimation of the unknown population probabilities
appearing in the inverse weights (van der Laan and Robins, 2003).
Unbiasedness of estimating equation (2.9)
For simplicity of notation, we write Utat (β) ≡ Utatk (htatk;β) for a given choice of htatk(Li0).
Using the law of iterated expectations, the population expectation of (2.9), evaluated at β, equals
E
[
E∑
t=1
∑
at
E
(
Utat (β)
t∏
s=1
I(As = as)I ((s) = 0) + I ((s) 6= 0)
P (As = as|(s), As−1, Ls−1)
|At−1, Lt−1, a(t)
)]
= E
[
E∑
t=1
∑
at
Utat (β)
t−1∏
s=1
I(As = as)I ((s) = 0) + I ((s) 6= 0)
P (As = as|(s), As−1, Ls−1)
× E
(
I(At = at)I ((t) = 0) + I ((t) 6= 0)
P (At = at|(t), At−1, Lt−1)
| At−1, Lt−1, a(t)
)]
. (2.10)
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Here, the expectation in the last line can be rewritten as
P (At = at|a(t), At−1, Lt−1)I((t) = 0)
P (At = at|(t), At−1, Lt−1)
+
I((t) 6= 0)
P (At = at|(t), At−1, Lt−1)
. (2.11)
The first term in (2.11) equals I((t) = 0) under the no unmeasured confounders assump-
tion. The second term in (2.11) equals I((t) 6= 0) by the fact that we defined P (At =
at|a(t), At−1, Lt−1) = P (At = at|(t), At−1, Lt−1) to equal 1 for subjects with (t) 6= 0.
Equation (2.10) thus simplifies to
E
[
T∑
t=1
∑
at
Utat (β)
t−1∏
s=1
I(As = as)I ((s) = 0) + I ((s) 6= 0)
P (As = as|(s), As−1, Ls−1)
]
Repeating these arguments another t − 1 times, we obtain E
{∑T
t=1
∑
at
Utat (β)
}
which has
mean zero by the fact that Utat (β) is an unbiased estimating function for each t and at. A
similar proof can be developed, starting from estimating function (2.6) to show that (2.3) is a
consistent estimator of the CIF under infection path a at time t.
Stable weights
For simplicity of notation and without loss of generality, we let k = 1 and drop this index in all
further expressions. To derive stabilized weights, we focus on 1 infection path a and calculate
the efficient index function htat(L0) in the estimating function
T∑
t=1
htat(L0)VtatWtat , (2.12)
where we define, for notational convenience,
Vtat ≡
{
I(a(t) = 1)− expit(β′X)
}
I(a(t− 1) 6= 1)
Wtat ≡
t∏
s=1
I(As = as)I ((s) = 0) + I ((s) 6= 0)
P (As = as|(s), As−1, Ls−1)
,
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whereX is, for instance, equal to (1 t at δt L0)′. It follows from standard semiparametric theory
(Chamberlain, 1987) that the efficient index function (in the sense of leading to an estimator
of β with minimal variance among all estimators obtained by solving an estimating equation
based on estimating functions of the form (2.12) with P (As = as|(s), As−1, Ls−1) known for
s = 1, . . . E) is given by
htat(L0) = E
(
∂
∂β
VtatWtat |L0
)
Var−1 (VtatWtat |L0) . (2.13)
Define ta ≡ (I(a(1) 6= 1), ..., (a(t) 6= 1)). Using similar arguments as in the previous
appendix, one can show that E
(
∂
∂βVtatWtat |L0
)
equals Xexpit(β′X){1− expit(β′X)}
×P (a(t − 1) 6= 1|L0). Using the law of iterated variances, the variance in (2.13) can be
calculated as
E {Var (VtatWtat |ta, L0) |L0}+ Var {E (VtatWtat |ta, L0) |L0} . (2.14)
The second term in (2.14) equals
expit(β′X){1− expit(β′X)}P (a(t− 1) 6= 1|L0)E (Wtat |ta, L0)2 .
The first term in (2.14) equals
E
{
V 2tatVar (Wtat |ta, L0) |L0
}
= E
[
V 2tat
{
E
(
W 2tat |ta, L0
)− E (Wtat |ta, L0)2} |L0] .
We first calculate E
(
W 2tat |At−1, Lt−1, ta
)
as
E
[
W 2t−1,at−1
I(At = at)I ((t) = 0) + I ((t) 6= 0)
P (At = at|(t), At−1, Lt−1)2
|At−1, Lt−1, ta
]
= E
{
W 2t−1,at−1
[
I ((t) = 0)
P (At = at|(t) = 0, At−1 = at−1, L0)
+ I ((t) 6= 0)
]
|At−1, Lt−1, ta
}
,
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where we use the no unmeasured confounders assumption along with the simplifying assumption
that At ⊥⊥ Lt−1|(t) = 0, At−1, L0 (note that violation of this assumption may affect the
efficiency, but not the asymptotic unbiasedness of the estimator because each choice of htat(L0)
yields a consistent estimator). Starting from here, we next calculate E
(
W 2tat |At−1, Lt−2, ta
)
as
E
(
W 2t−1,at−1
[
I ((t) = 0)
P (At = at|(t) = 0, At−1 = at−1, L0)2
+ I ((t) 6= 0)
]
|At−1, Lt−1, ta
)
= E
{
W 2t−1,at−1
(
I ((t− 1) = 0)
{
P ((t) = 0|(t− 1) = 0, At−1 = at−1, L0)
P (At = at|(t) = 0, At−1 = at−1, L0)
+P ((t) 6= 0|(t− 1) = 0, At−1 = at−1, L0)
}
+ I ((t− 1) 6= 0)) |At−1, Lt−1, ta}
where we now make the simplifying assumption thatP ((t)|(t−1) = 0, At−1 = at−1, Lt−1, ta) =
P ((t)|(t− 1) = 0, At−1 = at−1, L0) (note again that violation of this assumption may affect
the efficiency, but not the asymptotic unbiasedness of the estimator). Starting from here, we then
calculate E
(
W 2tat |At−2, Lt−2, ta
)
as
E
{
W 2t−2,at−2
[
I ((t− 1) 6= 0) + I(At−1 = at−1)I ((t− 1) = 0)
P (At−1 = at−1|(t− 1) = 0, At−2 = at−2, Lt−2)2
×
{
P ((t) = 0|(t− 1) = 0, At−1 = at−1, L0)
P (At = at|(t) = 0, At−1 = at−1, L0)
+ P ((t) 6= 0|(t− 1) = 0, At−1 = at−1, L0)
}]
|At−2, Lt−2, ta
}
= E
{
W 2t−2,at−2
[
I ((t− 1) 6= 0) + I ((t− 1) = 0)
P (At−1 = at−1|(t− 1) = 0, At−2 = at−2, Lt−2)
×
{
P ((t) = 0|(t− 1) = 0, At−1 = at−1, L0)
P (At = at|(t) = 0, At−1 = at−1, L0)
+ P ((t) 6= 0|(t− 1) = 0, At−1 = at−1, L0)
}]
|At−2, Lt−2, ta
}
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where we use the simplifying assumption that At−1 ⊥⊥ Lt−2|(t− 1) = 0, At−2, L0. Continu-
ing along these lines, we obtain that
E
(
W 2tat |tat , L0
)
=
t+1∑
d=1
P ((d) 6= 0|(d− 1) = 0, Ad−1 = ad−1, L0)
×
∏d−1
s=1 P ((s) = 0|(s− 1) = 0, As−1 = as−1, L0)∏d−1
s=1 P (As = as|(s) = 0, As−1 = as−1, L0)
,
where, for each t, we define P ((t + 1) 6= 0|(t) = 0, At = at, L0) = 1. A similar calculation
shows that E (Wtat |ta, L0) = 1. It thus follows that (2.14) equals
Var (Vtat |L0)
t+1∑
d=1
P ((d) 6= 0|(d− 1), (d− 1) 6= 1, Ad−1 = ad−1, L0)
×
∏d−1
s=1 P ((s) = 0|(s− 1) = 0, As−1 = as−1, L0)∏d−1
s=1 P (As = as|(s) = 0, As−1 = as−1, L0)
and that ht,at(L0) in (2.13) equals
X
[
t+1∑
d=1
P ((d) 6= 0|(d− 1), (d− 1) 6= 1, Ad−1 = ad−1, L0)
×
∏d−1
s=1 P ((s) = 0|(s− 1) = 0, As−1 = as−1, L0)∏d−1
s=1 P (As = as|(s) = 0, As−1 = as−1, L0)
]−1
.
Derivation of variance of expression 2.1
The attributable fraction is defined as:
F1(t)− F0(t)
F1(t)
= 1− F0(t)
F1(t)
Where F1(t) is the observed cumulative incidence function and F0(t) the counterfactual cumu-
lative incidence function under the no infection path. To get an estimate of the variance of this
estimator we can apply the delta method. We take the ln because the delta method assumes a
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normal distribution.
ln
(
1− F0(t)
F1(t)
)
⇒ ln
(
1− p
q
)
We obtain the variance as:
var(g(pˆ, qˆ)) =
(
∂g
∂(p, q)
)
var(pˆ, qˆ)
(
∂g
∂(p, q)
)T
∂g
∂p
=
−1
q − p
∂g
∂q
=
p
q(q − p)
In g(p,q), p = β and q = logit(F(t)) where F(t) is the observed cumulative incidence function. We
know that:
F (t) = 1− exp(−H(t))
so
g(p, q) = ln
1−
(
1− e−
∑t
s=1 expit(pX(s))
)
expit(q)

∂g
∂p
=
−e−
∑t
s=1 expit(pX(s))
expit(q)−
(
1− e−
∑t
s=1 expit(pX(s))
)
×
t∑
s=1
expit(pX(s))(1− expit(pX(s)))X(s)
∂g
∂q
=
−(1− expit(q))
(
1− e−
∑t
s=1 expit(pX(s))
)
expit(q)−
(
1− e−
∑t
s=1 expit(pX(s))
)
TIME-VARYING CONFOUNDING IN THE PRESENCE OF COMPETING RISKS 2-35
We obtain var(pˆ, qˆ) via a sandwich estimator:
1
n
E−1
(
∂U
∂(p, q)
)
var(U)E−1
(
∂U
∂(p, q)
)T
where U =
(
Up
Uq
)
.
Up = Uitatk (htatk;β)Wiat ≡ I(ia(t− 1) 6= k)htatk(Li0)XWiat
× [I(a(t) = k)− expit {βX}]
Uq = I(i(t) = 1)− expit(q)
Partial derivatives Up:
∂Up
∂p
= − I(ia(t− 1) 6= k)htatk(Li0)WiatX2expit(βX)(1− expit(βX))
∂Up
∂q
= 0
Partial derivatives Uq:
∂Uq
∂p
= 0
∂Uq
∂q
= − expit(q)(1− expit(q))
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Implementation in standard software
Here, we give a step by step procedure and provide syntax for the implementation of the de-
veloped methodology in R. In general the main steps in estimating the attributable mortality
are:
1. At each time, select those patients whose observed data are compatible with, or, informa-
tive about the hypothetical infection path a at that time.
2. Estimate the counterfactual CIF of death at each time t, based on the selected patients at
that time and use inverse probability of treatment weighting (IPTW) to account for the
selective nature of those patients.
3. Calculate the PAF as the difference between the observed ICU-mortality (F1(t)) and the
ICU-mortality that would have been observed (counterfactual) for the same population if
infection were prevented for all (F01(t)), divided by the observed ICU-mortality.
Data preparation
All available information is stored into two datasets. The patient dataset has one line per
patient and contains patient characteristics as age, gender, length of ICU-stay, discharged or not,
mortality status, infection related information (ever infected, time of infection, antimicrobial)
together with the severity of illness indicators measured upon ICU admission. The followup
dataset contains for every patient as many lines as the ICU length of stay (LOS) (from ICU-
admission until ICU-death or discharge). Additional to the information of the patient dataset
it contains daily measurements of severity of illness indicators.
The first step in the analysis of the data requires several data preparation steps because a patient
’s observed data can be compatible with (and thus carry information about) multiple infection
paths. Moreover, in the estimation of the subdistribution hazard, patients experiencing the com-
peting event stay in the risk set until the end of follow up. For patients who get discharged
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this requires some data expansion until the end of follow up. Patients who get discharged with-
out infection stay compatible with all hypothetical infection paths (see Figure 2.2 showing the
compatible infection paths for a patient who gets discharged without infection 20 days after ad-
mission (endpoint is 30 day ICU mortality))
The primary data preparation requires following steps:
1. Define new variables (e.g. number of days since start of the intervention, lagged vari-
ables,...)
2. Delete the first two days from the dataset because all patients stayed in the ICU for more
then 48h and therefore the analysis starts on day 3.
3. Sort the data on the outcome and infection status.
This last step divides the patients in the dataset into three blocks. First those patients for
whom data expansion is not needed (those who died or stayed longer then the follow up time)
followed by those for whom the data needs to be expanded with one infection path (patients who
were discharged with infection) and finally those for whom the data needs to be expanded with
all compatible infection paths (patients who were discharged without infection).
Calculation of the weights
The next step in the analysis involves fitting several models necessary for the calculation of the
(stabilized) weights. Therefore, at every day a patient was not previously infected (inf 1=0),
we fit a model (M1) for the daily probability of acquiring infection (inf) conditional on baseline
characteristics (base) and daily measured severity of illness indicators (dmsi). The underlying
time evolution (time) was modeled using cubic splines.
M1= glm(inf ˜ time + base + dmsi, family=binomial,
data=followup,subset=inf_1==0)
2-38 CHAPTER 2
P1=predict(M1,type = c("response"))
P1=ifelse(inf_1==1,1,P1)
For the calculation of the stable weights we need two additional models. One for the daily
probability of acquiring infection conditional on the baseline characteristics (M2)
M2= glm(inf ˜ time + base, family=binomial,data=followup,
subset=inf_1==0)
P2=predict(M2,type = c("response"))
P2=ifelse(inf_1==1,1,P2)
and a model (M3) for the discharge-probability (disch) .
M3= glm(disch˜ time + inf, family=binomial, data=followup)
P3=predict(M3,type = c("response"))
In the calculation of the stabilized weights on day t we need the discharge probability on
day t− 1 and therefore define
Pgist=c()
Pgist[1]=0
for (i in 2: dim(followup)[1]){
Pgist[i]=ifelse(time[i]==1,0,P3[i-1])
}
In a next step, the following algorithm was used to calculateWiat (W) and htatkWiat (Wstab).
W=c()
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Wstab=c()
h=c()
for (k in 1:n){ #n=number of patients
tmp=subset(followup,ID==k)
K1=c()
K2=c()
K3=c()
W.tmp=c()
Wstab.tmp=c()
h.tmp=c()
K1=cumprod((tmp$inf*tmp$P1)+((1-tmp$inf)*
(1-tmp$P1)))
K2=c(1,cumprod((tmp$inf*tmp$P2)+((1-tmp$inf)*
(1-tmp$P2))))
K3=c(1,cumprod(1-tmp$Pgist))
W.tmp=1/K2
h.tmp=1/(cumsum(tmp$Pgist*(K3[-length(K3)]/K1[-length(K1)]))+
(K3[-1]/K1[-1]))
Wstab.tmp=d.tmp*W.tmp
W=c(W,W.tmp)
h=c(h,h.tmp)
Wstab=c(Wstab,Wstab.tmp)
cat("iteration=",k, "\n")
}
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Data expansion
Patients who are discharged (and for whom data expansion is needed) stay compatible with all
infection paths so that no selection is made in this subgroup. For those patients, the denominator
probability in the weights is equal to 1 and the calculated (stable) weights are constant (equal to
the last calculated weight in the observed dataset). The htatk part of the stabilized weights only
depends on the time of infection (dayinf) and are stored in the vectors H 0 and H .
H_0=subset(followup,Sort==9)$d
tmp=c()
H=c()
for (i in 1:28){
tmp[i]=unique(subset(followup,dayinf==i)$ID)[1]
H[i]=subset(followup,ID==tmp[i])$h[i]
}
H=ifelse(is.na(H),0,H)
Note that in the analysis we were interested in the effect of an infection acquired within 30 days
after ICU admission. The 28 in the for loop comes from 30-2 (because the analysis started on
day 3).
Because in the data expansion we need information at the end of follow up we construct a
new dataset last containing per patient the last observation taken at the end of follow up
(LOS ICU).
last=subset(followup,time==LOS_ICU)
Remember that in the first data preparation step the data were sorted on their outcome and in-
fection status resulting in three blocks of patients. For the actual data expansion we use a for
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loop running over each patient’s data. By grouping the patients into blocks the algorithm can be
fastened. The total number of patients is defined as tot. From 1 to not no data expansion is
needed because these are the patients who died in the ICU or stayed until the end of follow up.
From not+1 to well the patients data is expanded until the end of follow up but with only one
possible infection regime (infected on everyday since discharge). Finally from well+1 to tot
full expansion with all compatible infection regimes is done.
To further fasten the algorithm, all compatible infection regimes for a patient discharged at a
given day since admission are constructed separately by
for (t in 1:27){
Day=c()
A=c()
first=c()
h=c()
Wstab=c()
l=28-t
for (j in 1:t){
tmp=rep(l+j,j+1)
Day=c(Day,tmp)
tmp1=c(0,rep(1,j))
A=c(A,tmp1)
tmp2=c(0,(l+1):(l+j))
first=c(first,tmp2)
tmp8=c(H_0[j],H[(l+1):(l+j)])
h=c(h,tmp8)
}
infdays=A*((Day-first)+1)
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inf=cbind(Day,A,first,infdays,h)
assign(paste("inf",t, sep=""),inf)
}
The actual data expansion is done as follows:
expand1=c()
for (i in (not+1):well){
l=28-followup$LOS_ICU[i]
Day=(followup$LOS_ICU[i]+1):28
A=rep(1,l)
first=rep(last$dayvap[i],l)
infdays=A*((Day-first)+1)
tmp=cbind(i,Day,A,first,infdays,0,rep(last$h[i]),
rep(last$W[i],l),rep(last$Wstab[i],l))
expand1=rbind(expand1,tmp)
}
expand2=c()
for (i in (well+1):tot){
l=28-followup$LOS_ICU[i]
inf=get(paste("inf",l, sep=""))[,-5]
d=get(paste("inf",l, sep=""))[,5]
tmp3=cbind(i,inf,0,h,last$W[i],h*last$W[i])
expand2=rbind(expand2,tmp3)
cat("iteration=",i, "\n")
}
expand1=as.data.frame(expand1)
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expand2=as.data.frame(expand2)
names(expand1)=names(followup)
names(expand1)=names(followup)
final_data=rbind(followup,expand1,expand2)
write.csv(final_data,"final.csv",row.names=FALSE,na=".")
An independence GEE approach is now used to fit the final analysis model (pooled logistic
regression model with patient specific, time varying weights). Because of the data expansion,
the final data dataset is to big to use geeglm in R (problems with memory allocation). For
that reason we did the final analysis in SAS using proc genmod.
proc genmod data=final_data desc;
class ID;
model ICUmort = time infdays/ dist=binomial;
repeated subject=ID/type=ind covb;
scwgt Wstab;
run;
Estimating the attributable mortality
After the analysis in SAS we return to R for the calculation of the population attributable
fraction (PAF). The estimated parameters from the subdistribution hazard model are stored in
parms no. The matrix XDAT contains the variables time (for 1 to end of follow up) and
infdays (which is equal to 0 because we want to estimate the CIF no which is the CIF under
no infection)
p_no=expit(parms_no%*%XDAT)
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CIF_no=1-exp(-cumsum(p_no))
PAF = 1-CIF_no/CIF_obs
where CIF no is the counterfactual CIF under no infection and CIF obs is the observed CIF
(which can be parametrically or non-parametrically estimated).
The variance of the PAF is obtained in several steps (see the appendix for the formulas). First,
for every type of patient we calculate Up and it derivatives.
Up=matrix(nrow=tot,ncol=length(parms_no))
dUp=matrix(nrow=length(parms_no),ncol=length(parms_no),data=0)
for (i in (1:tot)) {
dat=subset(followup,ID==i)
Xdat=cbind(1,time,infdays)
Up.tmp=Xdat*as.numeric(dat$ICUmort-expit(parms_no %*%
t(Xdat)))*dat$Wstab
dUp.tmp=t(Xdat*as.numeric(expit(parms_no %*%
t(Xdat))*(1-expit(parms_no %*% t(Xdat)))*
dat$Wstab))%*%Xdat
Up[i,]=apply(Up.tmp,2,sum)
dUp=dUp+dUp.tmp
}
for (i in (not+1):well){
l=28-patient$LOS_ICU[i]
Day=(patient$LOS_ICU[i]+1):28
A=rep(1,l)
first=rep(last$dayinf[i],l)
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infdays=A*((Day-first)+1)
Xdat=cbind(1,Day,infdays)
Up.tmp=Xdat*as.numeric(0-expit(parms_no %*%
t(Xdat)))*rep(last$Wstab[i],l)
dUp.tmp=t(Xdat*as.numeric(expit(parms_no %*%
t(Xdat))*(1-expit(parms_no %*% t(Xdat)))*
rep(last$Wstab[i],l)))%*%Xdat
u=apply(Up.tmp,2,sum)
Up[i,]=Up[i,]+u
dUp=dUp+dUp.tmp
}
for (i in (well+1):tot){
l=28-patient$LOS_ICU[i]
inf=get(paste("inf",l, sep=""))[,-5]
h=get(paste("inf",l, sep=""))[,5]
Xdat=cbind(1,inf[,1],inf[,4])
Uq.tmp=Xdat*as.numeric(0-expit(parms_no %*%
t(Xdat)))*(h*last$W[i])
dUq.tmp1=t(Xdat*as.numeric(expit(parms_no %*%
t(Xdat))*(1-expit(parms_no %*%
t(Xdat)))*(h*last$W[i])))%*%Xdat
u=apply(tmp,2,sum)
Up[i,]=Up[i,]+u
dUp=dUp+tmp1
}
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#check, needs to be equal to 0 !
apply(Up,2,mean)
In a second step we estimate the observed CIF (same principle as for the counterfactual CIF
but based on the observed data and without infection in the analysis model) and calculate Uq and
its derivatives.
Uq=matrix(nrow=tot,ncol=length(parms_obs),data=0)
dUq=matrix(nrow=length(parms_obs),ncol=length(parms_obs),data=0)
for (i in (1:tot)) {
dat=subset(followup,ID==i)
Xdat1=cbind(1,time)
Uq[i,]=t(Xdat1)%*%t(dat$ICUmort-expit(parms %*% t(Xdat1)))
dUq.tmp=t(Xdat1*as.numeric(expit(parms_obs %*%
t(Xdat1))*(1-expit(parms_obs %*% t(Xdat1)))))%*%Xdat1
dUq=dUq+dUq.tmp
}
for (i in (not+1):tot){
l=28-patient$LOS_ICU[i]
Day=(patient$LOS_ICU[i]+1):28
Xdat1=cbind(1,Day)
Uq.tmp=t(Xdat1)%*%t(-expit(parms_obs %*% t(Xdat1)))
Uq[i,]=Uq[i,]+t(Uq.tmp)
dUq.tmp=t(Xdat1*as.numeric(expit(parms_obs %*%
t(Xdat1))*(1-expit(parms_obs %*% t(Xdat1)))))%*%Xdat1
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dUq=dUq+dUq.tmp
}
#check, needs to be equal to 0 !
apply(Uq,2,mean)
In the next step we calculate the sandwich estimator of the variance as
U=cbind(Up,Uq)
VAR_U=var(U)
D11=dUp
D12=matrix(ncol=length(parms_obs),nrow=5,data=0)
D21=matrix(ncol=length(parms_no),nrow=length(parms_no),data=0)
D22=dUq
X <- rbind(cbind(D11/n,D12/n),cbind(D21/n,D22/n))
COV_sand=(solve(X)%*%VAR_U%*%t(solve(X)))/n
We use it in the expression obtained from the delta method (see appendix) to calculate the vari-
ance of the PAF
Xs=cbind(1,time,infdays)
Xs1=cbind(1,time)
lower=c()
upper=c()
for (k in 1:58){
x=as.numeric(expit(parms_no%*%t(Xs))*
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(1-expit(parms_no%*%t(Xs))))*Xs
y=apply(x,2,cumsum)[k,]
x1=as.numeric(expit(parms_obs%*%t(Xs1))*
(1-expit(parms_obs%*%t(Xs1))))*Xs1
y1=apply(x1,2,cumsum)[k,]
dgp=-(exp(-cumsum(expit(parms%*%t(Xs))))[k]/CIFno_parm[k])*y
dgq=(CIFobs1[k]/CIFno_parm[k])*(CIFno_parm[k]/CIFobs1[k]ˆ2)*y1
dG=c(as.vector(dgp),dgq)
V=t(dG)%*%COV_sand%*%t(t(dG))
lower[k]=1-exp(log(CIFno_parm[k]/CIFobs1[k])+1.96*sqrt(diag(V)))
upper[k]=1-exp(log(CIFno_parm[k]/CIFobs1[k])-1.96*sqrt(diag(V)))
}
3
Attributable mortality of ventilator associated
pneumonia:
A reappraisal using causal analysis.
This chapter is adapted from Bekaert et al. (2011) and is the result from a close collaboration
between statisticians and physicians in an attempt to apply our new methodology into the ICU-
literature and try to convince ICU-experts that the use of more sophisticated method is necessary
to answer the question if patients die from or with infection. With the help of my promoter and
a group of ICU-experts from the University Hospital in Ghent (P. Depuydt, J. Decruyenaere and
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my co-promotor D. Benoit) we found a good balance between the methodological and medical
relevant messages. The work is published in The American Journal of Respiratory and Critical
Care Medicine. The list of coauthors additionally includes physicians and researchers from the
Outcomerea R© group who collected the data and helped with the interpretation of the results.
(J-F. Timsit, A. Vsin, M. Garrouste-Orgeas, C. Clec’h, E. Azoulay).
Summary
Measuring the attributable mortality of ventilator-associated pneumonia (VAP) is challenging
and prone to different forms of bias. Studies addressing this issue have produced variable and
controversial results. We estimate the attributable mortality of VAP in a large multicenter cohort
using statistical methods from the field of causal inference. Patients (n=4479) from the longi-
tudinal prospective (1997-2008) French multicenter Outcomerea R© database were included if
they stayed in the ICU for at least 2 days and received mechanical ventilation (MV) within 48
hrs after ICU-admission. A competing risk survival analysis, treating ICU-discharge as a com-
peting risk for ICU-mortality, was conducted using a marginal structural modeling approach to
adjust for time-varying confounding by disease severity. 685 (15.3%) patients acquired at least
one episode of VAP. We estimated that 4.4% (95% CI 1.6%-7.0%) of the deaths in the ICU on
day 30 and 5.9% (95% CI 2.5%-9.1%) on day 60 are attributable to VAP. With an observed
ICU-mortality of 23.3% on day 30 and 25.6% on day 60 this corresponds to an ICU-mortality
attributable to VAP of about 1% on day 30 and 1.5% on day 60. Our study on the attributable
mortality of VAP is the first which simultaneously accounts for the time of acquiring VAP, for
informative loss to follow-up after ICU-discharge, and for the existence of complex feedback re-
lations between VAP and the evolution of disease severity. In contrast to the majority of previous
reports we detected a relatively limited attributable ICU-mortality of VAP.
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3.1 Introduction
Ventilator-associated pneumonia (VAP) is the leading nosocomial infection in mechanically ven-
tilated, critically ill patients, and is commonly considered as a partly preventable disease with a
high risk for adverse outcome (Safdar et al., 2005; Bonten et al., 2004). Assessment of the at-
tributable mortality of VAP nevertheless remains challenging (Carlet, 2001; Melsen et al., 2009;
Muscedere, 2009). The large variability (Safdar et al., 2005; Muscedere, 2009; Nguile-Makao
et al., 2010) in estimated excess risk of death from VAP (between 0 and 70%) has been pri-
marily explained by differences in the patient population under study (case-mix), as well as by
the absence of a reference standard diagnosis for VAP, which is usually replaced by a clinical
probability coupled with quantitative microbiological data to improve specificity (Timsit et al.,
1996b; Koulenti et al., 2009). In our opinion, also the use of various definitions of excess risk
contributes to that variation, as well as methodological shortcomings on the level of the data
analysis, which may lead to over-or underestimation of the mortality attributable to VAP. As
investigators have to rely on observational data alone, careful adjustment for confounding by
severity of illness is required to disentangle the complex relationship between VAP and mor-
tality. This is because VAP is essentially a complication of underlying critical illness (Krueger
et al., 2002; Rello et al., 1997) and because patients who acquire VAP tend to be more severely
ill than patients who do not.
In order to obtain unbiased estimates of the attributable mortality of nosocomial infections,
methods should account for obvious findings: (a) patients need to survive long enough in or-
der to acquire infection; (b) patients who acquire infection tend to be more severely ill in the
course of their critical illness and not only upon admission; (c) there is a dynamic interplay be-
tween VAP and the patients’ severity of illness, clinical characteristics and treatment over time;
(d) patients who get discharged from the ICU and whose survival time is therefore censored,
tend to be in different health conditions as compared to patients staying at the ICU.
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This study is the first to estimate the population attributable risk of ICU mortality by VAP in
a large size, high quality, multicenter database (Nguile-Makao et al., 2010), whilst overcoming
all of the aforementioned obstacles. This will be achieved through the use of statistical tech-
niques from the field of causal inference (Robins et al., 2000; Bekaert et al., 2010b). Similar
causal analyses have proved successful in the re-analysis of the Women’s Health Initiative Study
(Herna´n et al., 2008; Prentice, 2007) and of epidemiologic studies of AIDS therapies (Herna´n
et al., 2000) where standard statistical methods contradicted results from the analysis of ran-
domized trials. We adopted the same modeling approach as in these studies, but extended with
further refinements which carefully take into account that censoring of the survival time due to
discharge from the ICU contains information on the actual survival time (Bekaert et al., 2010b).
3.2 Methods
3.2.1 Study population and data collection
The analysis was based on all records in the longitudinal (1997-2008) French multicenter Outcomerea R©
database from patients who stayed in the ICU for at least 2 days and received mechanical ven-
tilation (MV) within 48 hrs after ICU admission. In accordance with previous reports (Nguile-
Makao et al., 2010), VAP was defined as persistent pulmonary infiltrates on chest radiographs
combined with purulent tracheal secretions, and/or body temperature ≥ 38.5◦C or ≤36.5◦C,
and/or peripheral blood leukocyte count ≥10 x 109 /L or ≤ 4 x 109/L; a definitive diagnosis
of VAP required microbiological confirmation by quantitative culture from a protected speci-
men brush (≥ 103cfu/ml), plugged telescopic catheter specimen (≥103cfu/ml), broncho-alveolar
lavage (BAL) fluid specimen (≥104cfu/ml), or endotracheal aspirate (≥105cfu/ml). The effect
of the first acquired microbiological proven VAP was modeled.
Data were collected as described previously (Nguile-Makao et al., 2010). In short, the par-
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ticipating ICUs provided a random sample of at least 50 ICU-admissions of >24h per year; per
case, data entered in the case report form included admission characteristics as well as events and
scores following ICU-admission that were recorded on a daily basis. Measured characteristics
upon admission consisted of demographic data, admission diagnosis and admission category,
chronic illness and comorbidity (using the Knaus definition and including the McCabe score),
clinical findings and laboratory investigations. Upon admission and subsequently on a daily ba-
sis, the following scores were calculated: Simplified Acute Physiology Score (SAPS) II (Legall
et al., 1993), Sequential Organ Failure Assessment (SOFA) (Vincent et al., 1996) and Logistic
Organ Dysfunction (LOD) score (Legall et al., 1993). In addition data on daily interventions
and treatments were collected: antibiotic treatment, enteral feeding, corticosteroids >0.5mg/kg,
invasive or non-invasive mechanical ventilation, vasopressor use, hemodialysis, placement and
presence of invasive devices (arterial catheter, central venous catheter, Swan-Ganz catheter and
Foley catheter), tracheotomy and do-not-resuscitate (DNR) orders. Throughout this chapter we
refer to the above described variables as severity of illness indicators. Antimicrobial treatment
was considered immediately appropriate if at the day of microbiological sampling, the patient
received at least one antibiotic to which the recovered pathogen(s) was susceptible in vitro.
3.2.2 Statistical analysis
A key challenge for statistical analysis is that VAP and non-VAP patients are inherently differ-
ent in severity-of-illness (prior to the acquisition of VAP) so that mortality differences between
these groups cannot be fully attributed to VAP. When differences in disease severity between
these groups are entirely explainable in terms of patient characteristics measured upon ICU ad-
mission, then adjustment is possible by including these as covariates in the analysis. This is
no longer sufficient when evolution in disease severity contributes as well to the difference be-
tween these patient populations. In that case standard regression adjustment for the evolution in
severity of illness eliminates the effects of early VAP that are mediated through severity of ill-
ness, and in addition induces a so-called collider-stratification bias (Robins et al., 2000; Herna´n
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et al., 2000; Bekaert et al., 2010a). In view of this, we opted for a marginal structural mod-
eling approach (Robins et al., 2000; Bekaert et al., 2010b), which enables to assess what the
ICU-mortality would have been, if all patients would have remained VAP-free or , alternatively,
would have acquired VAP on a specific day. Because information on this is lacking for patients
who acquired VAP, the observed data for VAP-free patients will be reweighted to predict what
the ICU-mortality status would have been for VAP patients, had VAP been prevented for them.
For instance, let us suppose that a VAP-free patient, based on his evolution in disease severity,
has a 1/3 chance of not acquiring VAP. Then for every such patient, one expects to find 2 pa-
tients in the population who experienced a similar evolution in severity-of-illness, but who did
acquire VAP. To estimate what the ICU-mortality would have been, if all patients would have
remained VAP-free, the data for that VAP-free patient will therefore be counted 3 times, one
time to represent himself, and 2 additional times to represent those like patients who did acquire
infection. By repeating this for all VAP-free patients, one can thus reconstruct how the data
on ICU-mortality status would have looked like, had VAP been prevented for all. The intuitive
principle underlying this estimation procedure is illustrated by numerical example in (Robins
et al., 2000). The details and validity of the approach in this context are reported in (Bekaert
et al., 2010b); we here outline the main steps.
In a first step, we fitted a logistic regression model for the daily probability of acquiring VAP. Be-
cause mechanical ventilation could be stopped or restarted on each day, this model includes the
patient’s time-dependent ventilation status. The obtained probabilities then served to generate
a daily patient-specific weighing factor, which was defined as the reciprocal of the probability
of this patient having his observed VAP-status and previous history by that day (Bekaert et al.,
2010b). Because severity of illness indicators measured on a given day may have been influ-
enced by infection acquired on that day, the model for VAP included only lagged values from
the day before. For the SOFA score and antibiotic use we adjusted for lagged values three days
(72hrs) before to recognize that the SOFA score and the antibiotic use within 48hrs before the
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onset of VAP are possible surrogate markers for an infection which was incubating, and which
may therefore be affected by VAP on the given day. All analyses were additionally adjusted for
the ICU-center and the admission year.
In the second stage of the analysis, we accounted for informative censoring of the survival time
through a competing risk analysis (Prentice et al., 1978; Satagopan et al., 2004) where we con-
sidered discharge from the ICU as a competing risk for ICU-mortality (Resche-Rigon et al.,
2006b). Our primary focus was on 60-day ICU-mortality because many VAP deaths occur after
the first 30 days of ICU stay, and because the analysis of more distal endpoints, such as over-
all hospital mortality, requires a more stringent confounding adjustment. Using the proposed
weights we evaluated hazard regression models, involving the so-called subdistribution hazard,
which measures at each time the instantaneous risk of ICU-death at that time amongst patients
who did not die within the ICU before that time (Bekaert et al., 2010b). From these models, we
inferred the impact of acquiring VAP in the ICU on the Cumulative Incidence Function (CIF) of
ICU-death, which is the probability of dying within the ICU before a given time, as a function
of time. This was then used to estimate the attributable mortality of VAP as the population at-
tributable fraction (Resche-Rigon et al., 2006b) of ICU-mortality related to infection. On each
day, this was calculated as the difference between the observed ICU-mortality and the ICU-
mortality that would have been observed for the same population if VAP were prevented for all,
divided by the observed ICU-mortality. It can be interpreted as the percentage of the observed
ICU-deaths that could be avoided by preventing VAP, or, as the percentage of the observed ICU-
deaths who died because of VAP (Tian and Pearl, 2000).
All models were built using a stepwise model selection approach at the 5% significance level us-
ing SAS 9.2 (SAS Institute Inc., Cary, NC, USA) and R (R foundation for Statistical Computing,
Vienna, Austria).
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3.3 Results
3.3.1 Descriptives
4479 patients from the Outcomerea database fulfilled the inclusion criteria, 685 (15.3%) of
whom developed pneumonia within 30 days after ICU admission. Forty-one patients (5.9%)
were diagnosed with pneumonia more than >48h after discontinuation of mechanical ventila-
tion; while strictly these patients could not be classified as VAP, though still representing ICU-
acquired pneumonia, we choose to retain the term VAP throughout the manuscript instead of
’ICU-acquired pneumonia’ as it is the more widely used term. Of the 685 patients who ac-
quired VAP, 405 (59.1%) immediately received appropriate antimicrobial treatment. The most
prevalent micro-organisms in the 685 episodes of VAP are detailed in table 3.1. From the 685
VAP episodes, 868 micro-organisms were isolated. The main micro-organisms were P. aerugi-
nosa (n=227,26.2%), S. aureus (n=133,15.3%) and E. coli (n=66, 7.6%). At the onset of VAP,
the median SOFA score was 6 (25th-75th percentile; 4-8). The median duration between ICU-
admission and the onset of VAP was 8 days (25th-75th percentile; 5-12).
The crude 60-day-ICU-mortality risk of the VAP patients was 33.0% (226/685) compared
to 24.3% (921/3794) for those who remained free of VAP. The crude 60-day-ICU-mortality in
patients with appropriate versus inappropriate antimicrobial therapy was 31.9% (129/405) and
34.6% (97/280), respectively. Median length of stay in the ICU was 7 days (25th-75th percentile;
4-13) and 22 days (25th-75th percentile; 13-38) in patients without and with VAP, respectively.
Patient characteristics upon admission are detailed in table 3.2.
3.3.2 Risk of acquiring VAP
The change in hazard of acquiring VAP with time was modeled in a flexible way allowing for dif-
ferences in evolution depending on the patient’s gender (p=0.01), underlying severity of illness
(as measured by the SOFA score upon ICU-admission) (p = 0.02), and on antibiotic treatment
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Patients with VAP: Patients without VAP:
(n=685) (n=3794)
Male gender, n (%) 493 (72.0) 2371 (62.5)
Age, mean (SD) 63.2 (15.5) 62.6 (16.8)
ICU-length of stay, median (Q1 , Q3) 22 (14 , 38) 7 (4 , 13)
Ventilation days, median (Q1 , Q3) 19 (11 , 33) 5 (3 , 10)
SAPS II, mean (SD) 49.9 (16.2) 48.4 (18.3)
Admission category
Medicine, n (%) 476 (69.5) 2317 (62.5)
Emergency surgery, n (%) 114 (16.6) 811 (21.4)
Scheduled surgery, n (%) 93 (13.6) 657 (17.3)
Main symptoms at ICU-admission
Shock, n (%) 185 (27.0) 1001 (26.4)
Coma, n (%) 143 (20.9) 884 (23.3)
Acute respiratory failure, n (%) 213 (31.1) 846 (22.3)
Other chronic illnesses
Hepatic,n (%) 53 (7.7) 253 (6.7)
Cardiovascular, n (%) 96 (14.0) 518 (13.7)
Pulmonary, n (%) 139 (20.3) 617 (16.3)
Renal, n (%) 25 (3.6) 147 (3.9)
Immunosuppression, n (%) 83 (12.1) 444 (11.7)
Crude Mortality rates
30-day ICU-mortality, n (%) 165 (24.1) 876 (23.1)
60-day ICU-mortality, n (%) 226 (33.0) 921 (24.3)
global ICU-mortality, n (%) 237 (34.6) 937 (24.7)
Table 3.1: Characteristics and crude mortality rates for patients with and without VAP.
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Micro-organism n(%)
Gram positive 244 (28.1)
S. pneumonia 45 (5.2)
S. aureus
Methicillin-susceptible 84 (9.7)
Methicillin-resistant 49 (5.6)
Coagulase-negative staphylococci 32 (3.7)
Enterococci 7 (0.8)
Streptococcus, other 27 (3.1)
Gram-negative 554 (63.8)
H. influenzae 63 (7.3)
Enterobacteriaceae
E. coli 66 (7.6)
Klebsiella sp. 38 (4.4)
Enterobacter sp. 37 (4.3)
C. freundii 16 (1.8)
S. marcescens 21 (2.4)
P. mirabilis 14 (1.6)
M. morganii 13 (1.5)
Non-fermenting pathogens
P. aeruginosa
Wild type 155 (17.9)
Resistance mechanism 72 (8.3)
Acinetobacter sp. 24 (8.2)
S. maltophilia 35 (4.0)
Other 70 (8.1)
Table 3.2: Overview of the main micro-organisms causing VAP. In total 868 micro-organisms
were isolated from the 685 VAP episodes.
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upon admission (p < 0.001). Mechanical ventilation (p < 0.001) and enteral feeding the day
before the possible occurrence of VAP were associated with an increased risk of acquiring VAP.
The magnitude of the effect of enteral feeding increased with higher SOFA scores 72hrs before
the possible occurrence of VAP (p = 0.02). The impact of SOFA on the risk of acquiring VAP
followed opposite directions depending on the value at admission (p=0.03), with an increasing
risk for patients with an initial value below 10, and a decreasing risk for patients with a higher
initial SOFA. A DNR-order (p=0.02) and antibiotic treatment on admission and 72hrs before
the occurrence of VAP (p <0.001) were associated with a lower risk of VAP. Finally, patients
with a urinary tract (p = 0.04) and catheter related infection (p<0.001) 24hrs before the possible
occurrence of VAP were more vulnerable to acquire VAP unless the urinary tract infection was
acquired more than 6 days (p=0.02) before the occurrence of VAP. Note that these results should
not be causally interpreted, as they are merely used to create a statistical population in which
VAP on each day is independent of measured daily indicators of disease severity, so as to enable
an unbiased assessment of the attributable ICU-mortality of VAP.
3.3.3 Attributable ICU-mortality due to VAP
From the marginal structural modeling analysis we found that the (subdistribution) hazard of
ICU-death increased with 2.3% per additional day since the onset of VAP (HR 1.023 with 95%CI
1.011 to 1.034; p< 0.001). Corresponding increases in hazard ratios of 2.0% (HR 1.02 with
95%CI 1.007 to 1.034; p=0.003) and 2.7% (HR 1.027 with 95%CI 1.017 to 1.047; p=0.001)
were observed for appropriately versus inappropriately treated VAP, respectively. The effect of
VAP on ICU-mortality further depended on the patients’ severity of illness upon ICU-admission
(p = 0.01). Table 3.3 gives an overview of the hazard ratios of ICU-death per additional day
since infection. The effect of VAP was the largest for patients with intermediate (28-40) SAPSII
scores and attenuated in patients with high (>65) or low (<20) SAPSII scores.
Figure 3.1 displays the effect of VAP on ICU-mortality over time. On day 30 and day 60,
the population attributable fraction of ICU mortality due to VAP Figure 3.2 equals 4.4% (95%
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Hazard ratio of ICU-death
SAPS II on admission per additional day since infection (95%CI) P-value
15 (5%) 1.023 (0.980 to 1.068) 0.31
20 (10%) 1.030 (0.997 to 1.063) 0.07
28 (25%) 1.037 (1.018 to 1.056) <.001
40 (50%) 1.038 (1.025 to 1.052) <.001
53 (75%) 1.027 (1.013 to 1.041) <.001
65 (90%) 1.00 (0.989 to 1.022) 0.49
73 (95%) 0.990 (0.960 to 1.010) 0.28
Overall 1.023 (1.011 to 1.034) <.001
Table 3.3: Hazard ratios of ICU-death per additional day since infection calculated for patients
with different SAPSII scores on admission (different percentiles).
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Figure 3.1: The observed cumulative ICU-mortality together with the ICU-mortality as it would
have been observed for the same population if VAP were prevented for all.
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Figure 3.2: The attributable ICU-mortality of VAP as a function of time, defined as the pop-
ulation attributable fraction (PAF). The solid line represents the percentage of ICU mortality
that could be attributable to VAP, or, the percentage of the observed ICU-deaths that could be
avoided by preventing VAP. The dashed line is the corresponding 95% confidence interval.
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CI 1.6%-7.0%) and 5.9% (95% CI 2.5%-9.1%), respectively. For instance, on day 30 this means
that if one were able to prevent VAP for all patients in the ICU, 4.4% (95% CI 1.6%-7.0%) of
the observed ICU-deaths within the first 30 days following ICU admission could be avoided.
3.4 Discussion
We estimated that 4.4% (95% CI 1.6%-7.0%) of the deaths in the ICU on day 30 and 5.9%
(95% CI 2.5%-9.1%) on day 60, could be attributed to VAP, after careful adjustment for time-
varying disease severity through the use of a marginal structural modeling analysis, and for ICU-
discharge as a competing risk for mortality through the use of competing risk analysis. With an
observed ICU-mortality of 23.3% on day 30 and 25.6% on day 60 this corresponds to an at-
tributable ICU-mortality of about 1% on day 30 and 1.5% on day 60. As in previous studies on
VAP and hospital acquired bloodstream infections (Nguile-Makao et al., 2010; Buenocavanillas
et al., 1994; Kim et al., 2005), our results also indicate that patients who are more critically ill
upon admission (higher range of SAPSII) do not experience a major attributable (or additional)
effect of VAP compared to those with an intermediate SAPSII score (28-40). The likely expla-
nation for this phenomenon is that the risk of death in patients with established severe organ
failure is less modifiable, neither by subsequent treatment nor by intercurrent complications. On
the other hand, the lower attributable mortality of VAP in patients in the lower range of SAPSII
could be biologically explained by better preservation of host defense mechanisms in these pa-
tients (Hotchkiss and Opal, 2010), and by a larger window of opportunity to alter natural history
of the infection by appropriate treatment.
The problem of attributable mortality of VAP has already generated a considerable literature.
However, only a minority of the studies published thus far performed multivariate analysis
to control the association between VAP and mortality for confounding by severity of illness
(Melsen et al., 2009; Muscedere, 2009). Furthermore, although a number of authors (Nguile-
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Makao et al., 2010; Wolkewitz et al., 2008, 2009; Schumacher et al., 2007) have previously
made progress in terms of estimating the attributable effect of VAP by carefully acknowledging
the time at which infection is acquired in their analysis, to the best of our knowledge, all previ-
ous reports ignored confounding by the evolution of disease severity over time. The challenge is
how to incorporate the existence of complex feedback relations between VAP, underlying critical
illness and evolving organ failure over time (Bekaert et al., 2010b,a). By using standard statis-
tical regression methods to control for severity of illness indicators, one introduces a so-called
collider-stratification bias (Robins et al., 2000; Greenland, 2003). Even when controlling only
for severity of illness before infection, such bias results because the severity of illness on a given
day is influenced by (the absence of) infection on the previous days. Therefore, whereas the
wide range of estimated attributable mortality may reflect true differences resulting from case
mix and appropriateness of treatment, in our opinion it additionally reflects incorrect and incom-
plete adjustment for the condition (and hence the inherent risk of death) of the patient at the very
time of developing VAP. The continuous monitoring of vital and biochemical parameters of pa-
tients during their stay at the ICU offers the potential to correct for longitudinal information on
the patient’s health condition evolving over the duration of their critical illness. To incorporate
this huge set of data in a meaningful way, a close collaboration between clinicians with a good
bedside experience in the treatment of these patients and statisticians who are able to develop
and/or use more advanced complex statistical techniques which appropriately account for the
aforementioned biases is mandatory. Our study is the first to address all of them via the use of
techniques from the field of causal inference.
In contrast to the majority of previous reports (see Melsen et al. (2009) for a systematic review),
we obtained a relatively mild attributable ICU-mortality of VAP. A comparison is nevertheless
difficult to make because previous studies often focus on alternative risk measures such as rel-
ative risks, odds ratios or hazard ratios. Our focus on the population attributable fraction has
the advantage that it translates into daily estimates of attributable mortality with a clear medical
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interpretation because they express the percentage of observed ICU-deaths by that day whose
death was a consequence of VAP. Similarly, they reflect the percentage of ICU-deaths by that
day which could be avoided if VAP could be completely prevented.
Since in the popular press, nosocomial infection, including VAP, is increasingly depicted as
a preventable disease leading to avoidable death, thus having legal implications, an accurate
measure of the attributable mortality of VAP has importance beyond its academic interest. How-
ever, it would be erroneous to use our result as a justification to neglect measures to prevent
VAP or to minimize the importance of VAP diagnosis and treatment. As in other studies, the
attributable mortality of VAP does not reflect the natural history of the disease itself, but the
effect of disease modified by therapy, including advanced organ support in addition to antimi-
crobial therapy. Since modern intensive care can support or partially replace vital functions for
prolonged periods of time and for high levels of organ dysfunction, the relationship between
VAP and overall mortality is mitigated or obscured. This is congruent to daily clinical practice,
in which a direct relationship between occurrence of VAP and death is rarely observed as long as
decisions to forego life-sustaining therapy are not taken. Furthermore, similarly to all previous
studies, the impact of VAP is measured relative to the absence of VAP, but not to the absence
of nosocomial infection altogether, such as urinary tract or catheter-related infections. Finally,
our study did not address attributable morbidity of VAP, such as expressed by ICU length-of-stay.
Although our study took into account as much information as possible and used advanced statis-
tical methodology to correct for various biases, several limitations must be acknowledged. First,
like all analyses of observational studies, the validity of our analysis relies on the assumption
that all relevant confounders have been taken into account. Without confounding adjustment,
one can only learn about the association between VAP and mortality. This association is of little
account when no causal interpretation can be given, because the relevant scientific question is
a causal one: do patients die from (i.e., due to) or with infection? Second, our analysis did not
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adjust for measurement error in the patient’s VAP status. Measurement error of the timing of
VAP onset may arise by the process of disease incubation being gradual. This could affect our
analysis, which is explicit that cause must precede effect. In view of this, we used lagged values
measured from the day before to predict VAP on each day (and of 3 days before in the case of
the SOFA score and antibiotic use). It is unclear whether this adjustment sufficiently corrected
for an incubation effect, although a sensitivity analysis (not shown) revealed little impact of the
chosen lag time. Measurement error may also arise when the VAP status is less recorded for pa-
tients with a DNR code, e.g. by refraining from microbiological sampling or chest X-ray. Third,
unlike others, we do not provide subgroup analyses. This is because restriction of the analysis to
subgroups that are defined on the basis of time-dependent health characteristics may introduce
a collider-stratification bias (Bekaert et al., 2010a; Greenland, 2003). For instance, the analysis
of subgroups defined by the type of pathogen is challenging because the type of pathogen can
be related with time dependent health characteristics. Indeed, it is well know that Pseudomonas
aeruginosa often persists in cultures of tracheotomized patients. As such, this pathogen may in
a certain number of patients be a surrogate marker of tracheotomy, which by itself is a surrogate
marker of severe critical illness polyneuropathy. Further methodological development is needed
to enable the assessment of effect modification by time-dependent measures of disease severity.
Finally, one should also note that, while all patients involved in this analysis were ventilated
for more than 48hrs, 5.9% of the 685 patients who acquired a VAP were already extubated
>48hrs. This small percentage of patients may not be technically classified as VAP patients. A
re-analysis in which these patients are reclassified as non-VAP patients gave similar results: that
3.7% (95% CI 0.5% - 6.8%) of the deaths in the ICU on day 30 and 5.2% (95% CI 1.6%-8.6%)
on day 60 are attributable to VAP.
In conclusion, this study on the attributable mortality of VAP is the first which appropriately ac-
counts for the timing of acquiring VAP, for the existence of complex feedback relations between
VAP and disease severity, and for informative loss to follow-up after ICU-discharge. In contrast
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to the majority of previous reports we detected a relatively limited attributable ICU-mortality.
4
On model selection and model misspecification in
causal inference
This chapter is adapted from Vansteelandt et al. (2010a) and published in Statistical methods for
medical research with Gerda Claeskens as a coauthor. My contribution was mainly to the model
selection part and less to the part on model misspecification (sections 4.3.2 and 4.3.3).
Summary
Standard variable-selection procedures, primarily developed for the construction of outcome
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prediction models, are routinely applied when assessing exposure effects in observational stud-
ies. We argue that this tradition is sub-optimal and prone to yield bias in exposure effect es-
timates as well as their corresponding uncertainty estimates. We weigh the pros and cons of
confounder-selection procedures and propose a procedure directly targeting the quality of the
exposure effect estimator. We further demonstrate that certain strategies for inferring causal
effects have the desirable features (a) of producing (approximately) valid confidence intervals,
even when the confounder-selection process is ignored, and (b) of being robust against certain
forms of misspecification of the association of confounders with both exposure and outcome.
4.1 Introduction
The primary goal of most observational studies is to assess cause-effect relationships. Model-
selection procedures - in particular variable-selection procedures - are routinely employed in
this process, but rarely with regard to the ultimate focus on causal effects (Hand and Vinciotti,
2003; Claeskens and Hjort, 2003). In addition, the reliance on model-selection procedures is
commonly ignored when causal inferences are ultimately drawn. We will reconsider principles
of model-selection when the focus is on the estimation of causal effects. We give a brief outline
below.
Decisions to exclude/include covariates in a regression model are commonly based on the strength
of evidence for their (residual) association with the outcome. When the (causal) effect of a given
exposure on the outcome is targeted, then this routine strategy is not ideal and may result in a
potentially substantial bias in the exposure effect estimate. The decision to include covariates
in a regression model must ideally be based on the strength of evidence for these covariates
confounding the association between exposure and outcome. Since by definition, confounders
are simultaneously associated with exposure and outcome, procedures that ignore the covariate-
exposure association can be sub-optimal, especially for covariates that have strong associations
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with the exposure (Crainiceanu et al., 2008; Rubin, 1997). Causal inference procedures that nat-
urally evaluate the strength of covariate-exposure associations (e.g. propensity score adjusted
estimators (Rosenbaum and Rubin, 1983)) may thus behave differently than standard (outcome-
regression based) procedures, especially when combined with model-selection strategies.
In Section 4.2.1, we argue that the set of potential confounders amongst all measured covari-
ates is often high-dimensional in practice and that there is some tension between the desire to
acknowledge all of them through regularization methods, such as ridge regression, and the desire
to reduce the covariate space through confounder-selection procedures. We discuss limitations
of the most commonly adopted confounder-selection procedures in Section 4.2.3 and argue in
Section 4.2.4 that ideally such procedures should directly target the quality of the exposure ef-
fect estimator. One proposal is worked out in detail for logistic regression models and applied in
Section 4.2.5 to the analysis of an observational study for the effect of right-heart catherization
on 180-day mortality in critically ill patients. A limitation to the use of confounder-selection
strategies is that they have a tendency to produce under-covering confidence intervals by not
acknowledging model uncertainty. In Section 4.2.6 we focus on causal inference procedures
that return consistent causal effect estimators when a model for the exposure distribution, given
confounders, is correctly specified. We demonstrate that, surprisingly, these procedures remain
(approximately) confidence valid in the presence of exposure model selection. For this and other
reasons mentioned in the article, they thus succeed better than standard estimation procedures at
quantifying the total degree of uncertainty.
In the remainder of this chapter, we focus on the broader problem of model building as op-
posed to variable-selection. We discuss principles of causal model building in Section 4.3.1 and
examine the consequences of model misspecification in Section 4.3.2. In particular, we study
misspecification bias affecting so-called doubly robust (Robins and Rotnitzky, 2001) estima-
tion procedures which promise consistent estimation of causal effects when at least one of two
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(possibly overlapping) nuisance working models is correctly specified. This leads to estimation
procedures that perform well under more global forms of working model misspecification, which
are seen to substantially outperform more standard procedures in simulation studies reported in
Section 4.3.3.
4.2 Confounder-selection
4.2.1 Confounder-selection versus regularization
Throughout - unless otherwise specified - we assume that a possibly high dimensional collec-
tion of covariates is available, which includes all confounders for the effect of exposure A on
outcome Y , and thus contains at least one subset of covariates that are sufficient to control for
confounding (Greenland et al., 1999a). Determining such subset is impossible in the absence
of background knowledge on the causal data-generating mechanism (Robins, 2001). This is
largely because adjustment for covariates that are affected by the exposure or the outcome can
actually increase bias (Rosenbaum, 1984; Pearl, 2009a; Schisterman et al., 2009), which makes
purely associational approaches to confounder selection fallible (Hernan et al., 2002). Causal
diagrams (Greenland et al., 1999a; Pearl, 2009a; Robins, 2001) are very helpful to communicate
and visualize the data-generating mechanism and, subsequently, to identify covariate sets that
are sufficient for confounding control (Greenland et al., 1999a) (see chapter 1 for an introduc-
tion on causal DAG’s).
It is presumably true that in most realistic applications, all covariates in a sufficient covari-
ate set will have some association with both the outcome and the exposure (Greenland, 2008).
From that perspective, with concern for bias, it seems beneficial to adjust for all available co-
variates in the set (D’Agostino, 1998; Greenland, 2007, 2008). This has the further advantage
that, by acknowledging the uncertainty regarding all covariate effects, it returns a more honest
reflection of the overall uncertainty regarding the exposure effect estimator. However, it has the
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disadvantage that it may induce a bias and inefficiency as a result of overfitting in the outcome
regression model. To guard against this, one could use regularization methods such as ridge
regression (see Greenland (2008) and Budtz-Jorgensen et al. (2007) for convincing examples).
Alternatively, because propensity-score adjusted estimators can cope better with some overfit-
ting in the propensity score (Robins et al., 1992; Vansteelandt et al., 2010b), one could consider
propensity-score adjustment based on a fitted propensity score model which includes all avail-
able covariates (D’Agostino, 1998).
The folklore that conditioning on measured covariates reduces bias, must however be taken
with caution. This is not only true because of the increased concerns of model misspecification,
of possible shrinkage bias and of missing or mismeasured covariate data as more covariates are
considered. More fundamentally, evidence is accruing that even adjustment for antecedents of
the exposure may induce or aggravate selection bias. This may happen when, as in the causal
diagram of Figure 4.1, non-causal relationships are observed between the confounders L and
both exposure A and outcome Y . In that case, the adjustment for L induces a so-called M-bias
(Greenland et al., 1999a; Greenland, 2003; Pearl, 2009b; Sjolander, 2009) by connecting expo-
sure A and outcome Y along the path A← U1→ L← U2→ Y . When the causal effects of L
on exposure and outcome are weak, this bias may in principle exceed the bias of an unadjusted
analysis. In particular, when L affects neither exposure, nor outcome, then interestingly the un-
adjusted analysis, but not the adjusted analysis, would be valid. A further problem occurs when
the association betweenA and Y is confounded through an unmeasured common cause (i.e., U3
in Figure 4.1). In that case, the bias of the unadjusted analysis may surprisingly be amplified
upon adjusting for L, provided L is strongly correlated with the exposure (Wooldridge, 2009;
Pearl, 2010) (see also Section 4.2.1).
In view of the concerns for M-bias and bias amplification, it may be advantageous to adjust
for a strictly smaller subset of covariates that are minimally (Greenland et al., 1999b) sufficient
to control for confounding (in the sense that, given these covariates, all remaining covariates are
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Figure 4.1: Causal diagram with measured variables A,L and Y , and with U1, U2 and U3
unmeasured variables.
only associated with either the exposure or the outcome, but not both). Adjusting for a subset of
available covariates may have the further advantage of yielding more efficient effect estimators.
In particular, Hahn (2004) elegantly shows that adjustment for covariates that have no (resid-
ual) association with the outcome can reduce the efficiency of nonparametric estimators of the
marginal treatment effect, unlike adjustment for covariates that have no (residual) association
with the exposure. In view of this and of the aforementioned concerns about bias amplification,
it has been suggested that the selection of confounders should be based on their importance with
respect to the outcome, rather than the exposure (Pearl, 2010; Brookhart et al., 2006). Whether
such recommendation to reduce a sufficient set of confounders is successful, is arguable how-
ever. First, the results of Hahn (2004) refer to settings where a priori knowledge is available
that certain covariates have no residual association with the outcome. In practice, the selection
of confounders is virtually always (at least partly) data-driven, but the ensuing uncertainty is
most often ignored. Upon acknowledging the additional model uncertainty, one may well find
effect estimators obtained after variable-selection being less efficient than those obtained from a
full model which includes all available covariates (Budtz-Jorgensen et al., 2007; Claeskens and
Hjort, 2008). Second, in the next section we will find that in well designed studies where efforts
have been made to collect data on causal risk factors for the exposure that are also associated
with the outcome, the concerns for M-bias and bias amplification may be more modest. Third,
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even when these concerns are justified, then as a result of multicollinearity, it would still be
difficult to measure the importance of a covariate with respect to the outcome whenever that co-
variate is strongly correlated with the exposure. Standard variable-selection based on hypothesis
testing in outcome regression models may therefore lack power to detect even relatively strong
confounders.
Extensive simulation studies are needed, complementing the early work of Mickey and Green-
land (1989) and Maldonado and Greenland (1993), to be able to gauge the relative importance of
the aforementioned pros and cons of confounder-selection versus no selection. Making a choice
between these strategies is further complicated by the fact that M-bias and bias amplification oc-
cur only in the presence of unmeasured common causes of exposure, outcome and confounders,
so that one cannot protect against it or know to what extent these biases - which primarily affect
strategies that avoid selection - are present. In the following section, which may be skipped by
the less interested reader, we therefore attempt to develop insight into the extent to which the
concerns for M-bias and bias amplification are justified in practical applications.
4.2.2 M-bias and bias amplification
We compute the magnitude of the biases of the unadjusted and adjusted analysis in the Appendix
for multivariate normal variates following the path diagram of Figure 5.1, extending the work of
Wooldridge (2009) and Pearl (2010). Let ρ1 denote the standardized path coefficients (Wright,
1934) between A and U1, L and U1, L and U2, or Y and U2 (which we assume to be equal for
simplicity), ρ2 denote the standardized path coefficients betweenA and U3, or Y and U3 (which
we assume to be equal for simplicity), ρal denote the correlation betweenA and L and ρyl denote
the correlation between Y and L in the absence of an exposure effect (or upon setting A to a
fixed value, uniformly in the population). Then the bias of the adjusted analysis (either based
on standard regression adjustment or based on inverse probability weighting by 1/f(A|L); see
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Section 4.3.2) is
ρ22 − ρ41
1− ρ2al
,
where the first term reflects bias due to the unmeasured common cause U3 of A and Y , and the
second term reflects M-bias; that is, the two terms reflect spurious associations along the paths
A ← U3 → Y and A ← U1 → L ← U2 → Y , respectively. The denominator suggests that
strong correlations between exposure and measured confounders not only have a tendency to
amplify bias resulting from unmeasured confounders U3, in line with the conclusions of others
(Wooldridge, 2009; Pearl, 2010), but also M-bias. The bias of the unadjusted analysis is
ρalρyl − ρ41 + ρ22,
which does not suffer this amplification. Here, the first two terms encode bias due to not ad-
justing for the measured confounder L and the last term measures bias due to the unmeasured
common cause U3 of A and Y ; that is, the three terms reflect spurious associations along the
paths A ← U1 → L → Y , A ← L → Y , A ← L ← U2 → Y and A ← U3 → Y . We
thus find that the adjusted analysis will have larger bias than the unadjusted analysis when the
correlation between Y and L (other than through A) is sufficiently weak in the sense that
ρyl <
ρal
1− ρ2al
(ρ22 − ρ41). (4.1)
Even if the presence of an unmeasured common cause U3 ofA and Y could be ruled out, the
existence of unmeasured common causes such as U1 and U2 would be difficult to exclude in any
given application. In particular when L is high-dimensional, it would be difficult to believe that
all of its components are only linked to A or Y by means of a causal effect. This suggests that
M-bias is likely to arise in practice, although the fourth order terms express that its magnitude is
likely going to be small. Similar findings were obtained by (Greenland, 2003) in the all binary
case. An exception occurs when the correlation between A and L is strong, for then even a
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modest degree of M-bias may in principle be amplified by a potentially important magnitude.
4.2.3 Confounder-selection strategies
Amongst the various confounder-selection strategies that are routinely adopted in practice, back-
ward elimination based on hypothesis tests in outcome regression models is the default strategy.
It is not ideal, however, because it is based on accepting the null hypothesis when covariates are
non-significantly associated with the outcome (Greenland, 2008) and because it ignores the as-
sociation between exposure and covariates when deciding whether a given covariate confounds
the association between exposure and outcome (Crainiceanu et al., 2008). As such, it has a
tendency to under-select important confounders (Greenland and Neutra, 1980) by ignoring co-
variates that have relatively weak associations with the outcome (conditional on the exposure),
but strong associations with the exposure (Crainiceanu et al., 2008; Rubin, 1997). Such co-
variates are typically dismissed because they induce problems of multicollinearity (arising from
correlation between the exposure and covariates), thereby inflating the uncertainty on the es-
timated treatment effect. This uncertainty is often interpreted as a sign of inefficiency, which
is justified in some cases but should more generally be viewed as a reflection of the lack of
information about the exposure effect (Tan, 2008). By eliminating these covariates, one thus
risks not only to induce a bias in the estimated exposure effect, but also to understate the actual
uncertainty. Precisely in settings where there is much separation in the covariate distributions
of exposed and unexposed subjects, and therefore much uncertainty about the exposure effect,
conventional backward elimination strategies will tend to remove covariates from the outcome
regression model and, thereby, yield misleadingly precise exposure effect estimates. Similar
concerns apply to penalization methods such as the lasso or elastic nets (Tibshirani, 1996; Zou
and Hastie, 2005) and certain confounder-selection methods based on identification results for
minimally sufficient sets of confounders (Greenland et al., 1999b; De Luna et al., 2010) because
of their tendency to dismiss covariates that are strongly associated with the exposure.
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In epidemiology, some of these concerns have contributed to the popularity of change-in-estimate
procedures which tend to have better success (Greenland and Neutra, 1980; Mickey and Green-
land, 1989; Maldonado and Greenland, 1993) by directly evaluating the impact of confounder-
selection on the magnitude of the exposure effect estimate. While these target more directly a
reduction of confounding bias, also these approaches are not ideal because they ignore estima-
tion uncertainty and may be inefficient by under-selecting covariates that are only predictive of
the response (Greenland, 1986). Furthermore, apart from finite-sample imprecision and model
misspecification, inclusion of a covariate in a regression model may induce a change in treatment
effect estimate, even when that covariate is not a confounder of the exposure-outcome relation.
This may happen as a result of non-collapsibility of association measures in nonlinear mod-
els (Mickey and Greenland, 1989; Maldonado and Greenland, 1993; Greenland et al., 1999b),
which may change in magnitude upon adjusting for a covariate that is solely associated with the
outcome (but independent of the exposure). This may also happen as a result of M-bias or bias
amplification in both linear and nonlinear models.
4.2.4 Focused confounder selection
We believe that an ‘optimal’ confounder-selection strategy should focus on the quality of the
exposure effect estimator. We will therefore closely follow the idea of change-in-estimate pro-
cedures, but accommodate their limitations, albeit necessarily presupposing that there are no
unmeasured confounders (i.e. in particular, that U3 and either U1 or U2 are absent in the
causal diagram of Figure 4.1). Specifically, let τ∗ denote the target effect parameter and τˆ
an estimator of it. Then we will focus confounder-selection on the precision of the exposure
effect estimator, as measured through its mean squared error E{(τˆ − τ∗)2}. Our choice not
to pursue conventional confounder-selection procedures based on the likelihood function (e.g.
based on the AIC or BIC), is further guided by the fact that, as shown in Section 4.3.2, stan-
dard maximum likelihood inference can be sub-optimal for the estimation of nuisance working
models (e.g. for modeling the association of confounders with either the outcome or exposure).
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Mean squared error is also the focus of Claeskens and Hjort (2003), whose focused informa-
tion criterion (FIC) is based on exact or asymptotic calculations in parametric models, and of
Brookhart and van der Laan (2006) who use cross-validation instead. Alternatively, one could
focus model/confounder selection on the (counterfactual) prediction error, as in Claeskens et al.
(2006), who use a prediction-focused information criterion, and Mortimer et al. (2005) and
Haight et al. (2010) who use cross-validation instead.
Given our focus on the mean squared error of the exposure effect estimator, an important consid-
eration is whether the estimators τˆS corresponding to different models S are all consistently esti-
mating the same parameter τ∗ under correct model specification. This is not usually the case for
conditional exposure effects due to noncollapsibility of nonlinear association measures (Green-
land et al., 1999b) and the possibility of effect modification. This makes approaches for model-
selection focused on the mean squared error not entirely appropriate for estimating the usual
conditional exposure effects. This problem can be overcome by targeting confounder-selection
at the marginal or population-averaged exposure effect. For instance, let A be a dichotomous
exposure (taking values 0 and 1) and consider the parameter β∗ indexing logitP (Y = 1|A,L) =
ω(L; γ∗) + β∗A, where is ω(L; γ) a known function, smooth in γ, and γ∗ is an unknown finite-
dimensional parameter. For instance, ω(Li; γ) = γ0 + γlLi in the case of standard regression
adjustment, or ω(Li; γ) = γ0+γppi(Li; γ) with pi(Li; γ) = P (Ai = 1|Li; γ) = expit(γ1+γlLi)
in the case of propensity score adjustment (Rosenbaum and Rubin, 1983). Then, with Y (a) de-
noting the counterfactual outcome following exposure level a, the marginal causal odds ratio
τ∗ = odds{Y (1) = 1}/odds{Y (0) = 1} can, for given estimates γˆ of γ∗ and βˆ of β∗, be
estimated as
τˆ =
∑n
i=1 expit
{
ω(Li; γˆ) + βˆ
}
/
∑n
i=1 expit
{
−ω(Li; γˆ)− βˆ
}
∑n
i=1 expit {ω(Li; γˆ)} /
∑n
i=1 expit {−ω(Li; γˆ)}
. (4.2)
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Thus focussing on the marginal treatment effect τ∗, we propose the following focused confounder-
selection procedure, which inherits from work by Claeskens et al. (2006) and Crainiceanu et al.
(2008). We divide the model space into M + 1 orbits, where M is the number of potential
covariates (i.e., confounders and/or functions of confounders, such as higher order terms or in-
teractions) and where the jth orbit, j = 1, . . . ,M+1 comprises all models with j−1 covariates
and an intercept. Within each orbit, we select the outcome regression model that minimizes the
mean squared error of τˆ . This is done using the following stochastic search method, which is
closely linked to that in Crainiceanu et al. (2008). Starting from a model in the (j − 1)th orbit,
we add the covariate that provides the largest reduction in mean squared error. The stochas-
tic search then selects at random one covariate which is in the model and one which is not in
the model, and constructs a new model by interchanging both covariates. The new model is
accepted when Lnew < Lold, where Lold and Lnew are the mean squared errors of τˆ under
the old and new model, respectively. When Lnew > Lold, the new model is accepted with
probability (Lold/Lnew)α, where α is a user-selected tuning parameter. Alternatively, a dele-
tion/substitution/addition algorithm (Haight et al., 2010) could be used, which involves exhaus-
tive model search within model subclasses obtained by either deleting, substituting or adding
one covariate to those already available in the model. In this process, the mean squared error
can be estimated based on a cross-validation procedure where the data are partitioned into a
training sample and validation sample V times. That is, the mean squared error of the esti-
mator τˆ can be approximated with (1/V )
∑V
v=1 (τˆv − τˆ0)2, where τˆv is the estimator of τ∗ as
obtained under the considered model on the training sample, and where τˆ0 is an estimator of
τ∗ as obtained under the full model on the validation sample. Minimization of this estimated
loss function is then equivalent to minimization of the mean squared error when the estimator
τˆ0 is unbiased (Brookhart and van der Laan, 2006). Computing time can be drastically reduced
through asymptotic approximations of the mean squared error, which can be made under a local
misspecification assumption (see Section 4.2.6). A framework for this is developed in Hjort and
Claeskens (2003) for parametric models and adapted to our specific setting in the appendix.
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4.2.5 Application
We evaluate the proposed confounder-selection procedure in an observational study investigating
the effect of right heart catherization (RHC) on 180 day mortality in 5735 critically ill patients
(Connors et al., 1996). For every patient, the exposure of interest A was coded 1 if RHC was
used within 24 hours of admission and 0 otherwise. In total, 61 covariates (L) on the patients’
underlying health condition within 24h of ICU admission (physiological status), on their under-
lying comorbidity and on demographic information were available for analysis. The original
analysis (Connors et al., 1996) used logistic regression to develop an estimated propensity score
for each patient, which was then used for matching RHC patients to non-RHC patients. In this
Section, we will contrast different confounder-selection methods, including the one proposed in
the previous section. R-code for the analyses can be found in the appendix
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Figure 4.2: Left: Mean squared error (MSE) of the best model within each orbit which is ob-
tained by minimizing the mean squared error of the marginal log odds ratio (MLOR) Right:
Estimates of the marginal and conditional log odds ratio as obtained through FIC-based covari-
ate adjustment, and through AIC-based selection as in Crainiceanu et al.
Figure 4.2 (left) shows the mean squared error (MSE) for the best model within each orbit
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as obtained by minimizing the mean squared error of the marginal log odds ratio (MLOR) (or
equivalently, by minimizing the focused information criterion (FIC) which measures the mean
squared error of the MLOR up to an additive constant, see the Appendix) in the case of standard
covariate adjustment (i.e., ω(Li; γ) = γ0 + γlLi in Section 4.2.4). The MSE is largest for the
narrow (due to large bias) and full model (due to large variance); minimal MSE is attained for
simple models involving 2 covariates only. For illustrative purposes, Figure 4.2 (right) compares
the thus obtained estimates for the MLOR under standard covariate adjustment (solid black line)
with the conditional log odds ratios (CLOR) corresponding to the same models (dotted line).
It demonstrates the stability of the estimated MLOR over the different orbits, which is useful
information in itself as the observed stability strengthens confidence in the analysis results. It
suggests also increasing conditional treatment effect estimates over different orbits, which is
due to noncollapsibility of the odds ratio. This underscores the potential limitations of variable-
selection procedures that focus on conditional effect measures, which tend to mix confounding
with non-collapsibility of association measures.
Figure 4.2 (right) also displays the results obtained upon applying the procedure advocated in
Crainiceanu et al. (2008). This procedure involves first selecting covariates on the basis of their
association with the exposure as measured in terms of the AIC, and subsequently selecting any
remaining covariates on the basis of their residual association with the outcome, again measured
in terms of the AIC. The estimates for the CLOR (which is the focus of that procedure) are
initially very unstable as a result of selecting covariates that are strongly associated with the ex-
posure, but not with the outcome. Stability in the estimates is attained only for very large orbits
which, again, may be partly due to non-collapsibility of the odds ratio. Like standard model
selection procedures, it thereby gives a somewhat misleading impression that the association
between RHC and mortality is confounded by many of the measured covariates. The proposed
procedure improves upon this (a) by focusing the model selection on a parameter which is iden-
tically defined over the different orbits, and (b) by selecting covariates on the basis of their
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potential to increase the precision of the treatment effect estimate, as well as their ability to
reduce confounding in the treatment effect estimate.
Model selection technique # covariates COR MOR 95% CI MSE FIC
Unadjusted analysis 0 1.25 1.25 [1.14 to 1.37] 0.0037 5.99
Full model 61 1.42 1.32 [1.18 to 1.49] 0.0035 5.01
BE covariate adjustment 15 1.39 1.31 [1.17 to 1.46] 0.0033 3.87
AIC (Crainiceanu et al.) 47 1.42 1.33 [1.18 to 1.49] 0.0035 4.94
FIC covariate adjustment 2 1.36 1.33 [1.21 to 1.46] 0.0027 0.04
Table 4.1: Estimates of the effect of RHC on mortality, as obtained using different confounder-
selection techniques and reported in terms of the conditional odds ratio (COR), the marginal odds
ratio (MOR) with 95% confidence interval, MSE (mean squared error) and the FIC (focused
information criterion).
Table 4.1 reports estimates of the effect of RHC on mortality as obtained from these different
confounder-selection procedures. As shown in Figure 4.2 (left), minimal MSE is attained for
simple models involving 2 covariates only (age and a covariate which indicates the presence of a
Solid Tumor, Metastatic Disease, Chronic Leukemia/Myeloma, Acute Leukemia or Lymphoma)
and results in a MOR of 1.33 (95% CI 1.21 to 1.46). The unadjusted analysis gave a MOR of 1.25
(95% CI 1.14 to 1.38) with an MSE of 0.0037, versus 0.0035 for the full model. In contrast, the
‘optimal’ model of Crainiceanu et al. (2008) includes 36 predictors of right heart catherization,
regardless of their association with the outcome, and 11 additional covariates on the basis of
their residual association with the outcome. Also covariate adjustment and propensity score
adjustment based on backward elimination (BE) strategies tend to select many more covariates
at the expense of accuracy. They do so because the decision to enter covariates into the model
is based on either their association with the outcome (as in standard covariate adjustment), or
their association with the exposure (as in propensity score adjustment), but not on the basis
of a more balanced evaluation in terms of the quality of the treatment effect estimate. Given
the large number of patients in this study, many of these associations are strong in terms of
the evidence provided by p-values, but not necessarily in terms of their potential to distort the
treatment-outcome association by an important magnitude.
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4.2.6 Model uncertainty
In small data sets where the variance of the exposure effect estimator is dominant, focused
confounder-selection strategies might have a tendency to delete confounders when their adjust-
ment causes a large variance inflation. While this may be beneficial to the overall accuracy of
the exposure effect estimator, a concern is that it may come at the expense of confidence valid-
ity, considering that confidence intervals capture sampling variability, but not bias. Confidence
validity may be further compromised by the fact that uncertainty resulting from the data-driven
model building process is commonly ignored. Although the bootstrap or asymptotic approx-
imations (Hjort and Claeskens, 2003) could be used to acknowledge this, these are often not
considered in practice. We will now argue that these concerns can be tempered to some extent
by the use of propensity-score based estimators.
First, propensity-score based estimators which force important predictors of the exposure into
the propensity score (e.g. the procedure advocated by Crainiceanu et al. (2008)) are relatively
less susceptible to bias resulting from insufficient confounding adjustment because the set of
confounders forms a subset of the exposure predictors; the same is not true for approaches
which rely on outcome predictors because the magnitude of the residual association between
outcome and predictor, given the exposure, is difficult to assess for predictors that are strongly
associated with the exposure. A drawback is that such propensity-score based procedures can be
inefficient and more prone to bias amplification when they include predictors that have (almost)
no residual association with the outcome (Pearl, 2010; Brookhart et al., 2006).
Second, in the Appendix, we study the asymptotic behaviour of exposure effect estimators
which solely rely on correct specification of a propensity score model, as obtained after model-
selection. Examples are the G-estimator (Robins et al., 1992) and the inverse probability weighted
estimator (Robins et al., 2000) of the average causal effect (see Section 4.3.2). Because the po-
tential for model misspecification cannot be ignored in the presence of model-selection, the
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asymptotic behaviour of such estimators is examined within the local misspecification frame-
work of Hjort and Claeskens (2003). More precisely, we assume that the true exposure data-
generating mechanism is of the form f(A|L) = f(A|L;α∗1, α∗2 + δ/
√
n), with f(A|L;α1, α2)
a conditional density function of A, given L, which is smooth in α1 and α2, where α∗1 and δ are
unknown finite-dimensional parameters and where α∗2 is a chosen finite-dimensional parameter
(e.g. α∗2 = 0). Here, α1 encodes the unknown part of the parameter vector which is shared be-
tween all competing submodels. Each exposure working model, denoted S, thus assumes some
of the components α−S of α2 to be known and equal to the corresponding components of α∗2,
and assumes the remaining components αS to be unknown. Note that the reason to allow for
misspecification of the model parameters within a 1 over root-n distance is because in large sam-
ples standard model selection techniques would systematically choose the narrow model (which
assumes α2 equals α∗2) when smaller misspecifications are considered, and systematically select
the wide model (which assumes α2 is unknown) when larger misspecifications are considered
(Hjort and Claeskens, 2003).
In the Appendix, we then show that interestingly a conservative asymptotic variance of the con-
sidered exposure effect estimators is obtained when imprecision due to estimation and model-
selection on the propensity score is ignored, provided that an efficient estimator is used for the
parameters indexing the propensity score model. This result is of importance as it suggests
that the model/confounder-selection procedure can be ignored in inference about the exposure
effect, provided that the local misspecification assumption holds. It does not immediately fol-
low, however, that confidence intervals which ignore estimation and model uncertainty in the
propensity score will attain the nominal coverage probability. This is because, as shown in the
Appendix, the distribution of the exposure effect estimator in the presence of model-selection is
not centered at zero, but follows a mixture distribution with bias components converging at root-
n rate to zero. Preliminary simulation studies (not shown) confirmed that, nonetheless, close to
nominal coverage levels are attained even when this is ignored.
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4.3 Model building
4.3.1 Principles of causal model building
We will now broaden the focus from confounder-selection to model building. Though histor-
ically, the use of parametric models combined with maximum likelihood inference has been
dominant (cfr. structural equation models (SEMs)), more recently - stimulated by pioneering
work of James Robins - a trend is now seen towards semi-parametric modeling of causal effects.
Path diagrams, used by SEM practitioners as convenient representations of a multivariate normal
model and as convenient tools for combining path-specific effects into exposure effects of inter-
est, are substituted by ‘non-parametric’ causal diagrams (Pearl, 1998); these can be combined
with semi-parametric models directly parameterizing the exposure effect of interest (Robins,
1997).
The appeal of semi-parametric inference for causal effects surmounts the usual concerns for
model misspecification and limited flexibility in parametric inference. Parametric likelihood-
based procedures explicitly ignore information on the exposure distribution which has never-
theless demonstrated to be relevant for confounder-selection in Sections 4.2.5 and 4.2.6. For
instance, in the absence of an exposure effect, the common strategy of forcing the exposure
into the model may lead one to systematically ascribe an effect of extraneous covariates to an
exposure effect (Robins and Greenland, 1986). This can be overcome using propensity score
methods which force the propensity score into the outcome regression model, irrespective of
whether it is significantly associated with the outcome. Robins and Ritov (1997) underscored
more formally the importance of using information on the exposure distribution in causal infer-
ence by demonstrating that, due to the curse of dimensionality, likelihood-based procedures fail
to estimate treatment effects in randomized experiments where randomization is conditional on
a high-dimensional covariate; see also (Vansteelandt et al., 2008; Rosenblum and van der Laan,
2009).
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In further clarification of the philosophical principles behind semi-parametric modeling of causal
effects, suppose that interest lies in the direct effect of A on Y which is not mediated by M in
the causal diagram of Figure 4.3.1. SEM procedures would typically dismiss U from the path di-
agram and thereby arrive at biased causal effect estimates. Alternatively, they would include U ,
thus requiring models for the conditional densities f(Y |A,M,U), f(L|U) and f(U), and sub-
sequently yield causal effects conditional on U . These are not only difficult to specify, estimate
and interpret by the fact that U is unmeasured, but additionally raise questions as to whether
the identification of the direct effect under the model comes from structural assumptions (e.g.,
assumptions about the absence of specific direct effects or common causes) alone, or from para-
metric assumptions (e.g. regarding the distribution of U ) in addition. In the latter case, we say
that the considered causal effect is not non-parametrically identified (Scharfstein et al., 1999).
This is not ideal as it can make the results heavily sensitive to the chosen (semi-)parametric
modeling assumptions (see e.g. Little (1985) and Scharfstein et al. (1999); see Vansteelandt
(2009a) for an example illustrating the importance of nonparametric identification in a more
general context).
G-computation (Robins, 1986) enables identifying the counterfactual mean E{Y (a,m)} cor-
responding to setting the exposure A at a and the mediator M at m as
∫
E(Y |A = a,M =
m,L)f(L|A = a)dL, where the conditional mean E(Y |A,M,L) and density f(L|A) could
be substituted with parametric likelihood-based estimators. Also this approach is not ideal as
it does not directly parameterize the (controlled) direct effect (Robins and Greenland, 1992)
E{Y (a,m) − Y (a∗,m)} of interest and henceforth does not enable researchers to express hy-
potheses of interest (e.g., that a direct effect of A on Y is not modified by M ) in a parsimonious
way. In addition, it is essentially impossible to postulate nonlinear models for E(Y |A,M,L)
and f(L|A), which accommodate a dependence on A (as suggested by Figure 4.3.1), and are
such that
∫
E(Y |A = a,M = m,L)f(L|A = a)dL does not depend on a for all m. This is the
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root cause of the so-called null paradox (Robins, 1997) according to which G-computation based
tests of the null hypothesis of no direct effect will with certainty be rejected in large samples.
These subtleties underscore the importance of parameterizing the exposure effect of interest di-
rectly, which may be most naturally approached through the use of semi-parametric inference
(Robins, 1999; VanderWeele, 2009; Vansteelandt, 2009b).
A
Y
L
M
U
Figure 4.3: Causal diagram with measured variables A,L,M and Y , and with U an unmeasured con-
founder of the L-Y relationship.
4.3.2 Model misspecification
Many semi-parametric procedures for causal effects separate the modeling of confounders from
the modeling of the causal effects of interest. The use of complex confounder models thus
need not complicate the interpretation of results; however, their misspecification may induce
a bias in the exposure effect estimator. To enrich our understanding, we study the impact of
working model misspecification in more detail for so-called G-estimators (Robins et al., 1992)
and inverse probability weighted (IPW) estimators (Robins et al., 2000) under the assumption
that
E(Y |A,L) = ω∗0(L) + τ∗A
for some unknown function ω∗0(L) of L, where τ∗ encodes the exposure effect. For simplicity
of exposition, we assume that A is a dichotomous exposure, taking values 0 and 1, and that Y
is a continuous outcome. The G-estimator (Robins et al., 1992) is obtained as the solution to an
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estimating equation of the form
0 =
n∑
i=1
{Ai − pˆi(Li)} {Yi − τAi − φωˆ0(Li)} ,
where ωˆ0(L) and pˆi(L) are estimates of ω∗0(L) and the propensity score pi∗(L) = P (A = 1|L),
respectively, based on possibly misspecified models. Further, φ is a user-specified constant. If
set to 0, it yields the so-called G-estimator which is a consistent and asymptotically normal
(CAN) estimator of τ∗ if pˆi(L) is a consistent estimator of pi∗(L) for all L. In linear models,
this estimator is equivalent with the ordinary least squares estimator obtained via regression
adjustment for the propensity score (Rosenbaum and Rubin, 1983). If set to 1, it yields the so-
called doubly-robust G-estimator which is a CAN estimator of τ∗ if for each L, either pˆi(L) is a
consistent estimator of pi∗(L) or ωˆ0(L) is a consistent estimator of ω∗0(L). Here, ωˆ0(L) may be
obtained via a standard (linear) regression model forE(Y |A,L); pˆi(L) is typically obtained via a
standard logistic regression model. The resulting (doubly-robust) G-estimator can be calculated
as
τˆG(φ) =
∑n
i=1 {Ai − pˆi(Li)} {Yi − φωˆ0(Li)}∑n
i=1 {1− pˆi(Li)}Ai
.
The (doubly robust) inverse probability weighted (IPW) estimator (τˆIPW (φ)) (Robins et al.,
2000) is obtained as
n∑
i=1
Ai
pˆi(Li)
{Yi − φωˆ1(Li)} − 1−Ai1− pˆi(Li) {Yi − φωˆ0(Li)}+ φ {ωˆ1(Li)− ωˆ0(Li)} ,
where ωˆ1(L) and ωˆ0(L) are estimates of E(Y |A = 1, L) and E(Y |A = 0, L), respectively,
based on possibly misspecified models. Again, φ is a user-specified constant. If set to 0, it yields
the so-called IPW-estimator which is a CAN estimator of τ∗ if pˆi(L) is a consistent estimator of
pi∗(L) for all L. If set to 1, it yields the so-called doubly-robust IPW-estimator which is a CAN
estimator of τ∗ if either pˆi(L) is a consistent estimator of pi∗(L) for each L or ωˆj(L), j = 0, 1 is
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a consistent estimator of E(Y |A = j, L) for each L (Leon et al., 2003).
Over the past decade, much attention has been given to the development of doubly robust esti-
mation procedures (Robins and Rotnitzky, 2001). Facing the truth that in practice ‘all’ models
are misspecified, the practical benefit of such doubly robust procedures has been questioned
and concerns have been raised that such procedures may be very sensitive to misspecification
affecting both nuisance working models (Kang and Schafer, 2008). We therefore evaluate the
asymptotic bias (i.e., mean difference between the estimator and estimand) of the suggested G-
estimators and IPW estimators under misspecification occurring in all nuisance working models.
Upon using that the asymptotic bias of a root-n (asymptotically linear) estimator of τ∗ with es-
timating function U(τ) equals E {∂U(τ∗)/∂τ}−1E {U(τ∗)}, we obtain asymptotic biases of
E [{pi∗(L)− pi(L)} {ω∗0(L)− φω0(L)}]
E [{1− pi(L)}pi∗(L)] (4.3)
for the G-estimator, and
E
[{
pi∗(L)
pi(L)
− 1
}
{ω∗0(L) + τ∗ − φω1(L)} −
{
1− pi∗(L)
1− pi(L) − 1
}
{ω∗0(L)− φω0(L)}
]
,
(4.4)
for the IPW-estimator. Here, pi(L), ω1(L) and ω0(L) are the probability limits of pˆi(L), ωˆ1(L)
and ωˆ0(L), respectively.
We will first focus on the estimators that set φ equal to zero. These are consistent estima-
tors of τ∗ under correct specification of the propensity score, but not necessarily otherwise. It
is then seen that any degree of model misspecification in the propensity score of magnitude
δ(L) = pi∗(L) − pi(L) at a given L, yields a contribution to the bias of the G-estimator of
magnitude
δ(L)ω∗0(L)
E [{1− pi(L)}pi∗(L)] (4.5)
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and to the bias of the IPW-estimator of magnitude
δ(L)
[
ω∗0(L)
{1− pi(L)}pi(L) +
τ∗
pi(L)
]
. (4.6)
In the absence of an exposure effect (i.e. τ∗ = 0), the bias contribution of the IPW-estimator is
thus
E [{1− pi(L)}pi∗(L)]
{1− pi(L)}pi(L)
times that of the G-estimator. This ratio can be substantial within L-regions corresponding to
propensity score values close to 0 or 1. Considering that such regions are typically located in the
tails of the data distribution where model misspecification is more likely, we conclude that the
IPW-estimator will generally be much more vulnerable than the G-estimator to misspecification
of the propensity score.
Interestingly, the G-estimator can be consistent under misspecification of the propensity score
model. This would happen for instance if the propensity score model were of the form pi(L) =
expit(α∗′L), α∗ were estimated using a maximum likelihood procedure and ω∗0(L) happened to
be linear inL. In that case, the fitted propensity score would satisfy 0 = E [{A− pi(L)}ω∗0(L)] =
E {δ(L)ω∗0(L)}, thus giving the estimating functions for the G-estimator, and in particular the
bias term (4.5), mean zero. This is not the case for the IPW estimator when the propensity score
is fitted using maximum likelihood inference as it follows from (4.6) that its bias due to propen-
sity score misspecification depends on the magnitude of the exposure effect. Any cancelation of
the bias of the IPW estimator under propensity score misspecification must thus be accidental
in the sense of occurring only at one specific exposure effect size τ∗. Following a Bayesian
argument (with an absolutely continuous prior density on τ ), such cancelation occurs with zero
probability. In view of this, it can be desirable to estimate the propensity score in such a way
that consistency of the IPW-estimator is attained within a larger class of data-generating distri-
butions than those that correspond to a correctly specified propensity score model. In particular,
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we recommend calculating the IPW-estimator (τˆIPW (φ)) as
n∑
i=1
Ai
pˆi1(Li)
{Yi − φωˆ1(Li)} − 1−Ai1− pˆi0(Li) {Yi − φωˆ0(Li)}+ φ {ωˆ1(Li)− ωˆ0(Li)} ,
where φ is as before, pˆi1(Li) is a consistent estimator of pi(Li) obtained by solving an estimating
equation of the form
0 =
n∑
i=1
(
Ai
pi(Li)
− 1
)
ϕ(Li), (4.7)
and pˆi0(Li) is a consistent estimator of pi(Li) obtained by solving an estimating equation of the
form
0 =
n∑
i=1
(
1−Ai
1− pi(Li) − 1
)
ϕ(Li), (4.8)
where ϕ(Li) is an arbitrary index function of the dimension of α∗. Note that we use the same
propensity score model, but different consistent estimators for the probability of exposure ver-
sus no exposure. Cancelation of the asymptotic bias may now occur when ϕ(L) includes the
constant 1 and ω∗0(L) happens to be a linear combination of the components in the vector ϕ(L).
This can be seen from (4.4) with φ = 0 upon noting that (4.7) and (4.8) then imply
E [{pi∗(L)/pi(L)− 1}ω∗0(L)] = E [{(1− pi∗(L))/(1− pi(L))− 1}ω∗0(L)] = 0
. This would happen for instance if ϕ(L) = (1, L)′ and ω∗(L) happened to be linear in L. Note
also that when ϕ(L) includes the constant 1, then the asymptotic bias of the IPW-estimator is no
longer dependent upon τ∗ because it follows from equation (4.7) that E {pi∗(L)/pi(L)} equals
1 in that case. In addition, the fitted propensity scores pˆi1(Li) (pˆi0(Li)) are then such that the
sum of the weights 1/pˆi1(Li) (1/{1 − pˆi0(Li)}) in the exposed (unexposed) subjects equals the
total sample size. We will therefore refer to estimation of the propensity scores following (4.7)
and (4.8) as stabilized estimation. With a different attainment goal in mind, namely improving
the stability of inverse weighting procedures,Cao et al. (2009) make a related, although different
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proposal in a missing data context.
We will now focus on doubly-robust estimators obtained by setting φ = 1. It is easily seen from
both bias expressions (4.3) and (4.4) that any degree of model misspecification in the propensity
score of magnitude δ(L) = pi∗(L)−pi(L) at a given L, and in the outcome regression models of
magnitudes ∆1(L) = ω∗0(L) + τ∗ − ω1(L) and ∆0(L) = ω∗0(L)− ω0(L) yields a contribution
to the bias of the doubly-robust G-estimator of magnitude
δ(L)∆0(L)
E [{1− pi(L)}pi∗(L)] (4.9)
and to the bias of the doubly-robust IPW-estimator of magnitude
δ(L)
[
∆1(L)
pi(L)
− ∆0(L)
1− pi(L)
]
. (4.10)
It is immediate from these expressions that the doubly-robust G- and IPW-estimator have mean
zero under misspecification of one, but not both nuisance working models. These estimators
will typically also have smaller bias under propensity score misspecification than the previously
considered G-estimator and IPW-estimator because any misspecification of magnitude δ(L) now
gets inflated only proportional to the degree of misspecification in the outcome regression model.
Interestingly, the doubly-robust G-estimator not only is consistent under the union model which
correctly specifies either the propensity score or the outcome regression, but also under certain
data-generating mechanisms corresponding to misspecification affecting both nuisance work-
ing models. This would occur, for instance, if the misspecified propensity score model were
of the form pi(L) = expit(α0 + α1L + α2L2) and fitted using maximum likelihood inference,
the fitted outcome regression model were of the form ω(L) = γ0 + γ1L and ω∗(L) happened
to be linear in L and L2. Indeed, in that case the fitted propensity score model would satisfy
E [{A− pi(L)} {ω∗0(L)− ω0(L)}] = E {δ(L)∆0(L)} = 0. The doubly-robust IPW-estimator
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with propensity scores fitted through maximum likelihood inference does not satisfy a similar
property. In addition, it follows from (4.10) that misspecification in the regression model for
E(Y |A = 1, L) (or E(Y |A = 0, L)) can get dramatically inflated in L-regions where data
on exposed subjects (on unexposed subjects) are relatively scarce. These are regions where
model misspecification is also most likely, suggesting that doubly robust IPW-estimators may in
fact exacerbate the extrapolation problem in view of which propensity-score adjusted estimators
were designed. As a way of improving the performance of doubly robust estimators in the pres-
ence of influential weights, Robins et al. (2008) proposed fitting the outcome regression models
ω1(L) and ω0(L), respectively, via standard weighted regression in the exposed and unexposed
subjects, with weights 1/pi(L) and 1/{1− pi(L)}, respectively:
0 =
n∑
i=1
Ai
pˆi(Li)
{Yi − ωˆ1(Li)}ϕ1(Li) (4.11)
0 =
n∑
i=1
{
1−Ai
1− pˆi(Li)
}
{Yi − ωˆ0(Li)}ϕ0(Li), (4.12)
where ϕ1(Li) and ϕ0(Li) are arbitrary vector functions of the dimension of the unknown pa-
rameters indexing ω1(Li) and ω0(Li), and including the constant 1. They refer to the resulting
doubly robust estimator of the exposure effect as a regression doubly robust estimator. The
advantage of this is clear from the fact that the above equations imply that
E {(1 + δ(L)/pi1(L))∆1(L)} = 0
and
E {(1− δ(L)/(1− pi0(L)))∆0(L)} = 0
so that the asymptotic bias of the doubly-robust IPW-estimator becomes
δ(L)
[
∆1(L)
pi(L)
− ∆0(L)
1− pi(L)
]
= −E {∆1(L)−∆0(L)} .
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Bias due to model misspecification in the tails of the data distribution is thereby no longer
inflated. Further robustness against model misspecification is attained by fitting the propensity
score through equations (4.7) and (4.8), for then bias due to model misspecification cancels
whenever ∆1(L) and ∆0(L) happen to be linear combinations of the components of ϕ(L).
This would occur, for instance, if the misspecified propensity score model were of the form
pi(L) = expit(α0 +α1L+α2L2), ϕ(L) = (1, L, L2), the fitted outcome regression model were
of the form ω(L) = γ0 + γ1L and ω∗0(L) happened to be linear in L and L2.
4.3.3 Simulation study
In this section, we illustrate the impact of global misspecification of the nuisance working mod-
els in G-estimators and IPW-estimators through a small simulation study. In each of 5000 sim-
ulation runs, a data set of 500 independent samples was generated with L a standard normal
variate. In the first experiment, Y = −2 + A + 2L + N(0, 1) and pi∗(L) = expit(−3 + L).
In the next 4 experiments, Y = −2 + A + 2L − L2 + N(0, 1), with pi∗(L) = expit(−4 +
1.5
√|L|+ 0.75L+ 0.5|L|1.5) in the second experiment, pi∗(L) = expit(−2 + 2 sin(2L)) in the
third experiment, and pi∗(L) = expit(−0.5 + sin(2L) − 0.5 cos(3L) − 0.25L2) in the fourth
and fifth experiment. In all experiments, linear outcome working models were used. Second
and third order logistic propensity score working models were used in the first three and last
two experiments, respectively. Table 4.3.3 shows the bias and empirical standard deviation of
the ordinary least squares estimates with (OLS-A) and without (OLS-U) adjustment for L, the
G-estimator (G), the IPW-estimator with (IPW-S) and without (IPW) stabilized estimation of
the propensity score, the regression doubly robust IPW estimator with (RDR-S) and without
(RDR) stabilized estimation of the propensity score and the doubly robust IPW estimator with
maximum likelihood estimation of the outcome working model and with (DR-S) and without
(DR) stabilized estimation of the propensity score. The results demonstrate that in the absence
of model misspecification (i.e. simulation experiment 1), stabilized estimation of the propensity
score improves the finite-sample bias of the IPW estimator and yields a minor efficieny gain,
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although an efficiency loss for the doubly robust estimators. In the presence of model misspec-
ification, major improvements in both the bias and precision of (doubly robust) IPW estimators
are observed. In particular, for the considered data-generating mechanisms, no bias was ob-
served despite all working models being misspecified. The fourth and fifth experiment used
the same data generating models, but ϕ(L) = (1, L, |L|1.5, L2) in (4.7) and (4.8) in the fourth
experiment and ϕ(L) = (1, L, |L|2, L3) in the fifth experiment.
Exp 1 Exp 2 Exp 3 Exp 4 Exp 5
Estimator Bias SD Bias SD Bias SD Bias SD Bias SD
OLS-U 1.856 0.39 0.503 0.37 0.821 0.34 0.974 0.23 0.974 0.23
OLS-A -0.002 0.18 -1.685 0.32 0.000 0.22 0.308 0.16 0.308 0.16
G -0.009 0.2 0.002 0.16 -0.154 0.23 -0.063 0.11 -0.063 0.11
IPW 0.151 0.45 -0.285 0.32 -1.716 1.86 -0.123 0.82 -0.123 0.82
RDR -0.005 0.28 -0.126 0.24 -0.363 0.20 0.014 0.30 0.014 0.30
DR -0.006 0.29 -0.115 0.86 -4.863 122.51 -1.879 43.72 -1.879 43.72
IPW-S 0.028 0.42 0.003 0.19 0.361 0.50 0.027 0.13 0.043 0.15
RDR-S -0.001 0.37 -0.027 0.21 -0.019 0.19 0.023 0.12 -0.004 0.12
DR-S -0.001 0.37 -0.027 0.21 -0.044 0.18 0.022 0.12 0.000 0.12
Table 4.2: Simulation results: empirical bias and standard deviation in 5 simulation experiments.
4.4 Discussion
Modern procedures for marginal causal effects (see e.g. Section 4.3.2) require working mod-
els for the outcome and/or exposure, but their complexity does not affect the interpretability
of the final effect estimand. The desire to use parsimonious models is therefore not so much
stimulated by the need for obtaining interpretable results, but rather by concerns of bias and in-
efficiency which may result from overfitting. Two caveats are in place, however. First, while the
possibility of bias resulting from overfitting is well understood for conditional effects (cfr. the
Neyman-Scott paradox), to the best of our knowledge, the extent to which it affects the estima-
tion of marginal effects remains to be evaluated. Second, it has been documented that efficiency
gains may be realized when a priori knowledge is available that given covariates are only associ-
ated with the exposure, but have no residual association with outcome (Hahn, 2004). However,
MODEL SELECTION IN CAUSAL INFERENCE 4-29
in practice, such a priori information is rarely, if ever, available. Without such information, data-
driven decisions must be made to exclude covariates from the analysis and it is unclear under
what conditions the additional uncertainty induced by these selection approaches still enables a
meaningful efficiency gain.
Most strategies used by practitioners to select confounders are based on excluding potential
confounders from the analysis when they are non-significantly associated with the outcome con-
ditional on the exposure; some focus on associations with the exposure instead. Such strategies
are sub-optimal for various reasons. First, since confounders are by definition jointly associated
with exposure and outcome, the importance of a variable as a confounder must ideally be judged
against criteria that involve both associations. Second, even when for a given variable both as-
sociations are assessed, their significance is not directly informative about the extent to which
adjusting for this variable will reduce confounding bias and, ultimately, improve the quality of
the exposure effect estimator. Third, even when a more rigorous confounder-selection process is
adopted, it remains difficult to acknowledge the uncertainty resulting from the selection process
into the final inference. By ignoring this, one risks to obtain under-covering confidence intervals.
We have attempted to shed light on these issues and proposed a focused confounder-selection
strategy which aims at minimum mean squared error of the exposure effect estimator. This
strategy is closely linked to one recommended in Brookhart and van der Laan (2006), but com-
putationally more attractive by avoiding the use of cross-validation. Its application overcomes
the aforementioned first two concerns. In particular, when applied to estimators that are consis-
tent under correct specification of a propensity score model, we expect it will overcome the usual
difficulties (Brookhart et al., 2006) in selecting confounders in the propensity score model as the
selection is made in terms of an ‘optimal’ trade-off between bias and efficiency of the exposure
effect estimate and thus will have a tendency to ‘automatically’ exclude covariates that are solely
associated with the exposure and include covariates that are solely associated with the outcome.
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For such estimators, as shown in Section 4.2.6, it also roughly overcomes the third concern in
the sense of retaining confidence validity even when the confounder-selection process is ignored.
In spite of these attractions of focused confounder-selection based on propensity-score adjusted
estimators, several limitations remain and warrant further study. First, the calculation of the
mean squared error relies on estimates obtained from a full model which involves all potential
confounders. Simulation studies are needed to evaluate finite-sample performance when these
estimates are inefficient or biased as a result of overfitting. Second, in small samples, the proce-
dure may choose to exclude potentially important confounders in order to reduce mean squared
error at the expense of a bias, whose magnitude is difficult to assess. Stability plots like Figure
4.2 may help detect whether this occurs; one may use them, for instance, to restrict the procedure
to all submodels that do not generate a bias exceeding a scientifically meaningful magnitude.
Given the aforementioned caveats and limitations of variable-selection, we see much value in the
idea of avoiding confounder-selection by using regularization techniques such as ridge regres-
sion instead. This idea has been much advocated by Greenland (2007, 2008). Further research
is needed to evaluate these contrasting viewpoints in realistic settings involving unmeasured
confounding, missing confounder data and large separation in the confounder distributions of
exposed and unexposed subjects. Perhaps the ideal future lies in an approach whereby the nui-
sance parameters indexing the working models for the association between covariates on the
one hand, and exposure and outcome on the other hand, are estimated as those values that mini-
mize the mean squared error of the exposure effect estimator. Such approach would combine the
benefits of focused confounder-selection and regularization approaches that do not involve selec-
tion, and might improve upon them in various ways. In comparison with confounder-selection
approaches, it would further lower the mean squared error by not being restricted to specific
submodels and, by avoiding repeated model fitting, might enable a more easy assessment of the
overall uncertainty. In comparison with approaches that involve no selection, it would have the
advantage of directly targeting minimal mean squared error of the exposure effect estimator. It
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is unclear at present whether such approach is attainable.
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Appendix
Assessment of M-bias and bias amplification
Consider the path diagram in Figure 4.1. Let Y ∗, A∗ and L∗ denote standardized (Wright, 1934)
variables corresponding to Y,A and L, respectively. Assume that E(Y ∗|A∗, L∗, U2, U3) =
cA∗+bL∗+c2yU2+c3yU3, thenE(Y ∗|A∗, L∗) = cA∗+bL∗+c2yE(U2|A∗, L∗)+c3yE(U3|A∗, L∗).
Let E(U2|A∗, L∗) = α2L∗ + β2A∗, E(L∗|U1, U2) = c1lU1 + c2lU2 and E(A∗|L∗, U1, U3) =
c1aU1 + c3aU3 + aL∗ Then, proceeding as in Pearl (Pearl, 2010), we have E(U2L∗) ≡ c2l =
α2 + β2ρal and E(U2A∗) ≡ c2la = α2ρal + β2, where ρal = a+ c1ac1l, from which
α2 = c2l
(1− ρ2al + c1ac1lρal)
1− ρ2al
, β2 = −c2l c1ac1l1− ρ2al
.
Likewise, E(U3|A∗, L∗) = −c3aρal/(1− ρ2al)L∗ + c3a/(1− ρ2al)A∗. It follows that
E(Y ∗|A∗, L∗) =
(
b+ c2yc2l
(1− ρ2al + c1ac1lρal)
1− ρ2al
− c3ac3yρal
1− ρ2al
)
L∗
+
(
c− c2yc2l c1ac1l1− ρ2al
+
c3yc3a
1− ρ2al
)
A∗,
and E(Y ∗|A∗) = {(b+ c2yc2l)ρal + c− c2yc2lc1ac1l + c3yc3a}A∗. The bias reported in the
main text is the difference between the coefficient joining A∗ in the above expressions, and the
population causal effect c. It is easy to demonstrate that inverse weighting by 1/f(A∗|L∗) yields
an exposure-outcome covariance equal to
∫
Y Af(Y |A,L)f(L)dY dAdL =
(
c− c2yc2l c1ac1l1− ρ2al
+
c3yc3a
1− ρ2al
)
.
In Figure 4.4, we develop a better understanding of the magnitude of these biases under
the assumption that ρ2, as defined in the main text, is at most ρal. We make this assumption to
respect that, arguably, U3 will have weaker correlations with exposure and outcome than Lwhen
the focus of the study is on assessing the effect of A on Y , as efforts have then been targeted
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at collecting data on common causes of exposure and outcome. We make a similar assumption
for ρ1 to respect the fact that ρ1 indirectly contributes to the magnitude of ρal. The solid line
in Figure 4.4 displays the upper bound (4.1) in a setting where ρ1 = ρal/2 and ρ2 = ρal/3.
It shows that the adjusted analysis will only be more biased than the unadjusted analysis when
the correlation between A and L is extremely large and the correlation between Y and L is
extremely small. We believe this is unlikely to occur in practice. The figure further suggests
that, under the considered scenario, the impact of M-bias (see bottom line in Figure 4.4) is not
much less sizeable than that of unmeasured confounding (see top line in Figure 4.4), although
only of importance for exposure-confounder correlations exceeding 0.5.
0.0 0.2 0.4 0.6 0.8
−
1.
0
−
0.
5
0.
0
0.
5
1.
0
ρal
ρ y
l
ρ1=0 , ρ2=ρal
ρ1=ρal , ρ2=ρal
ρ1=ρal 2 , ρ2=ρal 3
ρ1=ρal , ρ2=ρal 2
ρ1=ρal , ρ2=0
Figure 4.4: Values of ρyl below which the adjusted analysis has larger bias than the unadjusted analysis.
Implementation in standard software
In section 4.2.5 we evaluate the proposed confounder-selection procedure in an observational
study investigating the effect of right heart catherization (RHC) on 180 day mortality in 5735
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critically ill patients (Connors et al., 1996). In total, the confounder space consists of 61 co-
variates (L) or 62 orbits with orbit 1 equal to the narrow model (only intercept and exposure
of interest) and orbit 62 equals the full model (including the 61 confounders together with the
exposure of interest). Throughout the analysis we explore all orbits and select the jth orbit (with
j − 1 confounders) for which the quality (in terms of mean squared error) of the exposure effect
estimator is the best. We start by fitting a marginal model (orbit 1). From orbit 1 we then move
to orbit 2 by selecting 1 covariate that minimizes the MSE of the effect of interest. We transfer
the best covariate to orbit 3. In orbit 3 we choose a second covariate that minimizes the MSE of
the effect of interest. Then, a stochastic search selects at random one covariate which is in the
model and one which is not, and constructs a new model by interchanging both covariates. The
procedure continues until we arrive at the last orbit in which a full model is fitted to the data.
CONFOUNDER  SPACE 
61 covariates
62 orbits
Orbit 1: Narrow model
Jth Orbit
Orbit 62: Full model
Figure 4.5: Exploration of the confounder space
In this section we provide the syntax in R for:
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• The algorithm for the exploration of the orbits and the stochastic search (adapted from
(Crainiceanu et al., 2008)).
• The calculation of the MSE using an asymptotic approximation which can be made under
a local misspecification assumption.
Calculation of the MSE
A framework for this is developed in Hjort and Claeskens (Hjort and Claeskens, 2003) for para-
metric models and adapted to our specific setting. For the calculation of the MSE we wrote a
user friendly function:
MSE=function(design.matrix,full.model,sub.model)
which gives an estimate of the marginal log odds ratio together with a SE and 95% CI. It also
provides the MSE and FIC selection criterium. As an argument from the function one needs to
provide a dataset with all confounders design.matrix.nox , the full model full.model
and a model with a subset of confounders from which one wishes to know the MSE or FIC
sub.model.
What happens inside this function is further explained in the remainder of this section. We
consider the marginal log odds ratio as a focus parameter, which we define as
τ∗ = log
µ1(1− µ0)
µ0(1− µ1)
where µa = E [expit {ω(L; γ∗) + β∗0 + β∗aa}] for a = 0, 1. Denote furthermore
µˆa = n−1
n∑
i=1
[
expit
{
ω(Li; γˆ) + βˆ0 + βˆaa
}]
for a = 0, 1.
4-36 CHAPTER 4
In R, several steps are needed to calculate the the marginal log odds ratio. In a first step we
construct an index sub.ind indicating which confounders are included in the submodel.
sub.ind=(names(design.matrix) %in%
attr(summary(sub.model)$terms,"term.labels")[-1])
Xdat.sub=design.matrix[sub.ind]
In a next step we calculate µa for a = 0, 1 and obtain the marginal log odds ratio MLOR for a
given submodel S.
Xdat_1.sub=cbind(1,1,Xdat.sub)
Xdat_0.sub=cbind(1,0,Xdat.sub)
p1.sub=expit(coef(sub.model)%*% t(Xdat_1.sub))
p0.sub=expit(coef(sub.model) %*% t(Xdat_0.sub))
mu1.sub=mean(p1.sub)
mu0.sub=mean(p0.sub)
MLOR=log((mu1.sub*(1-mu0.sub))/(mu0.sub*(1-mu1.sub)))
Assume, as in Claeskens and Hjort (2003), that the true data density f(Y,A|L) is indexed
by a parameter β∗ = (β∗0 , β∗a)′, which is shared between all models, and γ∗ + δ/
√
n, where
the term δ/
√
n encodes local model misspecification (see Section 4.2.6) and γ∗ is the vector of
values to which the nuisance parameter γ is set in the narrow model (that is, typically γ∗ = 0).
Let further θS ≡ (β, γS)′ and θˆS ≡ (βˆS , γˆS)′. Then we have that for any submodel S, the
corresponding estimator µˆSa of µ∗a (which is defined like µˆa, but with γˆS and βˆS replacing γˆ
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and βˆ, respectively) satisfies
0 =
1√
n
n∑
i=1
expit
{
ω(Li; γˆS , γ∗−S) + βˆS0 + βˆSaa
}
−√nµˆSa
=
1√
n
n∑
i=1
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
aa
}−√nµ∗a
+ E
[
∂
∂θS
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
aa
}]√
n
(
θˆS − θ∗S
)
− E
[
∂
∂γ
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
aa
}]
δ −√n(µˆSa − µ∗a) + op(1)
from which
√
n(µˆSa − µ∗a) =
1√
n
n∑
i=1
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
aa
}− µ∗a
+ E
[
∂
∂θS
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
aa
}]√
n
(
θˆS − θ∗S
)
− E
[
∂
∂γ
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
aa
}]
δ + op(1).
It follows from the Delta method that the influence function (Tsiatis, 2006) for τˆS is Dµ +
dβ
√
n(βˆS − β∗) + dγS
√
n(γˆS − γ∗S)− dγδ, where
dγ =
1
µ∗1(1− µ∗1)
E
[
∂
∂γ
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
a
}]
− 1
µ∗0(1− µ∗0)
E
[
∂
∂γ
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0
}]
Dµ =
1
µ∗1(1− µ∗1)
[
expit
{
ω(Li;ω(Li; γ∗ + δ/
√
n) + β∗0 + β
∗
a
}− µ∗1]
− 1
µ∗0(1− µ∗0)
[
expit
{
ω(Li; γ∗ + δ/
√
n) + β∗0
}− µ∗0] ,
and where dβ and dγS are defined like dγ , but with derivatives taken w.r.t. β and γS , respectively,
rather than γ.
Xdat_1.full=cbind(1,1,design.matrix)
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Xdat_0.full=cbind(1,0,design.matrix)
p1=expit(coef(full.model) %*% t(Xdat_1.full))
p0=expit(coef(full.model) %*% t(Xdat_0.full))
mu1=mean(p1)
mu0=mean(p0)
d_beta=(1/(mu1*(1-mu1)))*mean(p1*(1-p1)*1)
d_int=(1/(mu1*(1-mu1)))*mean(p1*(1-p1)*1)-
(1/(mu0*(1-mu0)))*mean(p0*(1-p0)*1)
d_beta=c(d_int,d_beta)
if(sum(sub.ind)==0){
d_theta=d_beta}
if (sum(sub.ind) !=0){
tmp1.sub=apply(t(as.matrix(as.vector(p1.sub*(1-p1.sub))))*
(Xdat.sub),2,mean)
tmp0.sub=apply(p0.sub*(1-p0.sub)*Xdat.sub,2,mean)
d_gammas=(1/(mu1.sub*(1-mu1.sub)))*tmp1.sub-(1/(mu0.sub*
(1-mu0.sub)))*tmp0.sub
d_theta=c(d_beta,d_gammas)
}
tmp1=apply(p1*(1-p1)*design.matrix,2,mean)
tmp0=apply(p0*(1-p0)*design.matrix,2,mean)
d_gamma=(1/(mu1*(1-mu1)))*tmp1-(1/(mu0*(1-mu0)))*tmp0
D_mu=as.numeric(1/(mu1*(1-mu1))*(p1-mu1)-1/(mu0*(1-mu0))*(p0-mu0))
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VAR_DMU=var(D_mu)
With the information obtained above we can calculate the variance of the marginal log odds
ratio
COV=summary(sub.model)$cov.unscaled
SE=sqrt(VAR_DMU/n + d_theta%*%COV%*%t(t(d_theta)))
CI_95=c(MLOR-1.96*SE,MLOR+1.96*SE)
Using Lemmas 3.2 and 3.3 in Hjort and Claeskens (2003), it can be shown that
√
n(τˆS−τ∗)
converges in distribution to Λ0 + ω′(δ −GSD), where
Λ0 = dβJ−100 M
′ +Dµ
D = δ +Q(N ′ − J10J−100 M ′)
Q =
(
J11 − J10J−100 J01
)−1
ω = J10J−100 dβ − dγ
GS = piS
{
pi′SQ
−1piS
}−1
piSQ
−1
with piS the projection matrix for submodel S (i.e., a matrix of zeros with as many rows
and columns as the dimensions of γS and γ, respectively, and with a 1 on each row in the col-
umn representing the corresponding component of γS), (M ′, N ′) following a mean zero normal
distribution with covariance matrix
J =
 J00 J01
J10 J11
 ,
which is 1 over n times the inverse of the asymptotic covariance matrix of θˆ = (βˆ, γˆ)′. These
expressions rely on θˆ being a maximum likelihood estimator.
COV_full=summary(full.model)$cov.unscaled
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J=solve(COV_full)/n
J00=as.matrix(J[c(1,2),c(1,2)])
J10=as.matrix(J[,c(1:2)][-c(1:2),])
J01=as.matrix(J[c(1:2),][,-c(1:2)])
J11=as.matrix(J[-c(1:2),-c(1:2)])
var_LAMBDA0= d_beta%*%solve(J00)%*%d_beta + VAR_DMU
omega=t(J10%*%solve(J00)%*%as.matrix(d_beta))-d_gamma
Q=solve(J11-(J10%*%solve(J00)%*%J01))
The projection matrix piS the submodel S is calculated as follows:
PM=diag(dim(design.matrix)[2])
diag(PM)=sub.ind*1
PM=as.matrix(PM[apply(PM,1,sum)==1,])
and is used in the calculation of GS
if(sum(sub.ind)==1){
GS=PM%*%solve(t(PM)%*%(J11-(J10%*%solve(J00)%*%J01))%*%PM)%*%
t(PM)%*%(J11-(J10%*%solve(J00)%*%J01))
}
if(sum(sub.ind)==0){
GS=matrix(nrow=length(sub.ind),ncol=length(sub.ind),0)
}
if (sum(sub.ind)>1){
GS=t(PM)%*%solve(PM%*%(J11-(J10%*%solve(J00)%*%J01))%*%t(PM))%*%
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PM%*%(J11-(J10%*%solve(J00)%*%J01))
}
Further, Λ0 can be shown to be uncorrelated with D because M is independent of D by
Lemma 3.3 (Hjort and Claeskens, 2003), and because Dµ is uncorrelated with D by the fact
that (a) Q(N ′ − J10J−100 M ′) is the asymptotic distribution of
√
n(γˆ − γ∗ − δ/√n); and that
(b) the influence functions of γˆ are uncorrelated with Dµ by the fact that the former have mean
zero conditional on L, whilst the latter are functions of L. It now follows that
√
n(τˆS − τ∗) has
limiting mean squared error given by Var(Λ0)+ω′GSQG′Sω+ω
′(I−GS)δδ′(I−GS)′ω. Upon
substituting (Claeskens and Hjort, 2008) δδ′ with max(0, DnD′n−Qˆ), whereDn =
√
n(γˆ−γ∗),
we obtain
Var(Λ0)− ω′Qω + 2ω′GSQG′Sω + ω′(I −GS)DnD′n(I −GS)′ω.
Because the first two terms are common to all models, we employ the remaining terms as a Fo-
cused Information Criterion (Claeskens and Hjort, 2003, 2008), upon substituting all population
values with consistent estimates.
So finally everything is combined and the MSE and FIC are calculated as follows:
Dn=sqrt(n)*parms[-c(1,2)]
delta=Dn%*%t(Dn)-Q
delta1=Dn%*%t(Dn)
VAR= (var_LAMBDA0 + omega%*%GS%*%Q%*%t(GS)%*%t(omega))/n
BIAS2=((omega%*%(diag(dim(GS)[1])-GS)%*%delta1%*%
t((diag(dim(GS)[1])-GS))%*%t(omega)))/n
mse=VAR+BIAS2)
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FIC=2*(omega%*%GS%*%Q%*%t(GS)%*%t(omega)) + ((omega)%*%
(diag(dim(GS)[1])-GS)%*%delta1%*%t((diag(dim(GS)[1])-GS))%*%t(omega))
Orbit selection algorithm
We adapted the algorithm of Crainiceanu et al. (2008) and wrote a function to explore all the
orbits of a model space generated by an outcome and a list of covariates. The orbit can be seen
as the collection of models with the same number of covariates. The function starts from orbit
0 (no additional covariates) and iterates through orbits until the last orbit (containing all the
covariates). Within each orbit the function searches for model which reduces MSE/FIC of the
targeted effect. This is done in two phases. Phase one (the so called Project and Pursuit) is a
greedy search phase. Using the covariates identified on the previous orbit the model is looking
for the one additional covariate that reduces the MSE/FIC of the targeted effect. Phase 2 is a
fuzzy search phase. It starts with the best model identified in the greedy phase. At each step it
uses an MCMC update where any variable can enter or leave the model and again searches for
the model that reduces the MSE/FIC of the targeted effect.
Orbit <- function(n.iterations,family.name, always.in.var,
all.xs, dependent.variable,data,full.model)
n.iterations indicates the number of iterations in the fuzzy phase within each orbit.
The outcome regression family is given by family.name. All regression families accepted by
the glm() function are acceptable. always.in.var gives vector of labels of variables in the
original data set for those variables that are always in the model. It can be NULL. The labels of
the potential confounders which can be selected in each orbit and define the entire model space
that will be explored are given in all.xsand can be in or out of the model. The dependent
variable is given by dependent.variable for the original data set data. Finally in the
calculation of the MSE/FIC a full model is used and defined in full.model. The function to
calculate the MSE/FIC is embedded into the orbit function.
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The full R-code for the functions can be obtained upon request from maarten.bekaert@ugent.be
or stijn.vansteelandt@ugent.be
Model uncertainty
Let U(τ, α) be the estimating function for τ and SS(α) = ∂ log f(A|L;α)/∂αS , where αS is
the subvector of α which is free under model S and α−S is the remaining part. Let τˆS denote the
estimator of τ∗ as obtained under model S, and
∑
S∈A c(S|Dn)τˆS denote the estimator of τ∗
obtained under model selection, where the weight c(S|Dn) assigns 1 to the selected model and
0 to all other models and where A denotes the model space. Under the local misspecification
assumption, we have that (Claeskens and Hjort, 2003)
√
n
{∑
S∈A
c(S|Dn)τˆS − τ∗
}
d→
∑
S∈A
c(S|D)ΛS ,
where ΛS is the limit distribution of
√
n (τˆS − τ∗). Under this assumption, a Taylor series
expansion shows that
0 =
1√
n
n∑
i=1
Ui(τˆS , αˆS , α∗−S)
=
{
1√
n
n∑
i=1
Ui(τ∗, α∗Sn, α
∗
−Sn)
}
+ E
(
∂
∂τ
Ui(τ∗, α∗Sn, α
∗
−Sn)
)√
n (τˆS − τ∗)
+ E
(
∂
∂αS
Ui(τ∗, α∗Sn, α
∗
−Sn)
)√
n (αˆS − α∗Sn)− E
(
∂
∂α−S
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
δ−S + op(1),
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where δ−S is the subvector of δ corresponding to α−S and αSn = αS + δS/
√
n and α−Sn =
α−S + δ−S/
√
n. Likewise, we have that
0 =
1√
n
n∑
i=1
SSi(αˆS , α∗−S)
=
1√
n
n∑
i=1
SSi(α∗Sn, α
∗
−Sn) + E
(
∂
∂αS
SSi(α∗Sn, α
∗
−Sn)
)√
n (αˆS − α∗Sn)
− E
(
∂
∂α−S
SSi(τ∗, α∗Sn, α
∗
−Sn)
)
δ−S + op(1),
from which
√
n (τˆS − τ∗) = E
(
∂
∂τ
Ui(τ∗, α∗Sn, α
∗
−Sn)
)−1 [
− 1√
n
n∑
i=1
{
Ui(τ∗, α∗Sn, α
∗
−Sn)
−E
(
∂
∂αS
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
E
(
∂
∂αS
SSi(α∗Sn, α
∗
−Sn)
)−1
SSi(α∗Sn, α
∗
−Sn)
}
+δ−S
{
E
(
∂
∂α−S
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
− E
(
∂
∂αS
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
×E
(
∂
∂αS
SSi(α∗Sn, α
∗
−Sn)
)−1
E
(
∂
∂α−S
SSi(α∗Sn, α
∗
−Sn)
)}]
+ op(1).
Further, E
{
Ui(τ∗, α∗Sn, α
∗
−Sn)
}
= 0 implies that E
{
∂Ui(τ∗, α∗Sn, α
∗
−Sn)/∂αS
}
equals
−E {Ui(τ∗, α∗Sn, α∗−Sn)SSi(α∗Sn, α∗−Sn)} and likewise for SSi(α∗Sn, α∗−Sn). We thus find that
√
n (τˆS − τ∗) = E
(
∂
∂τ
Ui(τ∗, α∗Sn, α
∗
−Sn)
)−1 [
− 1√
n
n∑
i=1
{
Ui(τ∗, α∗Sn, α
∗
−Sn)
−E {Ui(τ∗, α∗Sn, α∗−Sn)SSi(α∗Sn, α∗−Sn)}E {S⊗2Si (α∗Sn, α∗−Sn)}−1 SSi(α∗Sn, α∗−Sn)}
+δ−S
{
E
(
∂
∂α−S
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
− E
(
∂
∂αS
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
×E
(
∂
∂αS
SSi(α∗Sn, α
∗
−Sn)
)−1
E
(
∂
∂α−S
SSi(α∗Sn, α
∗
−Sn)
)}]
+ op(1),
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where for an arbitrary matrix, A⊗2 ≡ AA′. It then follows that √n{∑S∈A c(S|Dn)τˆS − τ∗}
is
E
(
∂
∂τ
Ui(τ∗, α∗Sn, α
∗
−Sn)
)−1 [
−
∑
S∈A
c(S|D) 1√
n
n∑
i=1
{
Ui(τ∗, α∗Sn, α
∗
−Sn)
−E {Ui(τ∗, α∗Sn, α∗−Sn)SSi(α∗Sn, α∗−Sn)}E {S⊗2Si (α∗Sn, α∗−Sn)}−1 SSi(α∗Sn, α∗−Sn)}
+
∑
S∈A
c(S|D)δ−S
{
E
(
∂
∂α−S
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
− E
(
∂
∂αS
Ui(τ∗, α∗Sn, α
∗
−Sn)
)
×E
(
∂
∂αS
SSi(α∗Sn, α
∗
−Sn)
)−1
E
(
∂
∂α−S
SSi(α∗Sn, α
∗
−Sn)
)}]
+ op(1).
It now follows by the Cauchy-Schwarz inequality that an upper bound to the asymptotic variance
of
√
n
{∑
S∈A c(S|Dn)τˆS − τ∗
}
is the variance of
E
(
∂
∂τ
Ui(τ∗, α∗Sn, α
∗
−Sn)
)−1 1√
n
n∑
i=1
Ui(τ∗, α∗Sn, α
∗
−Sn).
It does not immediately follow that standard confidence intervals based on this conservative
variance estimate will themselves be conservative. This is because
∑
S∈A c(S|Dn)τˆS follows
a mixture distribution with bias components converging at root-n rate to zero. Because mis-
specifications δ of the order 1 over root-n are not consistently estimable (Claeskens and Hjort,
2003), there is little room for further correcting this, unless for instance a doubly robust estima-
tor with correctly specified nuisance outcome working model happens to be used, in which case
uncertainty in the propensity score model does not affect inferences for τ∗.

5
Estimation of natural direct and indirect effects
The work in this chapter is submitted and currently under review. The general idea about the
simultaneous estimation of natural direct and indirect effects using the simple IPW estimator
was independently developed by Theis Lange and submitted as a proof of concept paper. In a
follow up paper, from which this chapter is adapted, we propose additional estimators for the
natural direct and indirect effect which can be simply implemented in standard software.
Summary
Mediation analysis is widely adopted to infer causal mechanism by disentangling indirect or
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mediated effects of an exposure on an outcome through given intermediaries, from the remain-
ing direct effect. Traditional approaches build on standard regression models for the outcome
and mediator, but easily result in difficult-to-interpret or difficult-to-report results when some
of these models involve non-linearities. In this article, we focus on a broad class of so-called
natural effect models whose parameters encode both (natural) direct and indirect effects (medi-
ated through a given intermediary). We propose flexible estimation strategies for the parameters
indexing these models, that are easy to perform with standard statistical software: an inverse
probability weighted estimator, a regression mean imputation estimator and a doubly robust es-
timator. We give a theoretical discussion of the properties of these estimators and assess their
finite-sample performance through a simulation study and through the analysis of the WHO-
LARES study on the association between residence in a damp and moldy dwelling and the risk
of depression.
5.1 Introduction
Researchers in a variety of scientific fields, notably epidemiologists, have a longstanding inter-
est in using empirical studies to disentangle causal pathways by which an exposure or treatment
affects an outcome. Most popular is the use of mediation analysis (MacKinnon, 2008), whereby
an exposure’s effect is decomposed into an indirect effect mediated by a given intermediate vari-
able and the remaining direct effect. Prevailing methods for mediation analysis have their roots
in work by Baron and Kenny (1986), who focused on linear models for the outcome and medi-
ator. Baron and Kenny (1986) proposed estimating the direct effect as the residual association
between outcome and exposure after regression adjustment for the mediator(s). They further
proposed estimating the indirect effect as the product of the exposure’s effect on the mediator
and the mediator’s effect on the outcome, or equivalently, as the difference between the total
effect and the direct effect, where the former refers to the (unadjusted) association between out-
come and exposure, respectively. Both these approaches have subsequently been employed in a
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variety of statistical models other than the linear model and are typically referred to as ‘product
of coefficient methods’ and ‘difference in coefficient methods’ for indirect effects. Despite their
popularity, a theoretical basis beyond the linear model is lacking. Not only may these methods
fail to capture a measure of indirect effect, also the interpretation of the estimates that they return,
is often unclear (see e.g. VanderWeele and Vansteelandt (2009); VanderWeele and Vansteelandt
(2010)).
Robins and Greenland (1992) revolutionized mediation analysis by proposing a generic strat-
egy to decompose a total effect into a so-called pure or natural direct and indirect effect, that
is not tied to a particular statistical model. Under appropriate identification conditions, use of
the so-called mediation formula (Pearl, 2001, 2011) then enables combining arbitrary statistical
models for the outcome and mediator to obtain valid and well-understood measures of direct and
indirect effect (see e.g. VanderWeele and Vansteelandt (2009); VanderWeele and Vansteelandt
(2010); Imai et al. (2010); Lange and Hansen (2011); VanderWeele (2011)). The mediation
formula suggests a generic approach for mediation analysis, but has a number of important lim-
itations. First, the way to compute natural direct and indirect effects, and their standard errors,
can differ substantially depending on the model for the mediator and outcome. Second, even
simple models for the mediator and outcome (e.g. a linear model for the mediator and logistic
regression model for the outcome) tend to produce complex expressions of natural direct and
indirect effects. This can make results difficult to report. In addition, it can make testing for the
presence of a direct or indirect effect essentially impossible, as it generally turns out difficult to
choose models for the outcome and mediator that result in a natural direct effect of zero at all
covariate levels.
van der Laan and Petersen (2008) accommodated this by directly modeling the natural direct
effect of interest. More precisely, because application of the mediation formula to even simple
models for the mediator and outcome typically results in complicated models for the natural
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direct and indirect effect, they instead choose to a priori postulate a parsimonious model struc-
ture for the natural direct effect. Results thereby become simpler for reporting and interesting
hypotheses concerning these effects become easier to test. van der Laan and Petersen (2008)
proposed doubly robust estimators for the direct effect parameters indexing their model, which
require correct specification of a model for the distribution of the mediator (given exposure and
confounders), and for either the distribution of the exposure (given confounders) or the expected
outcome (given mediator, exposure and confounders). Tchetgen Tchetgen and Shpitser (2011)
proposed estimators with greater robustness against model misspecification, which require an
arbitrary 2 out of the 3 models for the exposure, mediator and outcome to be correctly specified.
These approaches are very elegant and appealing; arguably, their relative complexity may be a
barrier to routine application.
The goal of this article is to enhance the accessibility of methods for causal mediation anal-
ysis based on natural direct and indirect effects. We will attempt this by drastically widening the
scope of models (and hence outcome types) which can be dealt with, and by proposing flexible
estimation strategies for natural direct and indirect effects that are easy to perform with standard
statistical software. In particular, we propose a simple regression mean imputation approach
which relies on correct specification of a model for the outcome. In addition, we propose a
doubly robust imputation approach, which relaxes the assumptions of the simple imputation es-
timator by continuing to be valid when the outcome model is misspecified, provided that models
for both mediator and exposure are correctly specified. We further show that the doubly robust
imputation approach can be viewed as a compromise between the simple imputation approach
and an inverse probability weighting approach previously considered by Hong (2010) and Lange
et al. (2011). We give a theoretical discussion of the properties of these estimators and assess
their finite-sample performance through a simulation study and through the analysis of the WHO
LARES study on the association between residence in a damp and moldy dwelling and the risk
of depression.
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5.2 Natural direct and indirect effects
Let A be the observed exposure of interest, M the mediator, C a set of baseline covariates and
Y the outcome. Variables are allowed to be of any type e.g. continuous, binary, categorical, or
survival. Then, as in Robins and Greenland (1992) and Pearl (2001) we will describe direct and
indirect effects in terms of so-called nested counterfactuals, Y (a,M(a∗)), denoting the outcome
that would have been observed if A were set to a and M to the value it would have taken if A
were set to a∗. In particular, we will compare Y (a,M(a∗)) with Y (a∗,M(a∗)) to obtain a
measure of the direct effect of changing the exposure from a to a∗. Such comparison can for
instance be made in terms of an average difference within levels of covariates,E[Y (a,M(a∗))−
Y (a∗,M(a∗))|C], as a risk ratio, P [Y (a,M(a∗)) = 1|C]/P [Y (a∗,M(a∗)) = 1|C], etc. We
will refer to such contrasts as natural direct effects. Likewise we will compare Y (a∗,M(a))
with Y (a∗,M(a∗)) to obtain a measure of the indirect effect, referred to as a natural indirect
effect.
A Y
M
C
Figure 5.1: Causal diagram.
Throughout the article, we will assume that the causal assumptions underlying the causal
diagram of Figure 5.1 hold. In particular, we will assume that the same set of covariates C is
sufficient to control for confounding of the associations between exposure and outcome, expo-
sure and mediator, and mediator and outcome. Specifically, we thus assume that there are no
variables that are effects of exposure and that confound the mediator-outcome relationship. A
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formal description of these assumptions in terms of counterfactuals is for instance given in Van-
derWeele and Vansteelandt (2009). Under these assumptions, it follows from Pearl (2001, 2011)
that E[Y (a,M(a∗))|C = c] can be calculated using the mediation formula:
∑
m
E[Y |A = a,M = m,C = c]P (M = m|A = a∗, C = c). (5.1)
This corresponds to estimating the mean value of the outcome in each stratum defined by medi-
ator and confounders among the individuals with exposure a, but weighting these by the likeli-
hood of each mediator value among individuals with exposure a∗. On the basis of this, natural
direct and indirect effects can be obtained. For instance, if the outcome Y and mediator M
obey linear models, i.e. E[Y |A = a,M = m,C = c] = α0 + α1a + α2m + α3c and
E[M |A = a,C = c] = β0+β1a+β2c, then equation (5.1) greatly simplifies and the natural di-
rect and indirect effects are captured by E[Y (a,M(a∗))− Y (a∗,M(a∗))|C] = α1(a− a∗) and
E[Y (a∗,M(a)) − Y (a∗,M(a∗))|C] = α2β1(a − a∗) (VanderWeele and Vansteelandt, 2009).
However, equation (5.1) lends itself less ideally to non-linear models, where it tends to gen-
erate complicated expressions of natural direct and indirect effects (see e.g. VanderWeele and
Vansteelandt (2010) who find that the combination of a logistic model for the outcome and a
linear model for the mediator tends to generate complicated natural direct effect expressions
depending on covariates, even when the outcome is rare).
5.3 Simultaneous estimation of natural direct and indirect effects
5.3.1 Natural effect models
In this paper, as in Lange et al. (2011), we focus on conditional mean models for nested coun-
terfactuals Y (a,M(a∗)):
g [E {Y (a,M(a∗))|C}] = β′W (a, a∗, C),
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where g(.) is a canonical link function (e.g. the identity or logit link) andW (a, a∗, C) is a known
vector with components that may depend on a, a∗ and C. We term such models ‘natural effect
models’ because they encode the natural direct and indirect effects of interest. For instance, in
model
E[Y (a,M(a∗))|C] = β0 + β1a+ β2a∗ + β3C, (5.2)
β1(a − a∗) captures a natural direct effect and β2(a − a∗) captures a natural indirect effect.
Under model
logit [E {Y (a,M(a∗))|C}] = β0 + β1a+ β2a∗ + β3C + β4a · a∗ + β5a ·C + β6a∗ ·C, (5.3)
we find that the natural direct effect odds ratio
odds {Y (a,M(a∗)) = 1|C}
odds {Y (a∗,M(a∗)) = 1|C} = exp {(β1 + β4a
∗ + β5C)(a− a∗)}
and that the natural indirect effect odds ratio
odds {Y (a,M(a)) = 1|C}
odds {Y (a,M(a∗)) = 1|C} = exp {(β2 + β4a+ β6C)(a− a
∗)} .
Their product measures the total effect: odds {Y (a) = 1|C} /odds {Y (a∗) = 1|C} (Vander-
Weele and Vansteelandt, 2010).
We note that the considered class of natural effect models is richer than the classes of models
considered by van der Laan and Petersen (2008) and Tchetgen Tchetgen and Shpitser (2011).
First, it is richer in the sense that it simultaneously describes natural direct and indirect effects,
rather than separately. Second, it is richer by not being limited to the identity and log links. It
thus in particular enables the analysis of dichotomous outcomes, as in the motivating application
of Section 5.5.
In the following sections, we will discuss three estimation strategies for the parameters index-
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ing the natural effect model. For simplicity, we will focus on dichotomous exposures A taking
values 0 and 1. We will expand on the analysis of general exposures in the discussion section.
5.3.2 Simple IPW-estimator
Generalizing work by Hong (2010), Lange et al. (2011) showed that consistent estimators of the
parameters indexing natural effect models (i.e., estimators which approach the targeted popula-
tion value as the sample size goes to infinity) can be obtained by the following approach, which
is easy to perform in routine software packages:
1. Fit a suitable model for the mediator conditional on exposure and covariates using the
original data set.
2. Create a new data set by repeating each observation in the original data set twice and
including an additional variable A∗, which is equal to the original exposure for the first
replication and equal to the opposite of the actual exposure for the second replication. In
addition, add an id-variable to memorize which pseudo observations originate from the
same subject.
3. Compute a weight
f(M = m|A = A∗, C)
f(M = m|A = A,C)
in each line of the new data set using predict-functionality on the fitted model.
4. Fit the natural effect model of interest by regressing the outcome on A, A∗ and C on the
basis of the expanded data set, weighting the data by the weights from the previous step.
Lange et al. (2011) show that, provided the model for the mediator is fitted using a standard
maximum likelihood procedure, conservative confidence intervals can be obtained as the
estimate of the natural direct or indirect effect plus/minus 1.96 times a robust standard
error, which can be obtained using software for generalized estimating equations.
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The Inverse Probability Weighted (IPW) estimator is appealing for routine use, but its simplicity
may come at a cost. First, the IPW-estimator does not make efficient use of the information in the
data in the sense that more efficient estimators can be constructed under the joint model defined
by the natural effect model together with the model for the mediator. Second, the requirement
of full specification of the conditional mediator distribution can be prohibitive for quantitative
mediators. Third, when the exposure and/or covariates are strongly predictive of the mediator,
or when the mediator is quantitative, then the inverse weights may easily become large for
some subjects, making them very influential in the analysis. This can lead to an inflation of the
standard errors and, more importantly, to unstable estimators with an important degree of finite
sample bias. In particular, it may make the IPW approach of more limited use for the analysis
of continuous mediators. In the following sections, we propose alternative estimators designed
to overcome these limitations.
5.3.3 Simple (regression mean) imputation estimator
The nested counterfactual Y (a∗,M(a)) is only observable when a∗ equals a and, in addition,
a corresponds to the observed exposure level A. When a∗ differs from a, then it can still be
predicted as E(Y |A = a∗,M,C) under a model for the outcome. This can be seen upon noting
that M(a) equals M among subjects with a equalling the observed value A. This thus gives rise
to the following regression mean imputation approach:
1. Fit a suitable model for the outcome conditional on exposure, mediator and baseline vari-
ables using the original data set.
2. Create a new data set by repeating each observation in the original data set twice and
including an additional variable A∗, which is equal to the original exposure for the first
replication and equal to the opposite of the actual exposure for the second replication.
3. Predict the nested counterfactual Y (a∗,M(a)) as Y in those lines of the database where
A equalsA∗ and as the expected valueE(Y |A = A∗,M,C) on the remaining lines, using
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predict-functionality on the fitted outcome model.
4. Fit the natural effect model of interest by regressing the outcome on A, A∗ and C on the
basis of the expanded data set. Standard errors and confidence intervals can be obtained
using the bootstrap (including steps 1-4).
The (regression mean) imputation estimator is appealing for routine use because of its simplic-
ity and avoidance of inverse probability weighting. However, its simplicity may be somewhat
deceptive in that the difficulty in working with the imputation estimator - as with multiple im-
putation estimators for incomplete data analyses - is finding models for the outcome that are
congenial with the natural effects model of interest. Suppose for instance that the model for the
outcome were of the form
E(Y |M,A,C) = α0 + α1M + α2A+ α3C
and the natural effects model of interest were
E[Y (a,M(a∗))|C] = β0 + β1a+ β2a∗ + β3aa∗ + β4C.
Then, under data generating models where M is linear in A, the outcome model would preclude
the existence of interactions between a and a∗ and thus bias β3 towards zero. With concern for
such interactions, the user should therefore work with outcome models which are sufficiently
flexible not to preclude the existence of such interactions. As a guideline, we therefore recom-
mend that the outcome model should at least reflect the structure of the natural effect model,
but with a∗ substituted by M . Thus, given the above natural effects model, the outcome model
should at least contain main effects in A,M and C, as well as the product term A×M .
This concern for the imputation model (i.e., the outcome model) failing to reflect the structure
of the natural effects model gets exacerbated in non-linear models, where it becomes difficult
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or impossible to guarantee coherent model specifications. Noteworthy is that the imputation
estimator - like other imputation estimators (Tan, 2007; Vansteelandt et al., 2010) - may also
be more prone to model extrapolation, primarily in settings where A shows strong associations
with either M or C.
5.3.4 Doubly robust estimator
The foregoing concerns have lead us to consider a third estimator, which could be viewed as a
compromise between both previous approaches:
1. Fit a suitable model for the mediator conditional on exposure and baseline variables using
the original data set.
2. Fit a suitable model for the exposure conditional on mediator and baseline variables using
the original data set.
3. Fit a suitable generalized linear model for the outcome conditional on exposure, mediator
and baseline variables using the standard maximum likelihood procedure, but using the
weights
f(A = 1|C)
f(A = 0|C)
f(M |A = 1, C)
f(M |A = 0, C)
for the unexposed (A = 0) and
f(A = 0|C)
f(A = 1|C)
f(M |A = 0, C)
f(M |A = 1, C)
for the exposed (A = 1).
4. Create a new data set by repeating each observation in the original data set twice and
including an additional variable A∗, which is equal to the original exposure for the first
replication and equal to the opposite of the actual exposure for the second replication.
5. Predict the nested counterfactual Y (a∗,M(a)) as Y in those lines of the database where
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A equalsA∗ and as the expected valueE(Y |A = A∗,M,C) on the remaining lines, using
predict-functionality on the fitted models obtained in step 3.
6. Fit the natural effect model of interest by regressing the outcome on A, A∗ and C on the
basis of the expanded data set. Standard errors and confidence intervals can be obtained
using the bootstrap (including steps 1-6).
In the Appendix, we show that the resulting estimator is a doubly robust estimator of the pa-
rameters indexing the natural effect model. More precisely, it is a consistent estimator of these
parameters when the natural effect model holds and, in addition, either (1) the conditional ex-
pectation of the outcome, given the exposure and confounders, is correctly specified; or (2)
the conditional distribution of the mediator, given the exposure and confounders, and of the
exposure, given confounders, are correctly specified. This double robustness is theoretically
appealing because it implies that incongeniality of the outcome model and the natural effect
model is not of concern when the exposure and mediator models are reasonably well specified.
In addition, it implies that truncation of extreme inverse probability weights - which could be
viewed as a deliberate form of model misspecification - is justified when the outcome model
is reasonably well specified. Note in particular that the simple imputation estimator is attained
upon truncating all weights in the doubly robust estimator to 1.
Table 5.1 summarizes the properties of the considered estimators by indicating under what mod-
els they produce consistent estimators.
Estimator Weighting Imputation Model for
A M Y
IPW Yes No X
IMP No Yes X
DR Yes Yes X X X
Table 5.1: Properties of the simple IPW-estimator (IPW), the simple imputation estimator (IMP)
and the doubly robust (DR) estimator. Crosses (X) indicate what models need to be correctly
specified for the estimator to be consistent.
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5.4 Simulation study
To assess the performance of the three proposed natural direct and indirect effects estimators, a
simulation study with 1000 runs for data sets of 500 observations was performed. We evaluated
all proposed estimators as well as the more traditional estimators based on the product of coeffi-
cient method and difference in coefficient methods for the indirect effect. Standard errors were
obtained using the nonparametric bootstrap (1000 resamples) and the coverage of 95% standard
normal approximation bootstrap confidence intervals is reported. In all simulation experiments,
the natural effects model of interest was correctly specified.
5.4.1 Continuous outcome and binary mediator
The first setting focuses on a continuous outcome and binary mediator. In particular, C was
generated from a standard normal distribution. A binary exposure A and mediator M were
drawn from a binomial distribution with P (A = 1|C) = expit(0.25 + 0.5C) and P (M =
1|A,C) ≡ pi(A,C) = expit(−0.5 + A + C). The outcome Y was generated from a normal
distribution with mean
E(Y |A = a,M = 0, C = c) = β0 + β1a+ β3c− β2pi(0, c)
pi(1, c)− pi(0, c)
E(Y |A = a,M = 1, C = c) = β0 + β1a+ β3c+ β2 {1− pi(0, c)}
pi(1, c)− pi(0, c)
and variance equal to 2. In the appendix we show that these models were chosen to result in a
simple natural effects model of the form E[Y (a,M(a∗))|C] = β0 + β1a+ β2a∗ + β3c, which
can be verified upon applying the mediation formula.
Table 5.2 and 5.3 show simulation results for a settings with natural direct effect β1 = 0.5
and natural indirect effect β2 = 0.1. In the first simulation experiment (Table 5.2), we fitted
correctly specified models for the exposure and mediator, but misspecified the model for the
outcome which we chose to be linear with main effects in A,M and C. The weights corre-
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Estimator Estimate SE Variance bias2 MSE Coverage
DE Regression 0.49 0.10 0.011 1 10−4 0.011 0.94
IPW 0.50 0.10 0.012 0 0.012 0.94
Imputation 0.49 0.10 0.011 1 10−4 0.011 0.93
DR 0.51 0.11 0.015 1 10−4 0.015 0.94
IE Product 0.48 0.15 0.022 0.002 0.024 0.18
Difference 0.11 0.040 0.002 1 10−4 0.002 0.96
IPW 0.10 0.042 0.002 0 0.002 0.94
Imputation 0.11 0.040 0.002 1 10−4 0.002 0.96
DR 0.10 0.075 0.007 0 0.007 0.95
Table 5.2: Results from setting 1, simulation experiment 1: direct effect (DE) = 0.5, indirect
effect (IE) = 0.1, correctly specified model for A and M .
sponding to the IPW (min. 0.4, median 1, max. 2.5) and the doubly robust estimator (min.
0.2, median 0.6, max. 5) were very stable. In the second experiment (Table 3) we additionally
misspecified the models for the mediator by using the probit link rather than the logit link.
In the first experiment, all estimators perform well, with the exception of the doubly robust
estimator of the indirect effect, which has large variance due to the relatively less stable weights.
The regression mean imputation estimator is identical to the standard (difference of coefficient)
estimator based on regression adjustment for the mediator. However, a large bias is found in the
product of coefficient method for the indirect effect as a result of this strategy being essentially
limited to linear models for both outcome and mediator. Interestingly, neither the regression
mean imputation estimator nor the doubly robust estimator of the indirect effect are biased, in
spite of misspecification of the outcome model. Similar conclusions are obtained in the second
experiment in spite of misspecification of the mediator model, which harmfully affected only
the variance of the doubly robust estimator.
5.4.2 Binary outcome and continuous mediator
The second setting focuses on a binary outcome and continuous mediator. In particular, a binary
exposure A was drawn from a binomial distribution with P (A = 1|C) = expit(γ0 + γ1C)
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Estimator Estimate SE Variance bias2 MSE Coverage
DE Regression 0.49 0.10 0.011 1 10−4 0.011 0.94
IPW 0.49 0.11 0.015 1 10−4 0.012 0.94
Imputation 0.49 0.10 0.011 1 10−4 0.011 0.93
DR 0.51 0.12 0.017 1 10−4 0.017 0.93
IE Product 0.29 0.089 0.008 0.0008 0.008 0.44
Difference 0.11 0.040 0.002 1 10−4 0.002 0.96
IPW 0.10 0.042 0.002 0 0.002 0.95
Imputation 0.11 0.040 0.002 1 10−4 0.002 0.96
DR 0.11 0.093 0.010 1 10−4 0.01 0.95
Table 5.3: Results from setting 1, simulation experiment 2: direct effect (DE) = 0.5, indirect
effect (IE) = 0.1, correctly specified model for A but misspecified model for M .
with γ = (0.25,−0.5). The continuous mediator M was drawn from a normal distribution
with E(M |A,C) = α0 + α1A + α2C with α = (1, 3,−5) and variance σ2 = 1. The binary
outcome Y was drawn from a binomial distribution with P (Y = 1|A,M,C) = Φ(β0 + β1A+
β2M + β3C), with β = (0.5, 0.1,−0.05, 0.5) where Φ(.) refers to the cumulative standard
normal distribution function. It is can be verified upon applying the mediation formula that this
choice of models entails a natural effects model of the form
P [Y (a,M(a∗)) = 1|C] = Φ (θ′0 + θ′1a+ θ′2a∗ + θ′2C)
where
θ′0 =
θ0 + θ2α0√
1 + β22σ2
θk =
θk√
1 + β22σ2
,
for k = 1, 2, 3.
The weights corresponding to the IPW estimator (min. 1.2 10−6, median 1, max. 391) and
the doubly robust estimator (min. 9.1 10−7, median 0.01, max. 455) were very unstable. Be-
cause of unstable weights, estimators based on inverse probability weights are presented both
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Estimator Estimate SE Variance bias2 MSE Coverage
DE Regression 0.099 0.23 0.055 1 10−6 0.23 0.95
IPW 0.093 6.4 1014 0.33 4.9 10−5 0.33 1
IPWtrunc 0.028 0.17 0.061 5.2 10−3 0.17 0.79
Imputation 0.098 0.23 0.055 4 10−6 0.055 0.95
DR 0.11 2.23 0.61 1 10−4 0.61 1
DRtrunc 0.10 0.35 0.20 0 0.20 0.88
IE Product -0.15 0.19 0.037 1 10−4 0.037 0.95
Difference -0.15 0.19 0.037 1 10−4 0.037 0.95
IPW -0.13 6.5 1014 0.31 4 10−4 0.31 1
IPWtrunc -0.074 0.087 0.041 5.8 10−3 0.041 0.58
Imputation -0.14 0.19 0.037 1 10−4 0.037 0.95
DR -0.16 2.22 0.56 1 10−4 0.56 1
DRtrunc -0.15 0.32 0.19 0 0.19 0.89
Table 5.4: Results from setting 2: all models correctly specified with and without truncated
weights. DE and IE are simulated to be 0.1 and -0.15 respectively
with and without truncation of the weights at a maximum of 10 (max) and a minimum of 0.1. Re-
sults in table 5.4 show that the IPW-estimator has little bias which may be due to the large sample
size, but that it is very inefficient as a result of extreme weights. Truncating the weights pays off
in terms of efficiency, but at the expense of a large bias because weight truncation can be viewed
as a form of misspecification of the model for the mediator. This is not the case for the doubly
robust estimator as a result of the additional robustness of this estimator against model misspec-
ification. However, this estimator does not compete well with the regression mean imputation
estimator, which is much more efficient here. The standard regression approach performs very
well (not surprisingly, because it uses the data-generating models and because
√
1 + β22σ2 ≈ 1).
With concern for model incongeniality, we additionally evaluated a setting where we chose
the model for the outcome to be a logistic regression model. The results in Table 5.5 show that,
interestingly, this does not affect the adequate performance of the regression mean imputation
estimator.
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Estimator Estimate SE Variance bias2 MSE Coverage
DE Imputation 0.095 0.23 0.055 4 10−6 0.055 0.94
DR 0.11 2.3 0.59 1 10−4 0.59 1
DRtrunc 0.10 0.35 0.19 0 0.19 0.88
IE Imputation -0.14 0.19 0.037 1 10−4 0.037 0.95
DR -0.15 2.3 0.55 0 0.56 1
DRtrunc -0.14 0.32 0.19 0 0.19 0.89
Table 5.5: Results from an experiment with a misspecified model for the outcome. DE and IE
are simulated to be 0.1 and -0.15 respectively
Table 5.6 shows additional results from a setting with very strong mediator-outcome rela-
tionship (β2 = 1) resulting in
√
1 + β22σ2 = 1.41. The corresponding direct and indirect effect
were equal 0.35 en 2.12 respectively. The weights corresponding to the IPW estimator (min. 2.5
10−6, median 1, max. 215) and the doubly robust estimator (min. 1.8 10−8, median 0.01, max.
208) were again very unstable.
Estimator Estimate Variance bias2 MSE
DE Regression 0.52 0.29 0.03 0.32
IPW 1.15 0.64 0.64 1.28
IPWtrunc 1.53 0.30 1.38 1.68
DR 0.51 0.88 0.02 0.90
DRtrunc 0.42 0.41 0.004 0.42
Imputation 0.38 0.15 0.001 0.15
IE Product 3.19 0.41 1.14 1.55
Difference 2.03 0.12 0.01 0.13
IPW 1.73 0.45 0.15 0.60
IPWtrunc 1.06 0.08 1.14 1.21
DR 2.15 0.41 0.001 0.41
DRtrunc 2.22 0.20 0.01 0.21
Imputation 2.18 0.07 0.003 0.07
Table 5.6: Results from the setting with a strong mediator-outcome relationship. DE and IE are
simulated to be 0.35 and 2.12 respectively
Due to noncollapsibility, the regression estimator based on the product of coefficients is
severely biased. The simple IPW estimator for the direct and indirect effect has now a large bias
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(even without truncation of the weights) and is very inefficient. The doubly robust estimator
performs pretty well after trunctation of the extreme weights. But again, in terms of the MSE,
the imputation based estimator performs the best and actually extremely well compared to the
other estimators.
5.5 Data analysis
We re-analyze data of 5882 adult respondents from the WHO-LARES study (Shenassa et al.,
2007; VanderWeele and Vansteelandt, 2010), which investigated the association between resi-
dence in a damp and moldy dwelling and the risk of depression. Interest lies in whether the effect
of residence in a damp and moldy dwelling (A) on depression (Y ) is mediated by perception of
control over one’s home or mold-related physical illness, measured on a 5-point Likert scale
(reverse coded) (M ). A large set of potential confounders C is available on city of residence,
survey respondent characteristics (age, gender, marital status, education, employment, smoking,
and environmental tobacco smoke at home) and housing characteristics (ownership, size, tenure,
crowding, ventilation, natural light, and heating).
Tables 5.10, 5.11 and 5.12 in the Appendix show the results of a logistic regression model for the
outcome, mediator and exposure. They show differences in depression rates and in perception
of control over one’s home or mold-related physical illness between different cities of residence,
by respondent characteristics age, gender marital status, education and environmental tobacco
smoke, and by housing characteristics crowding and natural light.
For simplicity, we first focus on the natural effects model given by
logitP {Y (a,M(a∗)) = 1|C} = β0 + β1a+ β2a∗ + β3C.
The estimates of the natural direct and indirect odds ratios corresponding to the different esti-
mators based on models as in Table 5.10, 5.11 and 5.12 are given in Table 5.7. Both the IPW-
estimate and the imputation-based estimate suggest that the natural direct and indirect effect of
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Estimator OR 95% CI P-value
Direct effect Regression 1.36 1.10 to 1.68 0.0048
IPW 1.35 1.10 to 1.67 0.0049
Imputation 1.35 1.10 to 1.67 0.0048
DR 1.32 1.05 to 1.65 0.018
Indirect effect Product 1.05 1.03 to 1.08 < 0.0001
Difference 1.05 1.03 to 1.08 0.0001
IPW 1.05 1.03 to 1.08 < 0.0001
Imputation 1.06 1.03 to 1.08 0.0001
DR 1.07 1.01 to 1.13 0.021
Table 5.7: Estimates of the natural direct and indirect effect corresponding to different estimation
procedures.
the presence of dampness or mold exposure on the odds of depression amounts to odds ratios
e0.30 = 1.35 (95% CI 1.10 to 1.67, P 0.005) and e0.053 = 1.06 (95% CI 1.03 to 1.08, P< 0.001),
respectively. That is, if none of the residents were to reside in a damp and moldy dwelling, then
the effect of residence in damp and moldy dwelling would be to increase the odds of depression
with 35% if they were to maintain their perception of control over one’s home. Furthermore,
if all of the residents were to reside in a damp and moldy dwelling, then the effect of changing
their perception of control over one’s home to what it would be if they were not to reside in such
a residence, would be to reduce the odds of depression with 6%. Note that conservative stan-
dard errors and confidence intervals based on the IPW-estimate can be directly obtained from
software for generalized estimating equations and were found to be exactly the same here as the
bootstrap confidence intervals. The DR-estimates of the natural direct and indirect odds ratio
differ slightly: 1.32 (95% CI 1.05 to 1.65, P 0.018) and 1.07 (95% CI 1.01 to 1.13, P 0.021),
respectively. The weights corresponding to the IPW estimator (min. 0.46, median 1, max. 2.15)
were more stable that those corresponding to the DR estimator (min. 0.026, median 0.60, max.
19.1).
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We finally fitted the natural effects model given by
logitP {Y (a,M(a∗)) = 1|C} = β0 + β1a+ β2a∗ + β3C + β4aC + β5a∗C,
and found, using the IPW estimator, the magnitude of the natural direct effect to depend on
the number of residents per room and the strength of the natural indirect effect to depend on
the amount of natural light (see Table 5.8). The interaction of the natural direct effect with the
number of residents per room was also found by the imputation and the doubly robust estimator
(see Table 5.9). The evidence for the natural indirect effects interaction disappeared when using
the regression imputation estimator and the doubly robust estimator based on previous model
for the outcome (see Table 9 for corresponding p-values). This is because this outcome model is
not congenial with the natural effect model in the sense that it excludes such interactions. Upon
extending the outcome model by including interactions of A with the number of residents per
room and of M with the amount of natural light , the p-values of corresponding interactions
decreased a bit but were not significant due to inefficient parameter estimates. This underscores
the importance of choosing the model for the outcome in a way that is congenial with the final
analysis model.
Interaction Level OR 95% CI P-value
Direct effect
Crowding <0.5 2.04 1.40 to 2.98 0.0002
0.51-1 1.06 0.80 to 1.41 0.68
> 1 per room 1.35 0.91 to 2.02 0.13
Indirect effect
Light enough 1.10 1.06 to 1.15 < 0.0001
not enough 1.04 1.01 to 1.06 0.005
Table 5.8: IPW estimates of the natural direct and indirect effect with confounder-interactions.
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C Level IPW Imputation DR
Direct effect Crowding < 0.5 0.006 0.006 0.003
Crowding 0.51 to 1 0.14 0.13 0.12
Indirect effect Light Enough 0.019 0.17 0.28
Table 5.9: P-values for the interactions of direct and indirect effect with baseline covariates C
5.6 Discussion
In this paper, we have focused on so-called natural effect models, whose parameters encode the
natural indirect effect of an exposure on an outcome, through a given mediator, and the remain-
ing natural direct effect. We have reviewed and proposed estimators for the parameters indexing
these models based on inverse probability weighting, or imputation, or a combination of both.
For pedagogic purposes, we have explained the approach for generalized linear natural effect
models, including linear, loglinear and logistic models, although the IPW-estimator and the sim-
ple imputation estimator extend to other types of models, such as parametric survival models.
The proposed doubly robust estimator is essentially confined to generalized linear natural effect
models, but the results in the Appendix show how such estimators may be obtained for a wider
class of models. Noteworthy is that confounding adjustment in all considered approaches is
based on regression adjustment, and thus that the natural effect models must include all relevant
confounders, even when their association with the outcome is not of immediate interest.
All proposed estimators are easy to obtain using standard statistical software, but differ in terms
of their properties. The simple IPW-estimator does not make efficient use of the information in
the data and can suffer instability when some subjects in the analysis get assigned large weights.
While weight truncation may improve stability, this may come at the expense of bias. The simple
imputation estimator avoids inverse weighting and thereby tends to give more precise estimators.
However, it requires more care in choosing an adequate imputation model and may overstate the
precision of the resulting estimators by ignoring extrapolation uncertainty. From a theoretical
point of view, the doubly robust imputation estimator seems a useful compromise: it is valid
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when either the imputation model, or both the exposure and mediator models are correctly spec-
ified. In large samples, it may thus turn out to be less sensitive to bias resulting from truncation
of the inverse probability weights, as well as to bias resulting from the lack of a coherent model
specification. However, simulations studies and the data analysis have demonstrated that its
practical utility may be more limited because the inverse probability weights that it relies upon
tend to be much less stable than those employed by the simple IPW-estimator. Furthermore, the
asserted property of double robustness may be somewhat illusory (Robins and Rotnitzky, 2001)
because correct specification of the exposure and mediator model may anyway be essential in
the face of incoherent model specification. In this respect, the estimators of van der Laan and
Petersen (2008) and Tchetgen Tchetgen and Shpitser (2011) promise a more guaranteed robust-
ness against model misspecification, but rely on similar inverse probability weights and will thus
likely suffer the same instability.
Our recommendation is to use the simple imputation estimator for routine analysis. We make
this recommendation in view of the foregoing discussion, the empirical simulation findings, and
the fact that the concerns about model incongeniality may be relatively lenient if one is careful
to make the imputation model sufficiently flexible - as also confirmed in the simulation studies.
Note for instance that concerns about model incongeniality are much more conspicuous in the
widely adopted multiple imputation strategies for the analysis of incomplete data, where the im-
putation model typically not just refers to the outcome distribution, but to the high-dimensional
distribution of outcomes and covariates. We do believe that the simple IPW-estimator and the
doubly robust estimator are valuable, but primarily to confirm that similar results are obtained
upon relying on different models.
Our development has been confined to dichotomous exposures. For continuous exposures, we
recommend changing the second step of the imputation algorithm as follows: create a new data
set by repeating each observation in the original data set K times and including an additional
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variableA∗, which is equal to the original exposure for the first replication and equal to a (differ-
ent) random draw from the conditional exposure distribution, given C, for all K − 1 remaining
replications. While K is ideally as large as possible, computational resources will restrict the
maximum number that can be chosen in any given application. In future work, we will in-
vestigate whether this recommendation can be improved with a view towards both statistical
efficiency and computation time.
In summary, we have proposed and evaluated procedures for mediation analysis that are easy
to perform with standard software. We hope that the flexibility of the procedures for handling
arbitrary mediators and outcomes, as well as their simplicity, will aid to make inference for
natural direct and indirect effects accessible to a wider audience.
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Appendix
Derivation of the doubly robust estimator
In this section, we will explain how to obtain doubly robust estimators of the parameters indexing
the more general natural effects model
E {Y (a,M(a∗))|C} = m(a, a∗, C;β),
where m(a, a∗, C;β) is a known function, smooth in an unknown finite-dimensional parameter
β.
We start with a sketch of the derivation of the set of influence functions (Newey, 1990) for
β in the above model, which is closely related to the derivation given in Tchetgen and Schpitser
(2011). First note that
m(a, a∗, C;β) =
∫
E(Y |A = a,M = m,C)f(M = m|A = a∗, C)dm,
and let a and a∗ be fixed values for now. Taking derivatives along one-dimensional parametric
submodels, indexed by t, we obtain
0 =
∫ ∫
yf(Y = y|A = a,M = m,C)f(M = m|A = a∗, C)
× {Sy(y|A = a,M = m,C) + Sm(M = m|A = a∗, C)} dydm,
where Sy(y|A = a,M = m,C) and Sm(M = m|A = a∗, C) are the scores corresponding to
the components f(Y = y|A = a,M = m,C) and f(M = m|A = a∗, C), respectively. Note
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that
∫ ∫
yf(Y = y|A = a,M = m,C)f(M = m|A = a∗, C)Sy(y|A = a,M = m,C)dydm
=
∫ ∫ ∫
y
I(A = a)
f(A = a|C)
f(M = m|A = a∗, C)
f(M = m|A = a∗, C)Sy(y|A = a,M = m,C)
× f(Y = y,M = m,A|C)dydmdA
=
∫ ∫ ∫
{y − E(Y |A = a,M = m,C)} I(A = a)
f(A = a|C)
f(M = m|A = a∗, C)
f(M = m|A = a,C)
× Sy(y|A = a,M = m,C)f(Y = y,M = m,A|C)dydmdA
=
∫ ∫ ∫
{y − E(Y |A = a,M = m,C)} I(A = a)
f(A = a|C)
f(M = m|A = a∗, C)
f(M = m|A = a,C)
× {Sy(y|A = a,M = m,C) + Sm(M = m|A = a,C) + Sa(A = a|C)}
× f(Y = y,M = m,A|C)dydmdA,
and
∫
E(Y |A = a,M = m,C)f(M = m|A = a∗, C)Sm(M = m|A = a∗, C)dm
=
∫ ∫
E(Y |A = a,M = m,C) I(A = a
∗)
f(A = a∗|C)Sm(M = m|A = a
∗, C)
× f(M = m,A|C)dmdA
=
∫ ∫
{E(Y |A = a,M = m,C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C)Sm(M = m|A = a
∗, C)
× f(M = m,A|C)dmdA
=
∫ ∫ ∫
{E(Y |A = a,M = m,C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C)
× {Sy(y|A = a,M = m,C) + Sm(M = m|A = a,C) + Sa(A = a|C)}
× f(Y = y,M = m,A|C)dydmdA.
We conclude from both these expressions that for each one-dimensional parametric submodel,
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the score U = Sy(y|A = a,M,C) + Sm(M |A = a,C) + Sa(A = a|C) satisfies
0 = E
[
U
{
{Y − E(Y |A = a,M,C)} I(A = a)
f(A = a|C)
f(M |A = a∗, C)
f(M |A = a,C)
+ {E(Y |A = a,M,C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C)
}
|C
]
,
for each a, a∗. It is now immediate from Theorem 2.4 in Newey (1990) that all influence func-
tions under the mediation model for fixed a and a∗ are given by
da,a∗(C)
[
{Y − E(Y |A = a,M,C)} I(A = a)
f(A = a|C)
f(M |A = a∗, C)
f(M |A = a,C)
+ {E(Y |A = a,M,C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C)
]
,
where da,a∗(C) is an arbitrary index function. Because the mediation model is a union model
corresponding to all possible choices a and a∗, all influence functions under the mediation model
for arbitrary a and a∗ are given by
∑
a
∑
a∗
da,a∗(C)
[
{Y − E(Y |A = a,M,C)} I(A = a)
f(A = a|C)
f(M |A = a∗, C)
f(M |A = a,C)
+ {E(Y |A = a,M,C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C)
]
.
It follows from the above that for binary A taking the values 0 and 1, all influence functions
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for β are of the form
d0,0(C)
I(A = 0)
f(A = 0|C) {Y −m(0, 0, C;β)}
+ d0,1(C)
[
I(A = 0)
f(A = 0|C)
f(M |A = 1, C)
f(M |A = 0, C) {Y − E(Y |A = 0,M,C)}
+
I(A = 1)
f(A = 1|C) {E(Y |A = 0,M,C)−m(0, 1, C;β)}
]
+ d1,0(C)
[
I(A = 1)
f(A = 1|C)
f(M |A = 0, C)
f(M |A = 1, C) {Y − E(Y |A = 1,M,C)}
+
I(A = 0)
f(A = 0|C) {E(Y |A = 1,M,C)−m(1, 0, C;β)}
]
+ d1,1(C)
I(A = 1)
f(A = 1|C) {Y −m(1, 1, C;β)} .
Writing
da,a∗(C) = f(A = a∗|C)d∗a,a∗(C),
we obtain,
I(A = 0)d∗0,0(C) {Y −m(0, 0, C;β)}
+ I(A = 0)d∗1,0(C) {E(Y |A = 1,M,C)−m(1, 0, C;β)}
+ I(A = 1)d∗0,1(C) {E(Y |A = 0,M,C)−m(0, 1, C;β)}
+ I(A = 1)d∗1,1(C) {Y −m(1, 1, C;β)}
+
I(A = 0)f(A = 1|C)
f(A = 0|C)
f(M |A = 1, C)
f(M |A = 0, C)d
∗
1,0(C) {Y − E(Y |A = 0,M,C)}
+
I(A = 1)f(A = 0|C)
f(A = 1|C)
f(M |A = 0, C)
f(M |A = 1, C)d
∗
0,1(C) {Y − E(Y |A = 1,M,C)} .
In the proposed procedure, d∗a,a∗(C) is taken to be the vector of covariates appearing in the
outcome model, including 1 for the intercept. The impact of the second step of the proposed
algorithm is then to set the sample average of the last 2 lines in the above expression equal to
zero. The parameters of interest can now be estimated by setting the sample average of the
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remaining components in this expression to zero and solving for β. It is easily seen that this
amounts to the proposed imputation procedure in lines 3-5 of the proposed algorithm.
Demonstration of double robustness
In this section, we confirm that the proposed estimation strategy yields a doubly robust: estima-
tor. The development is again similar to that in Tchetgen and Schpitser (2011). Suppose first
that the outcome model for Y is correctly specified. Then
E
[
{Y − E(Y |A = a,M,C)} I(A = a)
f(A = a|C)
f(M |A = a∗, C)
f(M |A = a,C)
+ {E(Y |A = a,M,C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C) |C
]
= E
[
{E(Y (a,M(a∗))|A = a,M(a∗), C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C) |C
]
= E
[
{E(Y (a,M(a∗))|A = a∗,M,C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C) |C
]
= E
[
{E(Y (a,M(a∗))|A = a∗, C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C) |C
]
= E
[
{E(Y (a,M(a∗))|C)−m(a, a∗, C;β)} I(A = a
∗)
f(A = a∗|C) |C
]
= 0,
which confirms the unbiasedness of the estimating functions. Suppose next that the models for
M and A are correctly specified, then with E˜(Y |A = a,M,C) denoting the possibly misspeci-
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fied model,
E
[{
Y − E˜(Y |A = a,M,C)
} I(A = a)
f(A = a|C)
f(M |A = a∗, C)
f(M |A = a,C)
+
{
E˜(Y |A = a,M,C)−m(a, a∗, C;β)
} I(A = a∗)
f(A = a∗|C) |C
]
= E
[{
E(Y |A = a,M,C)− E˜(Y |A = a,M,C)
} I(A = a)
f(A = a|C)
f(M |A = a∗, C)
f(M |A = a,C)
+
{
E˜(Y |A = a,M,C)−m(a, a∗, C;β)
} I(A = a∗)
f(A = a∗|C) |C
]
=
∫ {
E(Y (a,M(a∗))|C)−
∫
E˜(Y |A = a,M,C)f(M |A = a∗, C)dM
}
I(A = a)
f(A = a|C)dA
+ E
[{
E˜(Y |A = a,M,C)−m(a, a∗, C;β)
} I(A = a∗)
f(A = a∗|C) |C
]
= E(Y (a,M(a∗))|C)−
∫
E˜(Y |A = a,M,C)f(M |A = a∗, C)dM
+
∫
E˜(Y |A = a,M,C)f(M |A = a∗, C)dM −m(a, a∗, C;β) = 0,
which shows that the estimating functions maintain their unbiasedness.
R-code for the data analysis
In the first step of the analysis we fit models for the outcome, mediator and exposure. For the
outcome and exposure we defined logistic regression models:
my <- glm(Y ˜ A + M + C , family = binomial)
ma <- glm(A ˜ M + C , family = binomial)
and a linear regression model for the mediator:
mm <- lm(M ˜ A + C)
The IPW-estimator of the natural direct and indirect effect odds ratio is obtained from a
model:
model_final = glm(Y ˜ A + Astar + C, family=binomial,data=newDAT,
weights=W)
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where the dataset newDAT is constructed by repeating each observations in the original data
set twice with an additional variable Astar, which is equal to the original exposure for the
first replication and equal to the opposite of the actual exposure for the second replication. The
weights W are obtained as follows:
W = as.numeric(dnorm(M,M_ASTAR,summary(mm)$sigma)/dnorm(M,fitted(mm),
summary(mm)$sigma))
where M is the observed mediator value and M Astar is a prediction from the model for the
mediator with A=Astar and calculated as:
M_ASTAR=predict.lm(mm,newDAT)
The standard error, can be obtained via the bootstrap or software for generalized estimating
equations by fitting the final model with the geeglm() procedure (from the geepack pack-
age) with an independence working correlation instead of the glm() procedure.
The mean imputation estimator is obtained by constructing a new outcome variable Ynew
which is equal to the observed outcome if A = a∗ and equal to E(Y |A = a∗,M,C) if A 6= a∗:
Ynew=ifelse(newDAT$A==newDAT$Astar,newDAT$Y,predict.glm(my,newDAT,
type=c("response")))
This outcome is then used in next model
model_final.imp = glm(Ynew ˜ A + Astar + C, family=binomial,
data=newDAT)
The standard error, can be obtained via the bootstrap
The doubly robust estimator uses a weighted model for the outcome:
myDR <- glm(Y ˜ A + M + C , family = binomial,weights=WDR)
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with corresponding weights WDR equal to:
WDR = as.numeric((A*pA0*f0)/(pA1*f1) + ((1-A)*pA1*f1)/(pA0*f0))
where
pA1=fitted.values(model_A)
pA0 = 1-pA1
f1=as.numeric(dnorm(M,newdat$M_ASTAR[newdat$Astar==1],
summary(mm)$sigma))
f0=as.numeric(dnorm(M,newdat$M_ASTAR[newdat$Astar==0],
summary(mm)$sigma))
Based on the weighted model for the outcome, we construct a new outcome variable YnewDR
which is equal to the observed outcome if A = a∗ and equal to E(Y |A = a∗,M,C) if A 6= a∗:
YnewDR=ifelse(newDAT$A==newDAT$Astar,newDAT$Y,
predict.glm(myDR,newDAT,type=c("response")))
The new outcome is then used in the model
model_final.DR = glm(YnewDR ˜ A + Astar + C, family=binomial,
data=newDAT)
The standard errors of the three estimators can be, can be obtained via the bootstrap. Before we
can perform a bootstrap we need to define a function which embeds the analysis.
anal1 <- function(data,index){
dat=data[index,]
#fit working models
model_Y =glm(Y ˜ A + M + C,family=binomial,data=dat)
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mm <- lm(M ˜ A + C,data=dat)
model_A =glm(A ˜ C=binomial,data=dat)
newdat=rbind(dat,dat)
newdat$Astar=c(rep(1,dim(dat)[1]),rep(0,dim(dat)[1]))
#!! rename Astar to A
newdat$M_ASTAR=predict.lm(mm,newdat)
newdat$W = as.numeric(dnorm(newdat$M,newdat$M_ASTAR,summary(mm)$sigma)/
dnorm(newdat$M,fitted(mm),summary(mm)$sigma))
pA1=fitted.values(model_A)
pA0 = 1-pA1
f1=as.numeric(dnorm(dat$M,newdat$M_ASTAR[newdat$Astar==1],
summary(mm)$sigma))
f0=as.numeric(dnorm(dat$M,newdat$M_ASTAR[newdat$Astar==0],
summary(mm)$sigma))
WDR = as.numeric((dat$A*pA0*f0)/(pA1*f1) + ((1-dat$A)*pA1*f1)/
(pA0*f0))
model_YDR =glm(Y ˜ A + M + C,weights=WDR,family=binomial,data=dat)
#do the imputations
newdat$YstarnoW=predict.glm(model_Y,newdata,type=c("response"))
newdat$YnewnoW=ifelse(newdat$A==newdat$Astar,newdat$Y,
newdat$YstarnoW)
newdat$YstarDR=predict.glm(model_YDR,newdata,type=c("response"))
newdat$YnewDR=ifelse(newdat$A==newdat$Astar,newdat$Y,
newdat$YstarDR)
#fit the final models
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model_final = glm(Y ˜ A + Astar + C ,family=binomial,
data=newdat, weights=W)
model_finalimp = glm(YnewnoW ˜ A + Astar + C ,family=binomial,
data=newdat)
model_finalDR = glm(YnewDR ˜ A + Astar + C,family=binomial,
data=newdat)
#save the estimates of intrest
c(model_Y$coeff[2], model_Y$coeff[3]*mm$coeff[2],
\diamondmodel_Ytot$coeff[2]-model_Y$coeff[2],
model_final$coef[2], model_final$coef[3],
model_finalimp$coef[3],model_finalimp$coef[2],
model_finalDR$coef[3],model_finalDR$coef[2])
}
The bootstrap itself is done as follows:
library(boot)
b1 <- boot(anal1,data = dataset,R=1000)
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Estimator Level OR 95% CI P-value
Dampness and mold 1.36 1.10 to 1.67 0.0040
Perception control 1.31 1.19 to 1.43 < 0.0001
Age 1.02 1.01 to 1.03 < 0.0001
Sex Women 1.63 1.34 to 1.99 < 0.0001
Crowding > 1 per room 1
< 0.5 0.95 0.74 to 1.22 0.68
0.51-1 1.42 1.02 to 1.99 0.040
Light enough 1.29 1.04 to 1.59 0.017
City Angers 1
Bonn 0.66 0.34 to 1.25 0.21
Bratislava 1.92 1.17 to 3.21 0.012
Budapest 2.41 1.50 to 3.98 0.0004
Ferreira 4.08 2.62 to 6.58 < 0.0001
Forli 1.00 0.61 to 1.69 0.99
Geneva 1.01 0.54 to 1.85 0.97
Vilnius 1.64 1.03 to 2.67 0.041
Marital status married 1
separated 1.34 1.02 to 1.74 0.032
single 0.91 0.67 to 1.23 0.55
Education primary 1
secondary 0.86 0.67 to 1.11 0.25
higher 0.49 0.35 to 0.68 < 0.0001
Env. tobacco smoke 1.54 1.26 to 1.88 < 0.0001
Table 5.10: Results from logistic outcome regression model.
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Estimator Level OR 95% CI P-value
Dampness and mold 1.22 1.15 to 1.28 < 0.0001
Age 0.99 0.99 to 1.00 < 0.0001
Crowding > 1 per room 1
< 0.5 1.33 1.25 to 1.41 < 0.0001
0.51-1 1.71 1.56 to 1.87 < 0.0001
Light enough 1.11 1.04 to 1.17 0.0007
City Angers 1
Bonn 0.73 0.65 to 0.81 < 0.0001
Bratislava 1.05 0.94 to 1.17 0.42
Budapest 0.60 0.53 to 0.67 < 0.0001
Ferreira 1.10 0.98 to 1.24 0.11
Forli 0.93 0.83 to 1.03 0.17
Geneva 0.97 0.86 to 1.10 0.64
Vilnius 1.14 1.02 to 1.26 0.019
Marital status married 1
separated 1.08 1.00 to 1.17 0.055
single 1.37 1.27 to 1.47 < 0.0001
Education primary 1
secondary 1.10 1.02 to 1.18 0.016
higher 1.11 1.02 to 1.20 0.016
Smoke > 15 cigarettes 1
No 1.02 0.94 to 1.10 0.65
Occasionally 1.00 0.92 to 1.08 0.92
5-15 cigarettes 1.13 1.04 to 1.23 0.0043
Home type 1.13 1.05 to 1.22 0.0008
Table 5.11: Results from logistic mediator model.
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Estimator Level OR 95% CI P-value
Age 0.99 0.99 to 1.00 0.0002
Crowding > 1 per room 1
< 0.5 1.66 1.43 to 1.93 < 0.0001
0.51-1 3.18 2.58 to 3.94 < 0.0001
Light 1.28 1.12 to 1.47 0.0003
City Angers 1
Bonn 0.54 0.42 to 0.70 < 0.0001
Bratislava 0.26 0.20 to 0.35 < 0.0001
Budapest 0.32 0.25 to 0.43 < 0.0001
Ferreira 2.93 2.11 to 4.07 < 0.0001
Forli 0.96 0.76 to 1.23 0.76
Geneva 0.32 0.24 to 0.42 < 0.0001
Vilnius 0.41 0.31 to 0.52 < 0.0001
Marital status married 1
separated 1.06 0.88 to 1.27 0.56
single 0.78 0.66 to 0.93 0.0059
Home type 1.82 1.53 to 2.17 < 0.0001
Home size 150m2 1
0m2-49m2 0.82 0.69 to 0.98 0.029
50m2 - 99m2 0.61 0.49 to 0.76 < 0.0001
100m2-149m2 0.53 0.38 to 0.72 < 0.0001
Ventilation free 1
No 0.71 0.60 to 0.84 0.0001
Forced 0.88 0.76 to 1.01 0.062
Heating 1.71 1.40 to 2.08 < 0.0001
Table 5.12: Results from logistic exposure model.
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General Conclusion
During my four years of research I have tried to find an answer to the question if patients die
with or from infection by:
1. Developing a new method which acknowledges the complex feedback relationship be-
tween severity of illness and infection and additionally takes into account the fact that
patients who are discharged from the ICU are not comparable with those still in the ICU
at that time.
2. Applying the method in the ICU-literature with the goal to convince physicians that the
complex nature of ICU-data requires innovative statistical methods for analysis.
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3. Bringing our message to the people (society) outside academia
In the final chapter of this thesis I look back at the challenges, achievements and some difficulties
I have faced. I also give a general overview how the insights from the model selection and
mediation part of my theses relate to the developed methodology for the analysis of ICU-data
and finally I also point out some possible directions for future research and ways to further
improve the estimation of the attributable mortaltiy of nosocomial infection.
It is not always about being right...
To me, an important achievement of this thesis is that, at some level, we have been able to con-
vince a number of medical experts that a more accurate answer to the question if patients die
with or from infection, requires acknowledging the dynamic relationship between severity of
illness and infection using a causal analysis. We not only addressed the problem from a method-
ological point of view but directly introduced and applied our newly developed method into the
ICU-literature. The key factor in the whole process was the close collaboration between statis-
ticians and physicians with a strong belief in statistics and a lot of bedside experience in the ICU.
An important thing I have learned is that it is not always about being right (gelijk hebben)
but actually a matter of proving right (gelijk krijgen). In my opinion, statistical research is (too)
often about being right. With mathematical proofs and simulations one can show that a newly
developed method performs better than e.g. a standard approach. Once this is achieved, there is
a certain chance that this will result in a publication in the statistical literature. Some theoreti-
cal developments can have a major impact and are necessary steps in the development of other
methods. But some methods, like ours, are explicitly developed to answer practical (medical)
questions. For that reason, it was important that after acceptance in the statistical literature (a
matter of being right) we had a strategy to convince ICU-experts (a matter of proving right) that
causal analysis is required to answer questions about the attributable mortality of nosocomial
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infection. This was a very difficult but nevertheless important and very interesting step because
if one is not able to convince researchers of the need for state-of-the-art statistical methodology,
then the hard work invested in the development of the methods is somewhat lost.
Skepticism about causal inference.
The steps that were taken from the development of the methodology to the successful application
in the ICU-literature were not without difficulties. The first step in this process was a letter to
the editor of Intensive Care Medicine (Bekaert et al., 2010a) where we joined Wolkewitz et al.
(2009) that statistical analysis should respect the time dependent nature of exposures, such as
infection, but emphasized that the analysis of time-varying exposures also calls for specialized
methods of confounder control which could be found in the field of causal inference. In their
reply (Wolkewitz et al., 2010) the authors gave the message that, in an ICU-setting, a causal
analysis is not appropriate because of the need for additional assumptions. In fact, also at a
more general level, causal analyses were often criticized for the assumptions which they expli-
cate. Many researchers then use more standard associational analysis instead, but nevertheless
conclude with a causal interpretation of the results. Not only are such analyses hiding the neces-
sary causal assumptions, the assumptions required for a causal interpretation to be justified are
also typically much stronger. In a causal analysis which appropriately adjusts for confounding
by including more detailed information about the daily health condition of the patients, the typi-
cal no unmeasured confounders assumption (which is also made by standard analysis) becomes
more likely to be satisfied. Note furthermore that, an association is of little account when no
causal interpretation can be given, because the relevant scientific question is a causal one: do
patients die from (i.e., due to) or with infection?
Personally I have the feeling that to many people (statisticians) who are not familiar with causal
inference think that it is only about the development and use of very complex methods involving
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weights and other fancy estimation procedures. In the ICU-setting, a causal analysis is mainly
about confounding adjustment (see chapter 5 for another focus) which in simple settings can be
done using standard regression techniques. In more complex settings (like ours) standard regres-
sion approaches fail to appropriately account for confounding so we need to use more complex
(non-standard) methods. A major difference between a standard analysis and a causal analysis
is that researchers in causal inference explicitly think and communicate about the assumptions
they made. Every statistical analysis which aims for a causal interpretation assumes e.g. that all
confounders for the exposure-outcome relationship are measured or that e.g the treatment or ex-
posure is randomized so that confounding can be ignored. This is no more than the unmeasured
confounders assumption necessary to link the observed data to the counterfactuals (see chapter
1 for a detailed description). A second important assumption in causal inference is the consis-
tency assumption which, in our nosocomial infection setting states that, if we were able to do an
intervention in which it was possible to prevent infection for all, this would be a non-invasive
one in which it would have the same consequences as if the patients would naturally prevent
infection. Or, if we could infect patients, this would have the same effect on their outcome as
they would naturally acquire infection.
Actually, the most important phase in the analysis is the one before the analysis of the data,
where we think about the data generating mechanism and how plausibly the assumptions are
met. In this first step, it is important to distinguish confounders from e.g. mediators. Expert
knowledge about the scientific topic is very important because the rest of the analysis relies on
this step. Therefore a close collaboration between statisticians and physicians with a lot of ex-
pertise and bedside experience with nosocomial infections and the link with underlying severity
of illness is very important and played an important role in this thesis.
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Causal inference in the ICU-literature
At the end of 2009 a review from Melsen et al. (2009) concluded that their remains much con-
troversy about the estimation of the attributable mortality of VAP. In an editorial (Muscedere,
2009) on the matter it was stated that ”Because observational data in regard to the attributable
mortality of VAP are all that we will ever have, studies of more methodological rigor are re-
quired if we are going to answer this important question.” Keeping this in mind, we have tried
to convince a number of ICU-experts about the need of more sophisticated statistical methods
and published a study with more methodological rigor in the world’s leading intensive care unit
journal. During that process, we found a good balance between the methodological and medical
relevant messages.
Personally I am very glad to read the conclusion of the most recent review on the attributable
mortality of VAP (Timsit et al., 2011) which stated that: ”Classical statistical analyses of VAP
attributable mortality have ignored the aforementioned issues of time-dependent confounding
and empirical results are therefore highly controversial, with several studies reporting estimates
for mortality ranging from neutral to severely harmful. To address these problems, many innova-
tive statistical approaches have been proposed that would shed new light on our understanding
of the role of VAP in ICU mortality and maximal efforts should be made for promoting their
uses among statisticians and clinicians and their appearance in medical journals.” A goal of
this thesis was to convince ICU-experts that the complex nature of ICU-data requires innovative
statistical methods for analysis. I am glad that I can end my four years of research with a high
quality medical publication and above message published in the ICU-literature. On the other
hand it would not be fair to claim that we already achieved our goal because the critical reader
will notice that Prof. Timsit is, as a VAP and ICU-expert, also one of the coauthors of our med-
ical paper. An important strategy in the process from being right to proving right is to convince
the right people so that they can further spread our message.
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Bringing our message to the people.
… …
February 2009 August 2011
In 2009, it was estimated (Vrijens et al., 2009) that nosocomial infections in Belgium have
an excess mortality of 2625 deaths per year and excess costs for the healthcare payer of nearly
400e million per year. These numbers are estimated from observed data without taking into
account the dynamic (time-dependent) relationship between severity of illness and infection.
Without appropriate confounding control one is estimating associations instead of causal rela-
tionships. Nevertheless, the message was brought as a causal one and got a lot of media attention
(see e.g. a press release on February 2009 in ’De Standaard’).
After the publication of our medical paper a next and final step was the communication of our
message outside academia because our results suggested that the numbers from the earlier report
were overestimating the attributable mortality of nosocomial infection. Although we could not
give a more accurate estimate for the earlier published numbers we were able to bring our main
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message that there is a difference in patients dying with or from infections depending on their
underlying severity of illness evolving over time. (see e.g. a press release on August 2011 in
’De Standaard’).
After four years of working on the topic, I somewhat have the feeling that my mission is com-
pleted: we started with an important medical question, we developed a new statistical method-
ology, introduced it in the ICU-literature to answer the question and brought our main message
outside academia.
Combining the insights from all methodological developments
In this thesis we worked on three methodological topics from the field of causal inference:
1. In chapter 2 we developed a method to estimate the causal effect of a time varying expo-
sure in the presence of competing risks. Because our focus was mainly on the cumulative
incidence function (CIF) we used a marginal structural model approach to model the sub-
distribution hazard (instead of modeling the cause specific hazard).
2. In chapter 4 we developed a model selection procedure which directly targets the qual-
ity of the causal exposure effect estimator. Additionally we studied the impact of model
misspecification the so-called G-estimators and inverse probability weighted (IPW) esti-
mators of a causal effect.
3. In chapter 5 we moved the focus to the estimation of natural direct and indirect effects
and developed three estimators: a simple IPW-estimator, a doubly robust version and an
imputation based estimators which doesn’t involve weighting.
The method developed in chapter 2 and applied in chapter 3 is a two step approach in which
the first step involves a model for infection conditional on the time varying severity of illness
indicators. A stepwise selection procedure was used to select the severity of illness indicators
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which were associated with infection. Based on this model, weights were calculated and used
to fit a marginal strucutural model for the subdistribution hazard. In a next step the cumulative
incidence function (CIF) was calculated and the attributable mortality, which was here the effect
estimand of interest, was then calculated as the population attributable fraction. In fact, the best
way to fit the models for the weights is unclear and was the main motivation to developed a model
selection procedure which focuses on the quality of the causal estimate of interest. In chapter
4 of this thesis we explored the ideas in a simple setting but it would theoretically possible to
directly target the quality of the attributable mortality in terms of the mean squared error (MSE).
The confounder space would consist of all possible time varying severity of illness indicators
which can be possibly included in the model for the weights. In every orbit, the covariate is then
selected which minimizes the MSE of the estimated population attributable fraction. Because
we are not directly modeling the quantity of interest, several steps are involved in the estimation
of it, and need to take into account in the calculation of the variance and the bias of our quantity
of interest:
• The population attributable fraction is calculated from the cumulative incidence function;
• The cumulative incidence function is calculated from the subdistribution hazard under a
marginal structural model;
• The weights used in the marginal structural model are calculated based on a model for the
exposure;
In the calculation of the variance of the attributable mortality we took into account all these
steps by using the theory of estimating equations. The major challenge is that the methodology
and the calculation of the MSE and FIC has only been developed so far for maximum likelihood
estimators. This means that additional theoretical work is needed to extend the estimation of
the FIC to a setting based on estimating equations because it will not be feasible to translate
the whole estimation problem into a likelihood based approach (Robins et al., 1999). From a
practical point of view I see several potential problems. The combination of the orbit selection
GENERAL CONCLUSION 6-9
algorithm with the algorithm to extend the dataset with all potential infection regimes will be
computationally very intensive.
The estimator of the causal effect of infection is called an IPW-estimator because it involves
weights. When those weights are highly variable those estimators may perform very badly and
can be very inefficient. The strategy we used was to stabilize the weights via the use of semi
parametric theory. This resulted in a more efficient estimator. Another possibility is the devel-
opment of a doubly robust estimator, as in chapter 5, for the causal effect of a time varying
exposure in the presence of competing risks. Such estimator would be protected against some
model misspecification in one of both working models (for the exposure or the outcome). Using
the property of a doubly robust estimator we can then truncate extreme weights and obtain more
efficient estimators of the effect of interest without worrying about the misspecification of the
model for the weights. As we saw in chapter 5 the imputation estimator of the natural direct and
indirect effect, which was obtained after extreme truncation of the weights (setting all weights
to 1) performed very well. The development of such estimators in the context of the more could
be an additional topic for future research.
Further research
Future collaborations between statisticians and physicians
One conclusion of this thesis is that a close collaboration between statisticians and physicians
can be beneficial for both parties. We were able to introduce our methodological ideas from
the statistical into the ICU-literature and they were able to bring an important medical message.
The success of state-of-the art statistical methods for confounding adjustment completely relies
on the quality of the data. Current surveillance systems have important limitations such as in-
accurate, incomplete and partly retrospective data, resulting in labour-intensive analysis and a
limited integration of the information regarding the matching of the nosocomial infection with
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the associated microbiology, given antibiotics and underlying severity of illness. The future lies
in the detailed translation of the health condition, in terms of physio-pathology and therapeutic
treatment, of the patient into high quality, longitudinal data used as a source for appropriate sta-
tistical techniques.
One example is the COSARA project leaded by prof. dr. Johan Decruyenaere from the Ghent
University hospital. COSARA stands for Computer-based Surveillance and Alerting of Noso-
comial Infections, Antimicrobial Resistance and Antibiotic Consumption in the Intensive Care
Unit. With the use of state-of-the-art ICT, the system completely automates the surveillance
of nosocomial infections and is able to give alerts if alarming trends occur in the incidence of
nocosomial infections, in the incidence of specific multi-resistant microorganisms or in the use
of antimicrobial drugs. Besides giving the alert itself, it is able to generate automatically all
information needed to interpret an alert easier. The cornerstone of COSARA is the ICU Patient
Infectious Agent (IPIA), responsible for collecting on a daily basis all necessary information on
the patient level. The IPIA is completely integrated in the already high-advanced ICU computer-
ization. To ensure the quality of the data by daily compliance of the intensivist, IPIA will offers
the physician important decision making support during his/her daily observations. The data
from such innovative surveillance systems are extremely useful and make it possible to obtain
further insights into the complex relationship of infection and underlying severity of illness.
Our method is not only useful to estimate the attributable mortality of nosocomial infections.
It can be applied to every time dependent exposure (e.g. effect of noninvasive ventilation (NIV),
DNR-codes) in the presence of complex feedback relationships between the exposure and time
dependent confounders (severity of illness) in the presence of competing risks (ICU-setting with
discharge as the competing event for ICU mortality). We mainly worked on the attributable
mortality but other very interesting directions are to estimate attributable length of stay (LOS)
in the ICU together with the attributable costs.
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Extending the existing methodology to the estimation of the attributable mortality
of VAP
Improvements can be done from two point of views. From a methodological point of view a dou-
bly robust estimator for the causal effect of time varying exposures in the presence of competing
risks could be derived and implemented in the software. An advantage of such estimators is that
they are, at some level, protected against model misspecification of one of the working models
for infection or mortality (see chapter 5 for an application in a more simple setting of direct and
indirect effects). One major improvement is needed in terms of the computational efficiency. In
our analysis, the marginal structural model for the subdistribution hazard is fitted using a pooled
logistic regression model in which the data is structured as one-line-per-patient-day. Because
every patient contributes several potential infection regimes some data extension is needed and
resulted for our example of 4479 patients in a final dataset of more than 2.5 million lines. Anal-
ysis of more patients over a longer follow up period would exceed the memory boundaries of R.
One possible solution lies in the use of multiple imputation. For those who are discharged we
know that they are compatible with several hypothetical infection regimes. Instead of extending
the data with all possibilities we may randomly impute one possible infection regime. By doing
so, we construct a dataset in which every patient is observed until death (the event of interest) or
the end of follow up (for those who were discharged). If we repeat the analysis several times we
can summarize the estimates by simply averaging all obtained estimates. In the calculation of
the variance the between and within imputation variability is taken into account as in multiple
imputation for missing data (Rubin, 1987).
In the discussion of chapter 3 we give an overview of the limitations of the existing method
(and a lot of other standard approaches). Marginal structural models model the causal effect of
a time dependent exposure on the distribution of treatment-specific counterfactual outcomes of
interest. It is a marginal model and the adjustment for time varying severity of illness indica-
tors is done by using weights which are obtained from the first step of the analysis. There is a
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strong belief that the infection effect depends on the evolution of severity of illness or antibiotic
treatment. These relationships can be modeled by statistical interactions. However marginal
structural models do not allow for interactions with time dependent covariates. If one is e.g.
interested in the impact of nosocomial infections caused by different germs it is not appropriate
to divide the population in subgroups defined by the type of germ because infection caused by
a given germ is not a random process. It is e.g. possible that the type of infection is related to
the underlying health status of the patient. What we can do is adjust the weights by additionally
including the probability of acquiring a germ specific infection. The same reasoning holds for
other time dependent characteristics, like appropriate treatment or not.
Another drawback of marginal structural models is that they compare the risk of death between
two hypothetical infection paths in which everybody vs. nobody acquires infection. Such effect
measures can be difficult to interpret because scenarios in which everybody acquires infection
(via a hypothetical intervention) are not realistic. The most relevant intervention is therefore
one where infection would be prevented for all patients and thus our substantive interest lies in
the infection-free path a(0). This is why our definition of attributable mortality compares the
counterfactual CIF under this infection path can be with the observed CIF.
In view of above limitations the future maybe lies in another class of models (structural nested
models) which model the impact of postponing the infection with a day within the infected pa-
tients. For instance, with At and Lt the history of infection and confounders respectively, we
can postulate that, on the logit scale, the difference in mortality risk due to postponing infection
with one day is constant over time:
logitP{Y (at−1 = 0, at = 1) = 1|At−1 = 0, At = 1, Lt}−
logitP{Y (at = 0, at+1 = 1) = 1|At−1 = 0, At = 1, Lt} = β
In the above model the odds of dying would change with exp(β) if infection was postponed with
1 day. If we are able to combine models of this form on different time points t from the time
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to infection until the end of follow up, we can calculate what the risk of dying would have been
if infection would have been prevented for infected patients. Because the model incorporates
time dependent covariates it would be possible to model interaction between infection and these
time dependent confounders (severity of illness). In addition, by quantifying the infection effect
within the infected, they yield possibly more meaningful causal parameters.
Statistical inference for logistic structural models has so far not been developed for longitu-
dinal data and can be a very interesting topic for future research. Recently, Martinussen et al.
(2011) made some progress in developments based on additive hazard models.
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D. (2008): ”Determinants and impact of multidrug antibiotic resistance in pathogens causing
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Bekaert, M., Vansteelandt, S. and Mertens, K. (2010): ”Adjusting for time-varying confounding
in the subdistribution analysis of a competing risk,” Lifetime Data analysis, 16(1) 45-70.
Bekaert, M., Timsit, J.F., Vansteelandt, S., Depuydt, P., Vsin, A., Garrouste-Orgeas, M., De-
cruyenaere, J., Clec’h, C., Azoulay, E. and Benoit, D. (2011): ”Attributable mortality of ventila-
tor associated pneumonia : a reappraisal using causal analysis,” American Journal of Respiratory
and Critical Care Medicine doi: 10.1164/rccm.201105-0867OC.
Bekaert, M., Benoit, D., Decruyenaere, J. and Vansteelandt, S. (2010): ”A note on statisti-
cal association and causality derived from epidemiological ICU data : reply,” Intensive Care
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